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ABSTRACT
The ability of acivicin (AT-125), probenecid, and aminooxyacetic acid 
(AOAA), to ameliorate l-cyano-3,4-epithiobutane (CEB)-induced 
nephrotoxicity and karyomegaly was evaluated by histopathology and 
histomorphometry. Epithelial cell necrosis and karyomegaly were observed 
in the renal proximal tubules at 24 and 48 hours in all of the treated groups 
with the exception of AOAA pretreated rats at 24 hours. A predominant 
urinary metabolite of CEB was identified as the mercapturate, N-acetyl-S- (4- 
cyano-2-thio-l-butyl)-cysteine. Evidence of other urinary metabolites was also 
demonstrated.
The influence of inhibitors on the GSH-enhancing effect of CEB was 
determined through measurement of tissue GSH levels and y-glutamyl- 
cysteine synthetase (GCS) activity. Hepatic and renal GSH levels were 
significantly elevated in rats treated with CEB alone or CEB in addition to any 
of the inhibitors, with the exception of hepatic GSH at 24 hours in probenecid- 
pretreated rats. Renal GCS activity was significantly decreased at 24 hours in 
all of the treated groups with the exception of AOAA-pretreated rats.
Activities of xenobiotic metabolizing enzymes were evaluated. No 
significant alterations were observed in renal or hepatic cytochrome F-450, 
ethoxyresorufin O-deethylase (EROD), pentoxyresorufin O-depentylase 
(PROD), and epoxide hydrolase (EH) activities. Renal and hepatic 
ethoxycoumarin O-deethylase (ECOD) and glutathione S-transferase (GST) 
activities, however, were significantly decreased in rats administered CEB.
These results indicate a protective effect of AOAA against CEB-induced 
nephrotoxicity at 24 hours. AOAA inhibits the formation of a reactive thiol
vii
suggesting that such a metabolite may be responsible for CEB-induced 
nephrotoxicity. The reactive thiol also appears to inhibit renal GCS activity.
The slight but statistically significant decrease in ECOD and GST are of 
questionable biological significance. However, diminished ECOD activity 
may be associated with the anticarcinogenic potential attributed to cruciferous 
vegetables.
Identification of the urinary mercapturate represents detection of a 
unique compound and provides further evidence of the importance of GSH 
conjugation in CEB metabolism.
CHAPTER 1 
INTRODUCTION, LITERATURE REVIEW,
AND OBJECTIVES
Introduction
This review focuses on various constituents of the human diet, 
particularly compounds derived from cruciferous vegetables, that have 
demonstrated anticarcinogenic potential in vitro and in vivo. Though 
compounds derived from cruciferous plants have demonstrated toxic 
effects when fed in high concentrations, these compounds may act as 
potential chernoprotective agents by inducing or inhibiting various 
xenobiotic metabolizing enzymes and enhancing intracellular glutathione 
(GSH) levels.
l-Cyano-3,4-epithiobutane (CEB) has been shown to be derived from 
glucosinolates found in cruciferous vegetables. Previous investigations 
have demonstrated nephrotoxicity as well sustained elevations in renal 
GSH in Fischer 344 rats following administration of CEB (VanSteenhouse, 
et al., 1989). This dissertation research was therefore designed to elucidate 
the mechanism of nephrotoxicity and GSH-enhancing effect of CEB as well 
as the effect of CEB on xenobiotic metabolizing enzymes.
The anticarcinogenic potential of various dietary constituents, the 
influence of these compounds on xenobiotic metabolizing enzymes, and 
the effect of these enzymes on anticarcinogenicity will be reviewed. 
Additionally, the functions, metabolism, and transport of GSH and the 
GSH-enhancing effect and toxicity of cyanoepithioalkanes similar to CEB 
will be described in detail.
1
2Influence of Dietary Constituents 
on Carcinogenesis
It has been estimated that approximately 35% of human cancer in the 
Western world may relate to the diet (Doll, 1992). Statistics such as this 
indicate a necessity for in depth evaluation of dietary constituents. Indeed, 
a myriad of chemical constituents from the human diet have been 
identified as natural carcinogens or anticarcinogens.
Since it has become apparent that complete avoidance of dietary 
carcinogens is realistically impossible, there has recently been an emphasis 
on the elucidation of dietary anticarcinogens. Deliberate consumption of 
anticarcinogens may directly or indirectly counteract the effects of 
carcinogens in the human diet (Ferguson, 1994). More than 500 chemical 
compounds have been evaluated thus far as potential chemoprotective 
agents (Boone et ah, 1992).
Natural cancer chemoprotective agents have been classified as dietary 
inhibitors of mutagenesis or dietary inhibitors of. Mutagenesis is a well- 
defined phenomenon referring to the induction of a permanent 
transmissible alteration in the genetic code (Cotran et a l ,  1989). 
Carcinogenesis, on the other hand, is a complex multistep process 
consisting of at least two stages - initiation and promotion. The 
anticarcinogenic mechanisms of dietary components are usually unclear 
and the inherent complexity of carcinogenesis makes it difficult to pinpoint 
the specific process that is inhibited.
Although initiation is probably synonymous with mutation, an 
antimutagenic agent should not be automatically considered 
anticarcinogenic. Ellagic acid, a plant polyphenol, demonstrated 
antimutagenic potential against benzo(a)pyrene diol epoxide in the Ames
3Salmonella assay and Chinese hamster V79 cells (Wood et al., 1982). In 
v i v o  testing in mice with ellagic acid, however, demonstrated an absence of 
inhibition towards benzo(a)pyrene-induced pulmonary tumors (Chang et  
al., 1985) and a lack of inhibition towards 3-methylcholanthrene-induced 
skin tumor formation (Smart et ah, 1986). Adsorption of ellagic acid to non- 
genetic substances such as proteins and oxidative breakdown of its 
polyphenolic structure may interfere with its effects (Hayatsu et al., 1988).
Many anticarcinogens have demonstrated antimutagenic effects, 
however, and may be generally classified as bioantimutagens or 
desmutagens (Kuroda, 1990). Bioantimutagens or "true" antimutagens, as 
defined by Clarke and Shankel (1975), act on the repair and replication 
processes of damaged DNA. Desmutagens, on the other hand, are defined 
as apparent antimutagens and pertain to any factor that directly inactivates 
mutagens or their precursors.
Mechanisms of desmutagens include binding or adsorbtion of dietary 
mutagens, scavenging of free radicals, and inactivation of chemically 
reactive metabolites (Hartman and Shankel, 1990). Chlorophyllin binds 
planar compounds through the formation of molecular complexes 
(Negeshi et al., 1989) while some dietary fibers adsorb mutagens from 
solution (Roberton et al., 1991). Desmutagens, such as carotenoids and 
retinoids, scavenge free radicals and prevent oxidative damage (Ames,
1983). Finally, desmutagens may inactivate chemically reactive metabolites 
or prevent the formation of reactive species through the induction or 
inhibition of phase I and II biotransforming enzyme systems. The phase I 
and II metabolizing enzyme systems are responsible for the biochemical 
processes that convert lipophilic compounds to more hydrophilic
4metabolites. Lipophilic compounds are more likely to diffuse into cellular 
membranes and become well distributed throughout the body whereas 
hydrophilic compounds are more easily excreted in the urine, bile, feces, 
expired air and perspiration. (Sipes and Grandolfi, 1986).
Although phase I and II enzymes are localized mainly in the liver, 
the literature indicates that every tissue analyzed thus far has demonstrated 
activity towards some xenobiotic. The liver receives blood from the 
splanchnic area which contains not only nutrients but various foreign 
substances, or xenobiotics, as well. These compounds are metabolized by 
the liver prior to release into the systemic circulation. Other tissues 
involved in biotransformation reactions include lung, kidney, intestine, 
skin, and gonads; however, these tissues are limited with respect to the 
diversity of chemicals they can detoxify as compared to the liver (Sipes and 
Gandolfi, 1986).
The need to metabolize various hydrophobic foreign compounds 
presents organisms with a unique challenge. Since it would be impractical 
to produce one enzyme for each compound an organism comes into contact 
with, families and subfamilies of enzymes with generally broad substrate 
specificity are encoded to metabolize a diversity of xenobiotics.
Phase I enzymes are localized primarily in the endoplasmic 
reticulum and inner mitochondrial membrane (Nebert et al., 1982; Black 
and Coon, 1987). These membrane-bound enzyme complexes are readily 
accessible to their lipophilic substrates. Phase I enzymes generally 
participate in oxidation, reduction, or hydrolysis reactions and may add or 
expose functional groups (eg. -OH, -SH, -NH 2 , -COOH) to form hydrophilic 
metabolites (Sipes and Gandolfi, 1986).
5One of the most important and, certainly, the most well-known and 
extensively studied phase I enzyme system is the cytochrome P450 (P450) 
system. This system is less commonly referred to as the polysubstrate 
monooxygenase system or the mixed-function oxygenase system. The 
Nomenclature Committee of the International Union of Biochemistry 
prefers the term "heme-thiolate" protein instead of "cytochrome" for P450 
since these proteins are not "cytochromes" in the true meaning of its 
terminology (Palmer and Reedijk, 1989). "Cytochrome P450" represents the 
original term designated by Sato and Omura (1961).
Sato and Omura (1961) identified an unusual protein in liver 
microsomal (smooth endoplasmic reticulum) fractions capable of carrying 
out mixed-function oxidation reactions. Mixed-function oxidation 
reactions involve the combination of one oxygen atom with two hydrogen 
atoms to form water while the second oxygen atom is incorporated into the 
substrate. This protein was shown to bear a heme group which, when 
bound to a molecule of carbon monoxide (CO), produced an absorbance 
spectrum with a peak at a wavelength of 450 nm. Sato and Omura (1961) 
therefore referred to this hemoprotein as "cytochrome P450".
Coon and Lu (1968) later identified two proteins in rabbit liver 
microsomes involved in the electron-transport chain of the mixed function 
oxidation reaction. These investigators demonstrated that the flow of 
electrons began with NADPH and proceeded to a flavoprotein. The 
electrons were subsequently transferred to the P450 molecule. They 
additionally demonstrated the necessity of phospholipids for the functional 
activity of these proteins. Lu and coworkers (1970) later identified these 
proteins in rat liver.
6The P450 system is actually a membrane-bound coupled enzyme 
complex composed of an NADPH-cytochrome P450 reductase flavoprotein 
and cytochrome P450 molecule. Cytochrome bs and cytochrome bs 
reductase are also associated with this complex.
The substrate for this enzyme system binds to the oxidized form of 
the P450 (Fe+3) molecule to form a substrate-P450 complex. This complex 
initiates the first electron reduction and accepts an electron from NADPH  
or cytochrome bs via NADPH-cytochrome P450 reductase or cytochrome bs 
reductase, respectively. The iron in the P450 is hence reduced to the ferrous 
(Fe+2) state. The ferrous form of the enzyme combines with a molecule of 
oxygen gas, and accepts a second electron from NADPH or cytochrome bs in 
addition to a proton (H+). Heterolytic cleavage of the oxygen molecule 
results in the release of water (H2O) leaving a (FeO) + 3  complex that directly 
oxidizes the substrate (Guengrich, 1993). Although substrate binding 
initiates the catalytic cycle, reduction and cleavage of molecular oxygen is 
rate-limiting (White and Coon, 1980).
Each P450 enzyme appears to be encoded by a separate gene. The few  
exceptions to this rule occur where functional alternative splicing might 
exist (Lacroix et a l,  1990; Lephart et a l ,  1990; Miles et al., 1990; Means et al.,
1991). To date, more than 40 different P450 genes have been identified in 
the rat and at least 20 P450s have been identified in humans (Guengrich,
1993). Though the enzymes are encoded by different genes, many exhibit 
overlapping substrate specificities.
Until recently the classification of P450 genes has been ambiguous 
and inconsistent with investigators utilizing diverse systems of 
nomenclature. Recently, Nebert et al. (1989 and 1991) classified P450 genes
7on the basis of structural and/or evolutionary relationships.
Complementary DNA sequences with at least 40% identity were grouped 
into families and given an Arabic number designating the P450 family (1,2,3 
etc). Sequences within families with at least 60% identity were grouped into 
subfamilies designated with letters (A, B, C, etc.) while individual enzymes 
were given specific Arabic numbers (1, 2, 3, etc.) unless only one gene is 
present within the subfamily. Some confusion remains regarding P450 
nomenclature, however, since the last number may refer in one instance to 
a specific animal species but in other instances may apply to all species 
(Guengrich, 1993). Additionally, cytochrome P450 genes may be given the 
prefix "cyp" for the corresponding gene in mice or "CYP" for genes isolated 
in other species (Nebert et ah, 1991).
As early as the 1950's investigators demonstrated induction 
(upregulation) of cytochrome P450 enzyme activity (Brown et al., 1954). A 
variety of compounds such as drugs, ethanol, substances in cigarette smoke, 
and certain constituents of food have since been found to induce or 
suppress the activity of cytochrome P450 genes (Diaz et a l,  1990; Murray, 
1992; Guengrich, 1993). Each type of inducer increases the synthesis of a 
characteristic range of P450s with each enzyme revealing a distinct, but not 
necessarily unique, substrate and reaction specifity (Guengerich et al., 1982). 
There does not, however, appear to be a close association between the ability 
of a chemical to induce a cytochrome P450 enzyme and its identity as a 
substrate for that particular enzyme.
In 1980, Bresnick demonstrated increased levels of mRNA specific for 
P450 enzymes following administration of phenobarbitol (PB) or 3- 
methylcholanthrene (3MC) to rats. These agents have since been shown to
8differentially induce P450 enzymes with distinct but overlapping substrate 
specificities in a variety of species (Yang and Lu, 1987). 3MC-pretreatment of 
rats caused selective induction of P450 enzymes with spectral and catalytic 
properties distinctly different from the PB-inducible P450s (Lu et al., 1973). 
One of the 3MC-inducible enzymes exhibited high catalytic turnover for 
benzo(a)pyrene and produced an absorbance spectrum with a peak at a 
wavelength of 448 nm instead of 450 nm. This enzyme was thus referred to 
as cytochrome P448. Other terms for this 3MC-inducible enzyme include 
cytochrome Pi-450 and aryl hydrocarbon hydoxylase (AHH; Sipes and 
Grandolfi, 1986).
The polycyclic aromatic hydrocarbons, including 3MC, have since 
been shown to induce the 1A subfamily of P450s whereas PB induces the 2B 
subfamily as well as other subfamilies (Okey, 1990). Interest in the 
regulation of P450s originally stemmed from the observation that 
administration of structurally diverse chemicals resulted in induction of 
one or more distinct P450 enzymes. Various agents have been synthesized 
to serve as model substrates for the assay of microsomal O-dealkylation as a 
measurement of induced P450 enzymes. Liver microsomes from the rat 
and hamster O-deethylated ethoxyresorufin to resorufin in an NADPH-, 0 2 - 
dependent reaction involving NADPH-cytochrome reductase and 
cytochrome P450 (Burke and Mayer, 1974). In both the rat and the hamster, 
ethoxyresorufin O-deethylation was considerably induced by 3MC (50-70 
fold) while its specific activity was induced less than 3-fold by PB. 
Ethoxyresorufin O-deethylase (EROD) activity has, accordingly, been shown 
to be highly selective for 3MC-induced P450 enzymes or the 1A subfamily 
(Guengerich et al., 1982).
9The pentyl homologue of ethoxyresorufin, pentoxyresorufin, appears 
to also be highly selective. In contrast to ethoxyresorufin, pentoxyresorufin 
is selective for PB-induced P450s (Burke and Mayer, 1983) since its activity is 
enhanced following administration of PB. Pentoxyresorufin O-depentylase 
(PROD) activity therefore correlates with induction of the IB subfamily. 
Alternatively, the O-dealkylation of 7-ethoxycoumarin was induced 3-fold 
by 3MC and 7-fold by PB in hepatic microsomes from C57BL/6-J mice 
(Greenlee and Poland, 1978). 7-Ethoxycoumarin O-deethylase (ECOD) 
activity is therefore a measure of induction of both the 1A and 2B 
subfamilies.
The selective induction of P450 enzymes is regulated by the 
expression of P450 genes under the control of a diverse multiplicity of 
regulatory mechanisms. P450 genes may be regulated at the level of 
transcription, processing, mRNA stabilization, translation, or enzyme 
stability in the presence of various inducing agents (Gonzalez et al., 1993).
The mechanism of induction of certain P450 enzymes by polycyclic 
aromatic hydrocarbons has spurred tremendous scientific interest. 
Cytochrome P450 1A1 monoxygenase activity, often measured as aryl 
hydrocarbon hydroxylase (AHH) activity, was induced in certain inbred 
strains of mice (e.g. C57BL/ 6 -J) following administration of SMC, while 
other inbred strains (e.g. D BA /2) failed to respond (Nebert et al., 1972; 
Thom as et al., 1972). The trait, referred to as aromatic hydrocarbon 
responsiveness, was found to be inherited in a simple autosomal dominant 
mode. The locus was designated the "Ah" locus (Thomas et al., 1972). 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a model halogenated aromatic 
hydrocarbon, induced AHH or P450 1A1 activity in all strains of mice tested;
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however, the 3MC-nonresponsive mice required a 10-fold greater dose of 
TCDD as compared to the 3MC-responsive strain (Poland and Glover, 1975). 
It was then discovered that TCDD, as well as other polycyclic aromatic 
hydrocarbons, bind to an "Ah" receptor, a product of the "Ah" locus 
(Poland et al., 1976).
Under normal conditions, the Ah receptor is complexed with a 90 kD 
heat-shock protein (hsp 90) within the cytoplasm (Poland et al., 1976). Once 
TCDD binds to the "Ah" receptor, the hsp 90 is displaced (Pongratz et al.,
1992). The TCDD-receptor complex then binds another protein, the Ah 
receptor nuclear translocator (ARNT) molecule (Reyes et al., 1992), which 
must be phosphorylated to an activated form (Carrier et al., 1992). The 
activated complex then enters the nucleus and binds to a specific region on 
the P450 1A1 gene referred to as the dioxin or xenobiotic regulatory 
element. The activated protein-receptor complex has been shown to bind to 
the regulatory sequence in gel shift and footprinting experiments (Denison 
et al., 1985,1988). Binding of the complex to this enhancer sequence allows 
other proteins to access the promoter region of the gene thereby enhancing 
synthesis of mRNA and inducing the cytochrome P450 1A1 protein. 
Although stimulation of transcription increases P450 mRNA 
concentrations, enhanced mRNA stability has also been shown to elevate 
P450 activity (Kimura et al., 1986).
The mechanism of induction of the P450 2B subfamily as well as 
other subfamilies by PB also occurs through transcriptional activation. To 
date, however, no receptor has been identified in mammals (Waxman and 
Azaroff, 1992).
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Other phase I metabolizing enzyme systems include the amine 
oxidase system, epoxide hydrolase, esterases and aminidases, and alcohol, 
aldehyde and ketone oxidation-reduction systems (Sipes and Gandolfi, 
1986). Amine oxidase is an FAD-flavoprotein, localized in the endoplasmic 
reticulum, capable of oxidizing nucleophilic nitrogen and sulfur atoms. 
Nonspecific esterases and amidases hydrolyze ester or amide linkages, 
respectively. Esterases liberate a carboxyl group and the corresponding 
alcohol while amidases release a carboxyl group and an amine or ammonia. 
Esterases and amidases are localized in both the endoplasmic reticulum and 
the cytosol (Sipes and Gandolfi, 1986).
Alcohol and aldehyde dehydrogenases, aldehyde and ketone 
reductases, and aldehyde oxidase are all involved in the oxidation or 
reduction of aldehydes, ketones, and alcohols produced during the 
oxidation of carbon or hydrolysis of ester linkages. These various enzymes 
have been identified in the endoplasmic reticulum as well as the cytosol 
(Sipes and Grandolfi, 1986).
Epoxide hydrolases have recently been reviewed by Guenther (1990) 
and represent a group of catalytically-related but distinct enzymes that 
catalyze the hydration of arene oxides and aliphatic epoxides to the 
corresponding dihydrodiols. Epoxide hydrolases are believed to have 
evolved as detoxifying enzymes which serve to protect cells from the 
deleterious effects of epoxides or oxiranes formed by virtue of the 
cytochrome P450 enzyme system or lipid peroxidation.
Discrepancies plague the nomenclature of this enzyme. Early 
investigators referred to it as 'epoxide hydratase’ or 'epoxide hydrase*.
When the Nomenclature Committee of the International Union of
12
Biochemistry suggested the enzyme be renamed 'epoxide hydrolase' (EG 
3.3.2.3) in 1978, it was not widely recognized that several forms of epoxide 
hydrolase existed. Two distinct forms of epoxide hydrolase were later 
isolated. One was found primarily within the microsomal fraction and the 
other within the cytosol and have since been referred to as "microsomal 
EH" or "mEH" and "cytosolic EH" or "cEH", respectively (Guenther, 1990).
Inconsistencies in this nomenclature arose, however, when mEH, 
also referred to in the literature as 'mEHb' (Oesch, et al., 1984), 'EHT 
(Guenther and Oesch, 1983), and 'mCSO' (Finley and Hammock, 1988), was 
isolated not only from the endoplasmic reticulum but also from the nuclear 
membrane, plasma membrane and golgi (Stasiecki et al., 1980) as w ell as the 
cytosolic fraction from human liver (Wang et al., 1982) and lung (Guenther 
and Karnazis, 1986). mEH demonstrates a broad substrate specificity and 
catalyzes the hydrolysis of a wide variety of arene and alkene oxides to 
dihydrodiols (Guenther, 1990). The best substrates for mEH are oxiranes 
with one or two hydrophobic substituents such as styrene oxide (Oesch et 
al., 1971a). Czs-disubstituted oxiranes are generally better substrates for mEH 
as compared to frans-disubstituted oxiranes (Oesch et al., 1971b).
mEH exhibits a wide tissue distribution and has been isolated from 
numerous organs in the rat. The highest activity of mEH in the rat was 
found in the liver, followed by the testis, kidney, ovary, and lung (Oesch et 
al., 1977; Seidegard and DePierre, 1983). The order of activity in the mouse 
was testis>liver>lung>skin>kidney>intestine (Oesch et al., 1977).
Similarly, cEH, also referred to as 'EH2 ' (Guenther and Oesch, 1983) 
and 'cTSO' (Finley and Hammock, 1988), has demonstrated the greatest 
activity in the cytosol but has been identified in small amounts from the
13
microsomal fraction (Guenther and Oesch, 1983) and nuclear membrane 
(Guenther and Karnezia, 1986). Like mEH, cEH demonstrates a broad 
substrate specificity; however, fraws-disubstituted oxiranes are rapidly 
hydrolyzed by cEH in contrast to cis-disubstituted oxiranes (Gill et ah, 1983a; 
Hammock and Hasagawa, 1983). The complementary substrate preference 
between cEH and mEH may aid in the detoxification of an extremely wide 
range of endogenous and exogenous compounds.
cEH activity is also observed in various tissues but differs markedly 
in organ distribution and activity between species. Hepatic cEH activity is 
highest in the mouse, intermediate in humans, rabbits, and guinea pigs, 
and low in the rat (Gill and Hammock, 1980; Ota and Hammock, 1980; Gill 
et ah, 1983a, Gill et ah, 1983b; Meijer et ah, 1987; Meijer and DePierre, 1988; 
Mertes et al., 1985). In mice, the order of activity in various organs has been 
shown to be liver > kidney > lung > testis > spleen (Gill and Hammock,
1980; Loury et ah, 1985) while in the rat the order is heart = kidney > liver > 
brain > lung > testis > spleen (Gill et ah, 1983b).
Additionally, a unique microsomal EH, known as cholesterol 5,6- 
oxide hydrolase, 'chEH' (Guenther, 1990), 'mEHch' (Oesch, et ah, 1984), or 
'mCE' (Finley and Hammock, 1988), catalyzes the hydration of steroid 5,6- 
oxides. cEH is located predominantly in the endoplasmic reticulum with 
smaller amounts present in the mitochondrial fraction, but not the cytosol 
(Aringer and Eneroth, 1974; Astrom et ah, 1986; Sevanian and McLeod,
1986). chEH exhibits a narrow substrate specificity. Steroid 5,6-oxides are 
the only known substrates while analogs of cholesterol 5,6-oxides and the 
3,5,6-triol product are the only known inhibitors of the enzyme (Guenther, 
1990; Nashed, et ah, 1985; Sevanian and McLeod, 1986). chEH is structurally
14
and catalytically distinct from mEH as demonstrated by different substrate 
and inhibitor specificities (Levin et al., 1983; Oesch et al., 1984; Kaur and 
Gill, 1986; Palakodety et a l,  1987) and a lack of cross-reactivity between chEH 
and mEH-specific antibodes (Levin et a l,  1983; Oesch et a l ,  1984).
A unique cytosolic epoxide hydrolase involved in leukotriene 
biosynthesis has additionally been characterized (Evans et a l ,  1985; McGee 
and Fitzpatrick, 1985; Ohishi et a l ,  1987). Leukotriene A4  (LTA4 ) hydrolase 
or LTA4 H hydrolyzes the oxirane ring of LTA4 to form LTB4. LTA4 H is 
located exclusively in the cytosol and differs catalytically from both cEH and 
mEH in that the addition of water by LTA4 H occurs at a position distant 
from the oxirane ring due to delocalization of the carbocation in the 
conjugate triene structure of the substrate (Guenther, 1990). Like chEH, 
LTA4 H demonstrates a narrow substrate specificity since only LTA4  and 
closely related analogs of LTA4  act as substrates (Evans et a l,  1985; McGee 
and Fitzpatrick, 1985; Ohishi et a l,  1987). LTA4 H differs from mEH and cEH 
by virtue of its molecular weight, stability, amino acid composition, 
substrate specificity, mechanism of action, and suicide inactivation via its 
substrate, LTA4  (McGee and Fitzpatrick, 1985; Ohishi et a l,  1987; Guenther,
1990).
LTA4 H has been isolated from a variety of tissues from the guinea 
pig with the highest activity found in the small intestine and lesser 
amounts in the adrenal, liver, lung, kidney, leukocytes, stomach, heart, 
brain, and spinal cord (Izumi et al., 1986). LTA4 H was also present in rodent 
(Evans et al., 1985; Haeggstrom et a l,  1985; Pace-Asciak et a l,  1985; Medina et 
a l ,  1987) and human (Evans et al,  1985; Haeggstrom et al., 1985; Ohishi et
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al., 1987) lung, liver, kidney, and neutrophil as well as human erythrocytes 
(McGee and Fitzpatrick, 1985).
Phase II biotransforming enzyme systems are usually localized in the 
cytosol and catalyze biosynthetic or conjugation reactions (Sipes and 
Gandolfi, 1986). Various high-energy intermediates or cofactors are 
activated to accomplish these transfer reactions. Covalent linkage of 
endogenous molecules to the parent compound or a phase I-derived 
metabolite not only confers increased water solubility to facilitate excretion 
but may also contribute a functional moiety enabling the metabolite to 
participate in various transport systems (Aitio, 1978). Phase II enzymes 
include glucuronosyltransferases, sulfotransferases, methyltransferases, 
N-acetyl transferases, ATP-dependent acid:CoA ligases, rhodaneses and 
glutathione S-transferases (Sipes and Gandolfi, 1986).
Glutathione S-transferases (GSTs; EC 2.5.1.18) are an extensive family 
of multifunctional isoenzymes found in various species including bacteria, 
yeast, trematodes and nematodes, insects, fish, rodents, and humans 
(Ketterer and Mulder, 1990; Buetler and Eaton, 1992). Although the primary 
function of GSTs involves catalyzing the conjugation reaction between 
GSH and a variety of endogenous and exogenous electrophiles, these 
enzymes may also catalyze organic nitrate and thiocyanate reduction, 
thioester formation, (Chasseaud, 1979) and the isomerization of 
prostaglandins (Christ-Hazelhof and Nutgeren, 1979). Alternatively, GSTs 
may function as intracellular carrier proteins by binding non-substrate 
hydrophobic molecules including heme, bile acids, bilirubin, thyroid 
hormones, and various drugs such as steroids, sulfobromophthalein, and
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iodinated contrast agents (Mannervik and Danielson, 1988; Ishigaki et al., 
1989; Deleve and Kaplowitz, 1990).
In a similar manner, GSTs may act as a nucleophilic target for 
electrophilic metabolites thereby removing toxic compounds through non- 
catalytic covalent binding (Jakoby, 1978; Listowsky et al., 1988). This has 
been proposed as a 'suicidal' defense mechanism since the enzyme 
molecule is often inactivated in the process (van Bladeren and van 
Qmmen, 1991; Pabst et al., 1974; Corrigall et al., 1989; Adams and Sikakana,
1990).
Over 100 GST isoenzymes have been characterized from a variety of 
species (Buetler and Eaton, 1992). Multiple forms of cytosolic GST arise 
from various dimeric combinations of separately functioning subunits. To 
date, 13 subunits have been identified in human tissues (Awasthi et al.,
1994) while 13 different subunits have been demonstrated in rats (Sternberg,
1991).
Various physical and biochemical criteria have been utilized to 
catagorize GST isoenzymes including substrate specificity (Boyland and 
Chasseaud, 1969), subunit molecular weight values (Taylor et al., 1987 Dao 
et al., 1982), relative motility on sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (McLellen and Hayes, 1987) or starch gels (Board, 1981), 
elution from carboxymethyl cellulose ion-exchange columns (Jakoby, 1978), 
and isoelectic point focusing of homodimers (Warholm et al., 1981,1983; 
Singh et al., 1988).
The use of diverse criteria has resulted in a complex, convoluted 
system of nomenclature. In 1984, Jakoby and coworkers devised a 
nomenclature in rats using arabic numerals for subunits identified
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chronologically. This naming system proved somewhat advantagous; 
however, Mannervik, et al. (1985) later recommended classifying 
mammalian, including rat, mouse and human, GSTs into three major 
classes based on partial sequence homologies, immunological similarities, 
and kinetic properties. These three classes were designated a , p, and re.
Although the majority of GST proteins in human muscle belong to 
the GST p and re classes, a small but significant portion of GSH conjugating 
activity of human muscle is represented by isoenzyme GST £ which is 
immunologically distinct from the a, p, and re classes of GST (Singh et al.,
1988). This isoenzyme appears to be specific to skeletal muscle and 
expresses interindividual variations.
Buetler and Eaton (1992) have established a fifth class of GST 
isozymes, o, (in addition to a, p, and re) to include S-crystallins from 
mollusk lens derived from squid and octopus. Their classification of GSTs 
is based upon computational analysis of cDNA sequences. According to this 
classification system, three recently purified GSTs, one from human and 
two from rat (Meyer et ah, 1991; Hussey and Hayes, 1992), have been placed 
in yet another GST class, 0. These GST isoenzymes are distantly related to 
cytosolic a, p, and % class GSTs. This new class also includes many of the 
non-mammalian GST isoenzymes from bacteria, yeast, insects, and plants 
and has become the 'catch all' class of archaic GSTs. It is theorized that the 
gene for the 0 class GST may be the parent gene from which the various 
classes of GST have evolved (Buetler and Eaton, 1992).
It should be noted that the o  and 0 class do not appear to be 
universally accepted by all investigators as several authors do not include 
them in the classification of GSTs. These should be considered minor
18
classes since greater than 90% of GST proteins from human tissue are 
isoenzymes of the a, ji, and n classes (Awasthi et al., 1994).
Though GSTs are found primarily within the cytosol, two 
membrane-bound forms have been identified in the endoplasmic 
reticulum and the outer mitochondrial membrane from both humans and 
rats (Kraus, 1975; Morgenstem and DePierre, 1988; Wahllander et al., 1979; 
Morgenstern et al., 1982). Membrane-bound GSTs have been found in all 
mammalian species studied thus far and constitute 3% and 5% of the total 
protein in the endoplasmic reticulum and the outer mitochondrial 
membrane, respectively (Morgenstern et al., 1984).
Though rat liver exhibits several 100 times more enzyme activity 
than extrahepatic tissues, membrane-bound GST proteins have been 
demonstrated via Western blot analysis in the intestinal mucosa, adrenal, 
testes, thymus, lung, and spleen; however, essentially none of this protein 
has been identified in the heart, brain, or kidney (Morgenstern et al., 1984). 
Conversely, Northern blot analysis demonstrated mRNAs expressed at 20% 
of the hepatic level in the kidney and testes, with much lower levels in the 
lung, spleen, and brain (Dejong et al., 1988). Though the reason for the 
discrepancies between Western and Northern blot analysis are not known, 
it is suggested that a different subcellular localization of membrane-bound 
GST proteins may occur in different organs since only the microsomal 
fraction was analyzed. Additionally, there may be different turnover rates 
for the protein and the mRNA (Andersson et al., 1994).
Membrane-bound GSTs have been shown to be structurally distinct 
and share minimal sequence homology with cytosolic GSTs (Buetler and
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Eaton, 1992). Additionally, microsomal GSTs were not induced by common 
inducers of drug-metabolizing enzymes (Morgenstern et al., 1980).
GST subunits within a given class form homo- and heterodimers or, 
in the case of microsomal GSTs, trimers with each subunit maintaining 
functional independence. Each subunit has a complete active site 
(Danielson and Mannervik, 1985; Tahir and Mannervik, 1986) with two 
adjacent binding sites. The glutathione-binding site, or G site, is highly 
specific with the only other endogenous thiol substrate being y- 
glutamylcysteine (Sugimoto et a l ,  1985). The GSH thiol moiety is thought 
to be activated or deprotonated to a reactive thiolate ion by the hydroxyl 
group on a highly conserved active-site tyrosine residue (Graminski et al.,
1989).
The electrophile-binding site, or H site, is located in the same general 
region as the G site; however, there is considerable variance in the 
associated amino acid residues (Gilliland, 1993). Variant amino acid 
residues dictate the substrate specificity for each isozyme and an increased 
degree of variance is obviously associated with a wide range of substrate 
specificity for the GSTs in general. It is proposed that the H site activates the 
substrate in a similar manner to the activation of GSH at the G site 
(Mannervik and Danielson, 1988). To increase electrophilicity, and activate 
the substrate, an amino acid residue must protonate the substrate.
Although GSH reacts with electrophilic carbon, oxygen, nitrogen, and 
sulfur atoms, the term GSH conjugation generally refers to products formed 
by the attack of GSH on an electrophilic carbon (Ketterer and Mulder, 1990). 
Although a diverse range of compounds act as substrates for GSTs 
(Chasseaud, 1979; Vos and van Bladeren, 1990), the typical reactions of GST
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conjugation include nucleophilic diplacement of good leaving groups, 
typically halides, from saturated and aromatic carbons, Michael additions, 
and nucleophilic attack on strained ring structures (Ketterer and Mulder,
1990). Nucleophilic displacement from a saturated carbon occurs when 
GSH conjugates a-bromoisovalerylurea and displaces the bromide to yield  
N-(aminocarbonyl-2-glutathion-S-yl)-3-methylbutanamide (Mulder and te 
Koppele, 1988). Bromide is also displaced from ethylene dibromide 
(Peterson and Guengrich, 1988) while chloride is displaced from 
hexachlorobutadiene during GST-catalyzed conjugation with GSH (Wolfe 
et al., 1984). Nucleophilic displacement reactions can also occur at aromatic 
carbons. This type of reaction has been observed with l-chloro-2,4- 
dinitrobenzene and l,2-dichloro-4-nitrobenzene (Habig et ah, 1974; Keen et 
al., 1976). Alternatively, GSTs may catalyze Michael additions with 
substrates such as diethyl maleate (Boyland and Chasseaud, 1967) and the 
toxic metabolite of acetominophen, N-acetyl-p-benzoquinone imine 
(Hinson et a l ,  1982; Coles et a l,  1988).
Reactions of GSH with substrates containing strained ring structures 
have typically been observed with oxirane rings or epoxides. Benzo(a)- 
pyrene (BP) is metabolized to various epoxides including BP-7,8-diol-9,10- 
oxide, which is selectively conjugated by GSTs (Cooper et al., 1980; Hesse et 
al., 1982), and BP-4,5-oxide (Nemoto and Gelboin, 1975; Nemoto et a l ,  1975; 
Hernanandez et a l ,  1980; Plummer et a l ,  1980), the most abundant epoxide 
metabolite of BP. The strained oxirane ring creates an electrophilic carbon 
susceptible to attack by GSH.
It should be noted that GSH conjugation reactions can occur 
spontaneously and need not always be catalyzed by GSTs. Soft electrophiles,
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compounds with a low charge density or readily polarizable reactive 
centers, are more likely to react spontaneously with GSH since GSH is a soft 
nucleophile. Conversely, hard electrophiles have a high charge density or 
polarized reactive center and more typically require catalysis by GSTs 
(Ketterer et al., 1986; Deleve and Kaplowitz, 1990).
Spontaneous reactions with GSH have been demonstrated with 
quinones such as 1,4-naphthoquinone (Takahashi et al., 1987) and N- 
acetylbenzoquinone imine (Ketterer et al., 1986). Spontaneous reactions 
have additionally been demonstrated with dihaloethanes and acrylonitrile 
and its metabolite, 2-cyanoethylene oxide (Peterson and Guengerich, 1988). 
l-Chloro-2,4-dinitrobenzene (CDNB), a commonly utilized substrate for 
measuring GST activity, undergoes noncatalytic conjugation with GSH; 
however, the spontaneous reaction rate of CDNB with GSH is only 0.01% of 
the total rate of conjugation (Ketterer, 1982; Ketterer et al., 1983).
Spontaneous GSH conjugation with soft electrophiles typically occurs 
at a much slower rate relative to GST catalyzed conjugation. Catalysis by 
GSTs not only increases the rate of conjugation, but affords independence 
over the intracellular GSH concentration. This allows GSH conjugation to 
occur rapidly in cells with low GSH concentrations (Ketterer et al., 1986).
Though all mammalian tissues possess some cytosolic GST activity 
(Mannervik, 1985), there is usually a spectrum of isoenzymes which is 
characteristic for the specific tissue. The isoenzyme pattern of distribution 
as well as the isoenzyme concentration may be strikingly different from one 
tissue to another. For example, rat liver contains the greatest amount of 
total GST protein (3-5% of total soluble protein) as compared to other 
organs and has significant amounts of all subunits except subunit 7 which is
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only minimally expressed (Vos and van Bladeren, 1990). Similarly, human 
liver exhibits high levels of a  and n class GSTs but only trace amounts of n 
which is analogous to rat subunit 7 (Awasthi et al., 1994). Substantial 
amounts of GST n, however, have been demonstrated in humans in the 
adrenal gland, cornea, gastric and small intestinal mucosa, testis, uterus, 
pancreas, retina, and kidney (Awasthi et al., 1994) and subunit 7 is found in 
moderate to large amounts in rat kidney, lung, and intestine (Vos and van 
Bladeren, 1990).
Isoenzyme distribution patterns also vary depending on species, sex, 
age, genetic composition, and exposure to inhibiting or inducing agents. In 
human fetal liver, as opposed to adult liver, GST n, as well as a  GSTs, are 
expressed in substantial quantities (Awasthi et ah, 1994).
H Class GSTs exhibit extensive genetic polymorphism. Only 40-50% 
of adult humans possess this class of GSTs (Vos and van Bladeren, 1990). 
The interindividual variation of /j class GSTs has been associated with 
variable susceptibility to various xenobiotics (Warholm et al., 1983).
When Seidegard and colleagues (1986) measured frans-stilbene oxide 
activity, most specific for GST p, in lymphocytes of patients with lung 
cancer and controls matched for smoking habits, a greater proportion of the 
control smokers (without cancer) exhibited GST n activity as compared to 
lung cancer patients. Additionally, fewer patients with adenocarcinomas 
appeared to to be positive for GST ]i as compared to patients diagnosed with 
squamous cell carcinomas or small or large cell carcinomas. A similar 
population-based, case-control study measuring cytosolic activity towards 
frans-stilbene oxide, l-chloro-2,4-dinitrobenzene, and benzo(a)pyrene-4,5- 
oxide in patients with smoking-related cancer, demonstrated
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proportionately fewer cancer patients with intermediate or high GST 
activity towards frans-stilbene oxide as compared to controls. In this latter 
study, however, the difference was plausibly due to chance (Heckbert et al.,
1992). These studies suggest that fi class GSTs may protect smokers from 
poly cyclic aromatic hydrocarbons and that n class proteins may serve as 
genetic markers for susceptibility to lung cancer. In fact, polymerase-chain 
reaction-based methods for the detection of genetic polymorphisms in 
human n class GST activity have been developed for rapid, accurate 
detection of the GST n gene (Bell, 1991).
GST isoenzyme distribution patterns are also subject to hormonal 
influences. Distinct sex differences have been noted in rats, mice, and 
humans (Igarashi et al., 1987; McLellen and Hayes, 1987). Both the male rat 
and mouse exhibit higher enzyme activity in the liver than their female 
counterparts and male rat liver contains higher levels of subunits 3 and 4 
while female rat livers preferentially express subunits 1 and 2 (Igarashi et 
al., 1987). In humans, there are gender related differences in the expression 
of GSTs within the colon (Singhal et al., 1992) and skin (Singhal et a l ,  1993).
GST isoenzyme expression is also mediated by various endogenous 
and exogenous inhibitors. An extensive list of inhibitors of GST activity 
has been published by Mannervik and Danielson (1988) and the various 
types of inhibition have been reviewed recently by van Bladeren and van 
Ommen (1991). GST activity may be inhibited in either an irreversible or 
reversible manner, the latter of which occurs most commonly.
Reversible inhibitors of GST include GSH analogs as well as "second 
substrate" analogs which bind to the G site or H site of GSTs, respectively. 
Obviously, 'second substrate' analogs include a diverse range of inhibitors
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consistent with the broad substrate specificity of GST isoenzymes. 
Essentially, the only common feature of this group of inhibitors is their 
lipophilic nature (van Bladeren and van Ommen, 1991). Many of the 
substrates for GST also act as reversible inhibitors.
GST activity may additionally be reversibly inhibited by 
'nonsubstrate ligands' such a heme, bilirubin, and bile acids. Interestingly, 
this binding occurs at a site distinct from the G or H binding sites and may 
cause conformation changes in the enzyme which alter its activity. Binding 
of nonsubstrate molecules to GST is believed to be a transport or storage 
function of the enzyme although no convincing evidence exists concerning 
these functions (van Bladeren and van Ommen, 1991).
Alternatively, few compounds have demonstrated irreversible 
inhibition of GST activity. Various quinones are among the strongest of 
these types of inhibitors with both tetrachloro- 1,4-benzoquinone and its 
GSH conjugate inhibiting rat and human GST (van Ommen et al., 1988; 
Ploemen et al., 1991). Most GSH conjugates are inhibitors of GSTs and the 
more hydrophobic the S-substituent, the greater the inhibitory effect 
(Ketterer and Mulder, 1990).
Inhibition of GST may have multiple effects in vivo (van Bladeren 
and van Ommen, 1991). While diminished GST activity may be of 
therapeutic benefit in allergic reactions via the inhibition of leukotriene 
formation, inhibition of prostaglandin synthesis may have toxic effects 
since these compounds are necessary for maintaining vasodilation within 
tissues (Cotran et al., 1989). GST catalyzed conjugation of electrophilic 
xenobiotics exhibits a similar dualism. Decreased GST activity may prove 
detrimental due to decreased detoxification of alkylating agents. However,
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increased GST concentrations have been documented in various tumor 
cells and especially tumors that have become resistant to cancer 
chemotherapeutic agents (Waxman, 1990). It is plausible that elevated 
levels of GST isoenzymes are associated with the drug resistant state. 
Ethacrynic acid, a known inhibitor of (i class GSTs, has been shown to 
potentiate the cytotoxicity of several cancer chemotherapeutics in tumor 
cell lines (Tew et al., 1988; Smith et al., 1989; Hansson et al., 1991) and 
implanted tumor cells in mice (Clapper et al., 1990).
Conversely, a large and diverse group of compounds, both naturally 
occurring and synthetic, induce GST isoenzymes. Induction of cytosolic 
GSTs in rat liver has been demonstrated following treatment with 
phenobarbital (Ding et al.,1986; Pickett et al., 1987; Hales and Neims, 1977; 
Ding and Pickett, 1985; Pickett et al., 1984; Grasl-Kraupp et al., 1993), 3- 
methylcholanthrene (Pickett et al., 1987; Hales and Neims, 1977; Ding and 
Pickett, 1985; Pickett et al., 1984), frans-stilbene oxide, and 
hexachlorobenzene (Di Simplicio et al., 1983; Vos et al., 1988). Phenobarbital 
additionally induces GST activity in rat small intestine and testis (Clifton 
and Kaplowitz, 1978; Sheenan et al., 1984) while 3-methylcholathrene 
induces GSTs in rat lung, small intestine, and kidney (Stewart and Boston, 
1987; Clifton and Kaplowitz, 1978). Microsomal GST activity in rat liver is 
similarly induced by treatment with phenobarbital (Aniya et al., 1993).
Naturally occurring compounds may also induce GST activity. 
Numerous investigators have demonstrated elevations in GST activity in 
animals fed cruciferous diets or degradation products derived from these 
plants (Sparnins et al., 1982a, b; Aspry and Bjeldanes, 1983; Chang and 
Bjeldanes, 1985; Salbe and Bjeldanes 1985; Ansher e ta l ,  1986; Kensler et al.,
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1987; Vos et al., 1988; Bogaards et al., 1990; Wortelboer et al., 1992; Zhang et 
al., 1992).
The induction of GSTs is believed to be an important mechanism of 
protection against chemical carcinogenesis (Prochaska et al., 1985; Prochaska 
and Talalay, 1988; Talalay et al., 1988) while inhibition of GST is theorized to 
increase human cancer risk (Schneider, 1992). Rat and human GST a  
inhibits covalent DNA binding of food-borne carcinogens (Lin et al., 1994). 
Similarly, the dietary antioxidants, 2(3)-ferf-butyl-4-hydroxyanisole and 1,2- 
dihydro-6-ethoxy-2,2,4-trimethylquinoline, enhance hepatic GST activities 
in mice and decrease the level of mutagenic metabolites formed from 
benzo(a)pyrene (Benson et al., 1978). It is similarly believed that induction 
of GST may be at least partially responsible for the anticarcinogenic effect of 
cruciferous vegetables.
Cruciferous Vegetables
The family Cruciferae, characterized by four petals standing opposite 
one another in a square cross (Bailey, 1949), consists of well over 2,000 plant 
species (Harberd, 1976). As a result, the classification of these plants poses 
major difficulties to the taxonomist. Fortunately, the economically 
important members are relatively few in number including those 
cultivated for human and/or animal consumption and grown as 
ornamentals. The Brassica genus encompasses the majority of the 
economically important members including koch and black mustard (B. 
nigra varieties), cabbage, cauliflower, broccoli, kale, kohl-rabi, cole wart, and 
Brussels sprouts (B. oleracea varieties), rape and rutabagas (B. napus 
varieties), turnip rape and Chinese cabbage (B. campestris varieties), and 
mustard (B. jancea) (Prakash and Hinata, 1980).
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Though in ancient times crucifers were used primarily as medicinals 
(Fenwick et al., 1983), cruciferous crops now account for a significant 
portion of the diets of people throughout parts of the world. Brassica 
species, including B. napus (rape) and B. campestris (turnip rape) are 
cultivated for their high oil content. These oilseeds are utilized in the 
production of margarine and soap, as a lubricating oil, and as a diesel fuel 
substitute (Fenwick et al., 1983). Rapeseed and crambe or Abyssinian kale 
(Crambe Abyssinian) are also cultivated as major oilseed crops for plastics 
and processed foods (Lenman, 1992).
The seed meal that remains following oil extraction contains 40-45% 
protein and is an excellent protein source for livestock and poultry 
(Lenman, 1992). The use of this meal, however, is limited by its pungent 
odor and taste as well as its toxic effects observed in the liver, kidneys, and 
thyroid (Tookey et al., 1980; Fenwick et al., 1983).
Cruciferous plants are additionally utilized in condiments including 
mustard (B. juncea, B. nigra, and Sinapis alba) and horseradish (Amoracia  
rusticana) and the roots (radish, turnip), stems (kohl-rabi), flower buds 
(cauliflower, broccoli), and leaves (cabbage, Brussels sprouts, Takana, 
Nozawana, Hiroshimana) are commonly consumed as vegetables 
(MacLeod, 1976; Tookey et al., 1980; Fenwick et al., 1983; Uda and Maeda, 
1986).
Cruciferous vegetables including cabbage, broccoli, turnips, 
cauliflower, and Brussels sprouts have become widely regarded as potential 
cancer chemoprotectives. Based on extensive experimental testing of crude 
vegetable extracts and epidemiologic data, both the National Research 
Councils' Committee on Diet, Nutrition, and Cancer (1982) and the
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American Cancer Society (1984) have recommended increased 
consumption of cruciferous vegetables to decrease human cancer incidence.
While occasional studies do not corroborate an inverse relationship 
between cancer and cruciferous vegetables (MacClure and Willett, 1990; 
McKeown-Eyssen, 1984), an abundance of epidemiologic studies indicate 
that the consumption of cruciferous vegetables reduces the risk for 
development of cancer at various sites including the colon, rectum, bladder, 
lung, thyroid, pancreas, skin, stomach, and mesothelium (Graham et al., 
1978; Graham et a l,  1983; Kune et al., 1987; Hoff et al., 1988; Schiffman et al., 
1988; Young and Wolf, 1988; Lee et al., 1989; LeMarchand et al., 1989; Olsen 
et al., 1989; Chyou et al., 1990; Kolonel et al., 1990; Wohlleb et al., 1990; Olsen 
et al., 1991; Kune et al., 1992; Swanson et al., 1992).
In experimental animal models, investigators have reported a 
reduced incidence of mammary cancer in dimethylbenz(a)anthracene- 
treated rats fed diets containing cabbage and cauliflower (Wattenberg, 1983). 
There was also a significant decrease in the number of pulmonary 
metastases in mice fed cabbage and collards after being injected 
intraveneously with BALB/ c mammary carcinoma cells (Scholar et al., 
1989). Animals fed cruciferous diets have similarly demonstrated 
anticarcinogenic effects against aflatoxin Bi-induced neoplasia (Boyd et al.,
1982).
Similarly, supernatant from crude homogenates of cruciferous 
vegetables have demonstrated antimutagenic activity against 2 -amino-3 - 
methylimidazo[4,5-f]quinoline, 2-amino-3,4-dimethylimidazo[4,5-f]- 
quinoline, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the Ames test 
(Edenharder et al., 1994) while boiled extracts of crucifers demonstrated
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significant "anti-tumor-promoter and radical-scavenging" activities in the 
phorbol myristate acetate/Epstein-Barr virus/B lymphocyte system (Maeda 
et a l ,  1992).
Despite the well-established inverse relationship between cruciferous 
vegetables and the incidence of various types of human cancer, the specific 
constituents responsible for this protective effect have not been well 
defined. Although vegetable fiber has been advocated as a risk-lowering 
factor for some types of cancer such as colon cancer, there has been a failure 
to establish a consistent inverse relationship between cancer and dietary 
fiber (Doll, 1992). Similarly, vitamin A and (3-carotene may contribute to 
the protective effects of crucifers against lung cancer in humans (National 
Research Council, 1982); however, experimental data regarding the indices 
of vitamin A intake were derived from food that may contain other 
anticarcinogenic agents. It is therefore plausible that dietary constituents 
other than vitamin A or (3-carotene may act as risk-reducing factors 
(National Research Council, 1982). In fact, a population-based study of diet 
and lung cancer incidence suggested that other components of crucifers 
appear to have a stronger inverse relationship with risk than (3-carotene 
(LeMarchand et al., 1989).
Chemoprotective effects are often attributed to induction of phase II 
xenobiotic metabolizing enzymes. Induction of GST activity in liver and 
small intestinal mucosa has been demonstrated in rats and female mice fed 
semi-synthetic diets supplemented with raw or cooked Brussel sprouts 
(Sparnins et ah, 1982b; Salbe and Bjeldanes 1985; Bogaards et ah, 1990; 
Wortelboer et ah, 1992). Similarly, diets supplemented with dried 
powdered preparations of cabbage increased GST activity in the liver and
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small intestine of female mice (Sparnins et al., 1982b) while broccoli 
supplemented diets elevated GST levels in rat liver (Aspry and Bjeldanes,
1983). Occasional investigators observed no induction in GST activity in 
animals fed cruciferous diets (Hendrich and Bjeldanes, 1986; Nijhoff et al.,
1993).
Various constituents of cruciferous vegetables have been shown to 
induce GST activity. Isothiocyanates (Bogaards et al., 1990; Sparnins et al., 
1982a; Vos et al., 1988; Zhang et al., 1992), indole-3-carbinol (Sparnins et al., 
1982a), goitrin (Bogaards et al., 1990; Chang and Bjeldanes, 1985) and 
dithiolthiones, such as oltipraz (Kensler et al., 1987; Ansher et al., 1986) are 
derived from cruciferous vegetables and have been shown to induce GST 
activity in rat and mouse liver and small intestine. Oltipraz induces 
hepatic GST activity via changes in steady state levels of GST mRNA and 
rates of GST gene transcription (Davidson et al., 1990).
Several natural substances derived from cruciferous vegetables 
including isothiocyanates, indoles, and dithiolthiones have been shown to 
possess anticarcinogenic properties (National Reseach Council, 1982). 
Indole-3-carbinol, a naturally occurring indole found in cruciferous plants, 
inhibits carcinogen-induced neoplasms of the forestomach, mammary 
gland, and tongue in mice and rats (Wattenberg and Loub, 1978; Tanaka et 
al,  1992).
Similarly, a variety of organic isothiocyanates have demonstrated 
chemoprotective effects against various types of cancer. A recent review by 
Zhang and Talalay (1994) outlines the ability of isothiocyanates to protect 
against carcinogen-induced tumors in rats and mice at various locations 
including liver, mammary gland, esophagus, forestomach, and lung.
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Occasional studies have examined the chemoprotective effects of 
glucosinolates. Administration of glucobrassicin (indolylmethyl- 
glucosinolate) or glucotropaelin (benzylglucosinolate) prior to DMBA 
exposure decreased both the incidence and multiplicity of mammary 
tumors in rats (Wattenberg et al., 1986). The interpretation of such studies 
is complex. It is not known to what extent the glucosinolates are degraded 
in vivo. Additionally, if the glucosinolates are hydrolyzed, it is unclear 
whether endogenous or microbial enzymes are responsible and what 
products are formed. Finally, it is not known whether it is the intact 
glucosinolate, a hydrolysis product, or a metabolite of either of these that is 
responsible for the anticarcinogenic effects.
Glucosinolates
Glucosinolates are thioglucosides found predominantly, but not 
exclusively, in plants of the Cruciferae family. These compounds occur 
ubiquitously throughout the order Capparales including not only the 
Cruciferae but the Capparaceae, Moringaceae, Resedaceae, and Tovariaceae 
Families as well (Fenwick et al, 1983). Glucosinolates also occur 
sporadically in other families including the Caricaceae, Euphorbiaceae, 
Gyrostemonaceae, Limnanthaceae, Salvadoraceae, and Tropalolaceae 
(Fenwick et al., 1983).
Glucosinolates, or their degradation products, are responsible for the 
pungent flavor of many of the cruciferous vegetables (Tookey et al., 1980). 
Though the biological function of these compounds is still unkown, it is 
theorized that glucosinolates or gucosinolate-derived compounds act as 
insect attractants or stimulants. Glucosinolates have been shown to affect 
the egg-laying behavior and feeding patterns of various insects
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(Thorsteinson, 1953; Coaker, 1969). It is proposed that these compounds 
may act as protectants against predators and parasites since glucosinolates 
and associated hydrolysis products have been reported to be fungistatic, 
bacteriostatic, and toxic to insects as well as mammals (Erickson and Feeney, 
1974; Fenwick et al., 1983; Chew, 1988a) Alternatively, glucosinolates may 
serve as a sulphur storage pool since the glucosinolate concentration in 
vegetative tissue increases with addition of sulphur fertilizer (Lenman, 
1992).
The evolution of the nomenclature of glucosinolates has been 
reviewed by Fenwick et al. (1983). In the early 1800's, the first glucosinolates 
isolated from cruciferous vegetables were given classical names such as 
sinalbin and sinigrin, derived from white mustard seed (Sinapis alba L.) 
and seeds of black mustard (Brassica nigra Koch), respectively. In 1960, a 
new system of nomenclature was adopted in which the glucosinolate was 
given the prefix "gluco" followed by part of the Latin species or botanical 
name of the plant from which it was originally isolated. Finally, a system  
was suggested with regards to the chemical structure of the glucosinolate 
(Ettlinger and Dateo, 1961) in which a chemically-descriptive prefix proceeds 
"glucosinolate".
The basic structure of most glucosinolates (Figure 1.1) consists of a p- 
D-thioglucose sugar and a sulfonated oxime moiety both bound to the 
terminal carbon of a variable organic side chain "R" (Ettlinger and 
Lundeen, 1956). The variable side chains of glucosinolates most commonly 
consist of alkenyls, alkyls, aryls, and indolyls as well as hydroxylated or 
sulfated alkyls and alkenyls (Muuse and Van der Kemp, 1987; Fenwick et 
al., 1983). Though most glucosinolates possess the same basic structure,
R1 \
H
NOSO3
Figure 1 . 1  Basic structure of glucosinolates.
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occasional glucosinolates, such as p-hydroxybenzyl-glucosinolate isolated 
from radish seed (Rapltanus sativus), contain a 6 -sinapoylthioglucose 
moiety instead of the typical thioglucose group (Linscheid et al., 1980). The 
ramifications of this alternative group are still unknown. It is possible that 
such glucosinolates could produce novel breakdown products that cause 
distinct physiological effects.
Glucosinolates are biosynthesized within the plant from amino acids 
including tryptophan, tyrosine, leucine, valine, alanine, and methionine 
(Kjaer, 1976; Moller 1981). Amino acids are oxidatively decarboxylated to an 
aldoxime which is sulfurated to a thiohydroximate. The latter intermediate 
is subsequently glycosylated to a desulfoglucosinolate which undergoes 
sulfation to the glucosinolate. 3'-Phosphoadenosine 5'-phosphosulfate 
(PAPS) has been shown to act as the sulfur donor in the final step of 
glucosinolate biosynthesis (Glendening and Poulton, 1988).
Glucosinolates are found within all tissues of Cruciferae including 
the root, stem, leaf, and seed (Fieldsend and Milford, 1994a). The type and 
amount of glucosinolate as well as the location of the glucosinolate within 
the plant are highly variable (Josefsson, 1967) and are dependent on various 
environmental and agronomic conditions. Glucosinolate levels and the 
types of gluconsinolates present are dependent on the developmental stage 
of the plant (Cole, 1978; Sukhija et al,  1985; Fieldsend and Milford, 1994b), 
the part of the plant examined (Joseffesson, 1967; Lenman, 1992), the 
processing conditions (Kondo et al., 1985; de Vos and Blijleven, 1988), 
storage conditions (Fales et al., 1987), cultivation conditions (Heaney and 
Fenwick, 1985; Fieldsend and Milford, 1994a), and the genetic composition 
(Paik et al., 1980; Bell, 1984; Martland and Butler, 1984; Fieldsend and
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Milford, 1994a). Considerable variation in glucosinolate levels may be seen 
not only among species, but among varieties or cultivars within a species 
(Josefsson, 1967; Fieldsend and Milford, 1994a; Fieldsend and Milford, 
1994b).
Glucosinolates normally remain intact within the plant but undergo 
enzymatic hydrolysis when plant cells are disrupted by crushing, cutting, or 
chewing (Tookey et al., 1980; de Vos and Blijleven, 1988). Glucosinolates 
have also been shown to be degraded chemically (Lanzani et al., 1976; 
Gronowitz et al., 1978) and thermally upon cooking (MacLeod et al., 1981).
Thioglucosidase glucohydrolase (EC 3.2.3.1), normally stored 
separately from glucosinolates in plant tissues (Lenman, 1992), represents a 
group of isoenzymes responsible for the hydrolysis of glucosinolates. The 
hydrolytic products include an organic aglucone moiety representative of 
the variable side chain and equimolar quantities of glucose and sulfate ions 
(de Vos and Blijleven, 1988; Tookey et al., 1980). As with many enzymes, 
especially those constituting large families of isoenzymes, there is some 
confusion within the literature regarding their nomenclature. This 
enzyme is referred to as 'glucosinolase' (Ettinger et al., 1961) in the older 
literature and is commonly termed 'myrosinase' throughout recent articles 
although the International Union of Biochemistry recommended 
thioglucosidase glucohydrolase as the preferred name in 1965 (Florkin and 
Stotz, 1965). Frequently, the name of the enzyme is truncated to 
thioglucosidase in many articles although thioglucosidases are not 
exclusive to plants and have been identified in fungi (Reese et al., 1958), 
bacteria (Oginsky et al., 1965), and mammals (Goodman et al., 1959).
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Thioglucosidase glucohydrolase produces a variety of hydrolytic 
products from the variable side chain of their glucosinolate substrates. The 
spectrum of products formed depends upon the chemical structure of the 
original glucosinolate, the conditions of hydrolysis, the characteristics of the 
thioglucosidase glucohydrolase isoenzyme, and the presence of various 
compounds which modify enzyme activity (Tookey et al., 1980; Fenwick et 
al., 1983; de Vos and Blijleven, 1988; Lenman, 1992).
Depending on these factors, glucosinolate hydrolysis may produce 
isothiocyanates, thiocyanates, oxazolidine-2 -thiones, nitriles or 
hydroxynitriles, amines, or epithionitriles (Ettlinger and Lundeen, 1957; 
Fenwick et al., 1983). In some cases, isothiocyanates appear to simply 
rearrange to give rise to epithionitriles by sulfur migration (Cole, 1976). 
Under certain conditions of processing, however, relatively greater 
amounts of epithionitriles, rather than the expected isothiocyanates, may be 
formed from cruciferous plants. The autolysis of crambe or rapeseed meal 
formed a predominance of nitriles and epithionitriles including l-cyano-2 - 
hydroxy-3,4-epithiobutane and 1-cyano-2-hydroxy-3-butene (Daxenbichler et 
al., 1967; Daxenbichler et al., 1968). Similarly, the hydrolysis of seeds or 
meal from Brassica campetris (turnip rape) under selected conditions 
produced l-cyano-3,4-epithiobutane as a major product (Cole, 1975; Kirk and 
MacDonald, 1974).
It has also been demonstrated that the formation of epithionitriles, 
including cyanoepithioalkanes, is dependent on the presence of ferrous ion 
(Fe+2) and a 30-40 kilodalton protein referred to as epithio specifer protein 
(ESP) which directs the inclusion of sulfur into a terminal unsaturation 
(Tookey and Wolff, 1970; Tookey, 1973; Tookey et al., 1980).
37
Cyanoepithioalkanes are formed from the rearrangement of alkenyl 
isothiocyanates derived from alkenyl glucosinolates (Cole, 1976) such as 2- 
propenyl glucosinolate (sinigrin), 3-butenyl glucosinolate (gluconapin), and 
4-pentenyl glucosinolate (glucobrassica nipin) (deVos and Blijleven, 1988). 
According to this observation, l-cyano-3,4-epithiobutane (CEB) would be 
derived from 3-butenyl glucosinolate which is found in relatively high 
concentrations in Brussels sprouts, swede, turnip rape, Yellow Sarson, and 
turnips (Josefsson et al., 1967; Josefsson and Appelqvist, 1968; Downey et al., 
1969; Kondra and Downey, 1969; Heaney and Fenwick, 1985). In fact, CEB 
has been demonstrated as a major hydrolysis product from B. campestris 
(turnip rape and Chinese cabbage), Alyssum perenne (madwort), B. rapa 
(turnip), B. napus (rapeseed), Hirchfieldia incana (hoary mustard),
Lobularia maritima (sweet alyssum), Cakile maritima Scop, (sea rocket), and 
Turritis glabra (tower-mustard) (Kirk and MacDonald, 1974; Cole, 1975; Cole, 
1976; Paik et al., 1980) as well as the leaves of B.campestris L. var. rap if  era 
(Nozawan) and B.campestris L. var. pekinensis (Hiroshimana) used for 
pickling in Japan (Uda and Maeda, 1986).
While the administration of intact glucosinolates has resulted in 
various toxic effects in vivo, it is generally believed that the hydrolysis 
products derived during processing or by the intestinal microflora are 
responsible for glucosinolate-related toxicoses. Diets rich in glucosinolates 
cause marked decreases in feed intake, weight gain, and food conversion in 
poultry (Turner, 1946; Clandinin et al., 1966; Campbell and Smith, 1979; 
Mawson et al., 1944a), swine (Nordfeldt et al., 1954; Aherne and Lewis, 1978; 
Bell et al., 1991; Mawson et al., 1944a), rodents (Kennedy and Purves, 1941; 
Bell, 1957; Belzile et al., 1963; Vermorel et al., 1987; Nugon-Baudon et al.,
38
1990; de Groot et al., 1991; Smith and Bray, 1992; Mawson et al., 1944a), and 
ruminants (DePeters and Bath, 1986; Mawson et al., 1944a) and have 
demonstrated goitrogenic effects in pigs (Bell and Belzile, 1965; Ochetim et 
al., 1980; Rundgren, 1983; Mawson et al., 1944b), rats (Kennedy and Purves, 
1941; Vermorel et al., 1988; Mawson et al., 1944b), poultry ( Bell and Belzile, 
1965; Elwinger, 1986; Mawson et al., 1944b), ruminants (Iwasson et al., 1973; 
Seimiya et al., 1991; Mawson et al., 1944b), and rabbits (Chesney et al., 1928).
Dietary gluconsinolates additionally cause hepatotoxicity in poultry 
(Jackson, 1969; Umenura et al., 1977, Martland and Butler, 1984) and rats 
(Mawson et al., 1944b) and hemolytic anemia in ruminants (Greenhalgh et 
al., 1969) They also cause enlargement of the liver and kidneys in swine 
(Nordfeldt et al., 1954; Bowland et al., 1963) and rodents (Miller and 
Stoewsand, 1983; Vermorel et al., 1986; de Groot et al., 1991).
Due to the adverse effects of glucosinolates, the Food and Drug 
Administrations' Center for Veterinary Medicine has provided strict 
guidelines for the use of cruciferous meals as a feedstuff for livestock and 
poultry (Price et al., 1993). Plant breeders have developed cultivars 
containing low levels of glucosinolates (0.5% as compared to 5-6% for other 
cultivars) which are referred to as 'single low' varieties if they are low in 
glucosinolates or 'double low' if they are genetically low in both 
glucosinolates and erucic acid (Lenman, 1992). 'Single low' and 'double 
low' cultivars can be fed at higher concentrations and are excellent protein 
sources for livestock and poultry.
Despite the toxic effects of glucosinolates, numerous studies have 
revealed a protective effect against naturally occurring and synthetic 
carcinogens in animals administered products of glucosinolate degradation
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(Wattenberg, 1977; Wattenberg and Loub, 1978; McDanell et a l,  1988; 
Ramsdell and Eaton, 1988; Morse et al., 1989; Ishizaki et al., 1990;
Wattenberg, 1990; Bailey et al., 1991; Bradfield and Bjeldanes, 1991; Rao et al., 
1991; Steinmetz and Potter, 1991; Stoner et al., 1991; Chung et al., 1992; 
Tanaka et al., 1992; Benson, 1993; Chung et al., 1993; Preobrazhenskaya et al., 
1993; Smith et a l,  1993; Sugie et al., 1993; Jiaro et al., 1994; Kojima et al., 1994; 
Stresser et a l,  1994; Zhang and Talalay, 1994). Many investigators have 
theorized, and some have actually demonstrated, that the anticarcinogenic 
effect of these compounds is the result of induction and/or inhibition of 
phase I and phase II metabolizing enzyme systems (McDanell et a l,  1988; 
Nugon-Baudon et a l,  1990; Smith et al., 1990; Rao et al, 1991; Steinmetz and 
Potter, 1991; Baldwin and LeBlanc, 1992; Loft et a l,  1992; Ferguson, 1994; 
Stresser et a l ,  1994; Zhang and Talalay, 1994). Although elevations in 
cytochrome P450 enzymes may accelerate the metabolism and excretion of 
toxic xenobiotics, induction can either activate or detoxify carcinogenic 
compounds depending on the carcinogen and the specific P450 enzyme. 
Recent studies, however, support the conclusion that inactivation of phase 
I enzymes may diminish the formation of toxic metabolites thereby 
reducing DNA-adduct formation and carcinogenesis (Ishizaki et a l ,  1990; 
Smith et a l ,  1990; Zhang and Talalay, 1994).
In tandem with the inhibition/ activation of phase I enzymes, 
products of glucosinolate hydrolysis may block carcinogenesis through the 
induction of phase II enzymes, particularly GST. It is assumed that 
glucosinolates must be hydrolyzed during processing or by the intestinal 
microflora to attain their inducing effect since intact glucosinolates do not 
themselves induce xenobiotic metabolizing enzymes in germ-free rats fed
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glucosinolate-rich diets (Rabot et al., 1993). In addition, several 
glucosinolate degradation products induce GSTs in the lung, liver, and 
kidney (Sparnins et al., 1982a, 1982b; Rao et al., 1991; Smith and Bray, 1992; 
Benson, 1993; Kore et al,  1993).
Functions of Glutathione
Glutathione ( y-glutamylcysteinylglycine; Figure 1.2) is a ubiquitous 
tripeptide widely distributed in animal tissues, plants, and many 
microorganisms (Larsson et al., 1983). Glutathione occurs primarily 
intracellularly at concentrations ranging from 0.1- 10 mM (Meister, 1988a) 
with the highest concentrations existing in ocular lens epithelium and 
cortex (Hockwin and Korte, 1990). As such, it is the most prevalent 
intracellular thiol in almost all biological species studied and accounts for 
>90% of the total non-protein thiol concentration within most cells 
(Meister, 1983).
Most of the intracellular glutathione exists in the reduced, or thiol, 
form (GSH), although mixed disulfides (G-SS-protein), thioethers, and, to a 
lesser extent, the glutathione disulfide (GSSG) contribute to the total 
cellular pool of glutathione. The ratio of reduced glutathione (GSH) to 
oxidized glutathione (GSSG) within the cell is typically 300 ± 60 (Qian and 
Murphy, 1993). GSSG is accumulated within the cell to a limited extent due 
to the action of GSSG reductase (EC 1.6.4.2). This reductase is a flavoprotein 
which utilizes NADPH as an electron donor for the reduction of GSSG to 
GSH (Stryer, 1988).
The majority of intracellular GSH is found within the cytosol despite 
the existence of small but significant mitochondrial and nuclear pools 
(Reed and Olaffsdottir, 1989; Romero and Galaris, 1990; Jevtovic-Todorovic
Figure 1 . 2  Structure of glutathione (y-glutamylcystemylglycine).
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and Guenther, 1992). Additionally, GSH and GSSG are also present in 
various body fluids including plasma, bile, and urine, although at much 
lower 0/M) concentrations (Anderson and Meister, 1980; Moldeus and 
Quanguan, 1987). In rodents about 90% of the total GSH within the plasma 
is in the reduced form (Anderson et al., 1980).
In its predominant state, GSH acts as a critical reducing agent in a 
variety of biological functions including protein and DNA synthesis, 
maintenance of protein conformation and enzyme activity, leukotriene and 
prostaglandin synthesis, amino acid transport, and protection of cells from 
free radical damage and carcinogenesis. GSH is also involved in 
maintenance of membrane integrity and cytoskeletal organization (Larsson 
et al., 1983; Meister and Anderson, 1983; Meister, 1988b; Fettman, 1991).
One of the best known functions of GSH resides in its ability to 
protect cells from free radical and organic peroxide-mediated protein and 
DNA damage or lipid peroxidation. Superoxide radicals and hydrogen 
peroxide formed in biological systems produce reactive species that lead to 
organic peroxide formation (Chance et al., 1979). Some reduction of 
hydroxy radicals and hydroperoxides occurs nonenzymatically (Krinsky, 
1992; de Groot, 1994); however, glutathione peroxidase (EC 1.11.1.9), first 
identified in erythrocytes (Mills, 1957 and 1959), is a GSH-dependent 
cytosolic enzyme involved in the reduction of hydrogen peroxide and 
organic peroxides (including ethyl hydroperoxide, cumene hydroperoxide, 
and linoleic acid hydroperoxide) to water and their corresponding alcohols, 
respectively (Sies et al., 1980).
Both selenium-dependent (Se-GSH-Px) and selenium-independent 
(Se-I-GSH-Px) glutathione peroxidases have been described (Flohe' et al..,
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1973; Lawerence and Burke, 1976; Burke et al., 1978). Se-GSH-Px is thought 
to require phospholipase A2  (PLase A2 ) which converts potentially harmful 
phospholipid hydroperoxides (PLOOH) to free fatty acid hydroperoxides 
(LOOH). Se-GSH-Px subsequently converts LOOHs to harmless fatty acid 
alcohols (van Kuijk et al., 1987). Conversely, Se-I-GSH-Px acts directly on 
phospholipid hydroperoxides, without the necessity of hydrolyzing the free 
fatty acid hydroperoxide from the phospholipid. Accordingly, it is referred 
to as phopholipid hydroperoxide glutathione peroxidase (Ursini et al., 1982). 
Se-I-GSH-Px can also reduce membrane-associated cholesterol 
hydroperoxides (Thomas, 1990).
GSH also provides reducing capacity for cellular macromolecules and 
intracellular thiol-containing proteins. Proteins involved in membrane 
stability, DNA and protein synthesis, and other enzymatic reactions are 
maintained in the reduced state by thiol transfer reactions catalyzed by thiol 
transferases (Racker, 1955; Chang and Wilken, 1966; Nagai and Black, 1968). 
Glutaredoxin, a thiol transferase homologous to thioredoxin, transfers 
electrons from NADPH to ribonucleotide reductase via a glutathione 
electron donor. Ribonucleotide reductase catalyzes the reduction of 
ribonucleoside diphosphate to deoxyribonucleoside diphosphate and is 
therefore essential for DNA synthesis (Stryer, 1988).
Glutaredoxin also provides protection against oxidative damage 
through the reduction of dehydroascorbate to the powerful antioxidant, 
ascorbic acid (Meister, 1992). GSPI may also keep other antioxidants such as 
a-tocopherol (Niki et al., 1982; Reddy et al., 1982; Leedle and Aust, 1990) and 
p-carotene (Jialal and Grundy, 1991) in the reduced form, either by a direct 
reaction or by thiol transferases.
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GSH also reduces coenzyme A, the universal donor of acyl groups. 
Coenzyme A possesses a terminal sulfhydryl moiety essential to the citric 
acid and glyoxalate cycles (Stryer, 1988). Once the acyl group is donated, the 
terminal sulfur must be reduced by a GSH-dependent thiol transferase in 
order to bind another acyl group (Chang and Wilken, 1966). Similarly, 
cystine and homocystine are reduced to cysteine and homocysteine, 
respectively, by thiol transferases (Racker, 1955; Meister, 1988b).
GSH-insulin transhydrogenase (GIT; EC 5.3.4.1) is yet another protein 
dependent on GSH for its reducing power. GIT catalyzes the first step in the 
degradation of insulin by cleaving three disulfide bonds (Tomizawa and 
Halsey, 1959; Varandani, 1972).
GSH is additionally involved in the metabolism of prostaglandins 
and leukotrienes (Huber and Keppler, 1988; Ketterer et a l,  1988). 
Arachadonic acid, found within cellular membranes, is converted to 5- 
hydroperoxy-eicosatetraenoic acid (5-HPETE) by 5-lipoxygenase which, in 
turn, is converted to leukotriene A4  (LTA4 ). LTA4  is metabolized by 
glutathione S-transferase to its GSH conjugate, LTC4, which is cleaved at its 
y-glutamyl linkage to yield LTD4 . The cysteinyl-glycine linkage of LTD4  is 
then cleaved to produce LTE4 . Leukotrienes are important in vascular 
permeability and chemotaxis (Cotran et al,  1989).
GSH contributes to the regulation of prostaglandin and thromboxane 
synthesis and metabolism. The effect of GSH on prostaglandin and 
thromboxane levels and patterns of synthesis are dependent on the tissue 
or organ as well as the level of GSH utilized in the experiment (Mimata et 
a l ,  1988; Hidaka et al, 1990; Buckley et al,  1991; Nejad et a l,  1991; Mimata et 
a l ,  1993).
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Decreases in GSH by administration of diethyl maleate tend to 
suppress prostaglandin synthesis as a whole but may dramatically alter the 
prostaglandin pattern or profile within the tissue (Mimata et a l,  1988; 
Hidaka et al., 1990; Nejad et al., 1991). Increases in GSH appear to stimulate 
the synthesis of PGE2  relative to other prostaglandins in the urinary bladder 
epithelium (Mimata et ah, 1988) and renal medullary homogenates (Nejad 
et a l,  1991).
The effect of GSH on prostaglandin biosynthesis may be mediated 
through GSH conjugation. Glutathione S-transferases have been shown to 
reduce PGH2  to PGF20U presumably due to GSH peroxidase activity (Burgess 
et a l,  1987) and may be involved in isomerization of PGH2  to PGE2  and 
PGD2  (Meyer and Ketterer, 1987).
GSH has been shown to function as a coenzyme in various biological 
reactions. First discovered was the glyoxylase reaction responsible for the 
conversion of methylglyoxal to lactate. GSH is essential for the formation 
of a hemimercaptal from methylglyoxal (Meister, 1988b). Glyoxylase then 
converts the hemimercaptal to lactate. Methylglyoxal theoretically retards 
cell growth (Meister, 1988a) so that increases in GSH may actually stimulate 
cell growth.
Formaldehyde dehydrogenase also utilizes GSH as a coenzyme in the 
conversion of formaldehyde to formic acid (Meister, 1988b). The actual 
substrate is believed to be the hemimercaptal formed from the interaction 
of formaldehyde with GSH.
The reducing power of GSH is not only utilized intracellularly but 
has a variety of similar functions extracellularly. Extracellular GSH has 
been shown to protect retinal pigment epithelial (RPE) cells, unable to take
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up intact GSH, from oxidative damage. Isolated RPE cells were exposed to 
diethyl maleate, buthionine sulfoximine, and AT-125 to deplete 
intracellular GSH, prevent de novo synthesis of GSH, and impede 
degradation and uptake of plasma GSH, respectively. The presence of small 
concentrations of extracellular GSH protected these cells from subsequent 
exposure to t-butyl hydroxyquinolone (Sternberg et ah, 1993).
Extracellular GSH may also maintain antioxidants, such as ascorbate 
and vitamin E, and membrane-bound enzymes in the reduced state 
(Meister, 1992; Sternberg et al., 1993). For example, ATPase possesses a 
sulfhydryl group on both the cytoplasmic and external aspect which must be 
kept in the reduced form to be functional (Qian and Murphy, 1993).
GSH has also been advocated as a storage form of cysteine since the 
intracellular concentration of GSH far exceeds that of cysteine with a ratio of 
>100:1 (States and Segal, 1990). GSH provides a "bound" form of cysteine 
residues since high concentrations of intracellular cysteine are considered 
toxic (Bannai and Tateishi, 1986). GSH is an appropriate alternative since 
the sulfhydryl group of GSH is more stable than that of cysteine (Bannai 
and Tateishi, 1986). Additionally, the tripeptide contains a large number of 
hydrophilic functional groups which increase its water solubility (Kosower, 
1976). Cystine, the disulfide form of cysteine, has a low water solubility and 
may be biologically unsuitable for a thiol-disulfide system in which the two 
oxidation states are interconverted.
GSH also functions in the transport of amino acids by moving readily 
across cell membranes possessing particular enzyme systems (Meister, 
1988b). Translocation of extracellular amino acids into the cell appears to be 
linked to efflux of GSH (Griffith et al., 1979).
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GSH is intimately associated with phase II conjugation reactions 
which render nonpolar xenobiotics to more hydrophilic compounds for 
elimination in the urine and the bile. GSH conjugates and detoxifies a 
variety of classes of electrophilic, hydrophobic compounds. The ability to 
detoxify a diversity of xenobiotics is probably the most obvious 
physiological benefit of GSH.
N-methyl-4-aminoazobenzene (MAB) and N-acetyl-2-aminofluorene 
(AAF) are potent hepatic carcinogens detoxified by GSH conjugation 
(Ketterer et al., 1983). N-Acetylbenzoquinone imine (NAPQI) is a reactive, 
soft electrophile produced by cytochrome P450 oxidation of paracetamol 
(Hinson, 1983). NAPQI may react with soft nucleophilic sites in cellular 
macromolecules or may be metabolized to a toxic phenoxy radical (Fisher 
and Mason, 1984). GSH can compete with these reactions either by 
conjugating NAPQI or by reducing it back to paracetamol (Hinson, 1983).
Biotransformation of benzo(a)pyrene (BP) by cytochrome P450s forms 
reactive metabolites which may be detoxified by conjugation with GSH.
The toxic effects of BP appear to be mediated by BP quinones and epoxides 
(Huberman et al., 1976; Wislocki et al., 1976). GSH conjugation of 
electrophilic BP epoxides and quinones detoxifies these compounds and 
enhances their excretion in the bile (Plummer et al., 1980; Chipman et al., 
1981; Elmhirst et al., 1985). Similarly, the addition of GSH to S9 liver 
fractions from the rat results in the reduction of BP and BP 7,8-diol-induced 
cytotoxicity while the presence of GSH in addition to glutathione S- 
transferase eliminates BP-induced cytotoxicity and reduces the mutagenicity 
of BP (Recio and Hsie, 1987).
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Similar to BP, the powerful hepatotoxin aflatoxin Bi exerts its 
carcinogenic effect through microsomal activation to a reactive epoxide 
(Swenson et al., 1977). This epoxide reacts with DNA primarily at the N-7 
of guanine bases in DNA (Lin et al., 1977). Detoxification of the epoxide by 
GSH conjugation appears to depend on the presence of cytosolic GSH S- 
transferases (Degen and Neumann, 1978; Emerole et al., 1979).
Glutathione Metabolism and Transport
GSH possesses two structurally characteristic features: 1) the y- 
glutamyl linkage between the y-carboxyl group of glutamate and the amino 
group of cysteine that protects the cysteinyl-glycine linkage from attack by 
intracellular peptidases and 2 ) a reactive thiol that provides the reducing 
power of the tripeptide. These components not only promote the 
intracellular stability of glutathione but are intimately associated with its 
functions (Meister, 1988a).
The y-glutamyl cycle (Figure 1.3), present in various types of cells 
including renal and intestinal epithelial cells, hepatocytes, and erythrocytes 
(Meister, 1994), is responsible for the degradation and resynthesis of cellular 
GSH. GSH utilized by this cycle is derived from the plasma or is directly 
transported out of the cell (Meister, 1988b). y-Glutamyltranspeptidase (GGT; 
EC 2.3.2.2), present on the external cell membrane, catalyzes the initial step 
of GSH degradation and cleaves the y-glutamyl linkage releasing 
cysteinylglycine and a y-glutamyl moiety. Since GGT is the only known 
enzyme able to cleave the y-glutamyl linkage (Meister, et al., 1981), GSH is 
protected from intracellular degradation. The cleaved y-glutamyl moiety 
binds to an extracellular amino acid and the resultant y-glutamyl amino 
acid is transported into the cell. Though other neutral amino acids such as
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methionine and glutamine may bind to the y-glutamyl moeity, cystine and 
cysteine are the most active amino acid acceptors for y-glutamyl 
transpeptidase (Meister, 1988b). Once within the cell, y-glutamyl 
cyclotransferase converts the y-glutamyl amino acid to 5-oxoproline and 
releases the amino acid. 5-oxoproline is then decyclized by 5-oxoprolinase to 
glutamate in an ATP-dependent step.
Coincidental to the transport of the y-glutamyl amino acid, cysteinyl- 
glycine may be transported into the cell where it is further degraded by 
cysteinylglycine dipeptidase (EC 3.4.13.6) or aminopeptidase M (EC 3.4.11.2) 
to cysteine and glycine. Alternatively, membrane-bound dipeptidase on the 
exterior of the cell may also cleave cysteinyl-glycine (Ketterer and Mulder, 
1990).
GSH resynthesis is then accomplished in two ATP-dependent steps 
from its glutamate, cysteine, and glycine constituents. The initial step is 
catalyzed by y-glutamylcysteine synthetase (GCS, EC 6.3.2.2). This forms the 
y-glutamyl linkage between the y-carboxyl group of glutamate and the 
amino group of the cysteine residue. y-Glutamylcysteine synthetase is 
feedback inhibited by glutathione (Richman and Meister, 1975) and is the 
rate-limiting enzyme in GSH synthesis (Meister, 1974). This suggests a 
physiologically significant feedback control on GSH synthesis. The synthesis 
of GSH is then completed by addition of a glycine moiety in an ATP- 
dependent reaction catalyzed by glutathione synthetase (EC 6.3.2.3).
Those organs expressing high enzyme activity for the y-glutamyl 
cycle are actively involved in GSH metabolism and transport as either "net 
exporters" or "net importers" of GSH. The liver actively synthesizes large 
quantities of GSH and is a" net exporter" of the tripeptide. Hepatic
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turnover (t1 /2  = 2 hours) is determined by the rate of GSH efflux (Bartoli et 
al., 1978; Lauterberg et al., 1984). Efflux of GSH from cells was first observed 
in perfused liver preparations (Bartoli and Sies, 1978) and has subsequently 
been shown to be translocated from hepatocytes into the plasma and the 
bile. The rate of hepatic efflux of GSH into the plasma is approximately 
four times greater than that translocated into the bile (Lauterburg et al., 
1984).
Though GSH efflux has been observed in a variety of cells including 
lymphoid cells (Griffith et al,  1979b), fibroblasts (Bannai and Tsukeda, 1979) 
and macrophages (Rouzer et al., 1982), efflux of GSH from the liver 
accounts for greater than 90% of the total GSH within the circulation 
(Bannai and Tateishi, 1986). Studies on the plasma levels of GSH in 
various blood vessels in the rat provide evidence supporting GSH efflux 
across the sinusoidal membrane (Anderson et al., 1980). Relative to the 
hepatic artery or inferior vena cava, the hepatic vein had a much higher 
level of plasma GSH. This reflects translocation of hepatic GSH across the 
sinusoidal membrane into the plasma. Under physiological conditions, 
GSH sinusoidal transport was observed as zero order with a rate near 
maximum (80% of Vmax). In the rat, sinusoidal export of GSH has been 
shown to be a saturable, carrier-mediated process that can be inhibited by 
organic anions such as bilirubin, BSP, and the sulfobromophthalein-GSH 
conjugate and can be stimulated by adenosine 3',5'-cyclic monophosphate- 
dependent hormones (Lu et al., 1990). Using hepatic sinusoidal membrane 
vesicles, investigators have described a multispecific, electrogenic transport 
system for GSH with low affinity kinetics (Ookhtens et al., 1985; Aw et al., 
1986; Ookhtens et a l ,  1988; Garcia-Ruiz et al., 1992) although Inoue et al.
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(1984) characterized two kinetically distinct, Na+-independent transport 
systems, one with a high affinity and the other with a low affinity for GSH. 
GSSG and GSH S-conjugates inhibited the latter transport system suggesting 
that GSH, GSSG, and some GSH conjugates are transported by the same 
system.
Though it has been widely accepted for some time that translocation 
of intact GSH across the hepatic sinusoidal membrane is a undirectional 
process and plasma GSH cannot be taken up by hepatocytes, recent evidence 
supports the theory that bidirectional transport of intact GSH actually occurs 
in rat and human hepatocytes. Bidirectional GSH transport across the 
sinusoidal membrane has been demonstrated in freshly isolated rat 
hepatocytes, membrane vesicles, and in Xenopus laevis oocytes expressing 
rat liver mRNA encoding the sinusoidal GSH transporter (Garcia-Ruiz et 
al., 1992; Fernandez-Checa et al., 1993) as well as in human hepatoblastoma- 
derived Hep G2 cells (Sze et al., 1993). Since both the efflux and uptake 
systems exhibit low affinity for GSH and the intracellular GSH 
concentration is several orders of magnitude greater than the extracellular 
GSH concentration, a net efflux of GSH occurs under normal physiological 
conditions. Additionally, low extracellular concentrations of GSH and 
GSSG have been shown to fra/zs-stimulate GSH efflux (Garcia-Ruiz et al.,
1992) while GSH uptake in Hep G2 cells, as well as rat hepatocytes, exhibit 
no Na+-dependence suggesting there is no driving force for net uptake 
against the intracellular concentration (Garcia-Ruiz et al., 1992; Sze et al.,
1993).
The activity of the sinusoidal GSH transporter in rats has also been 
shown to be modulated by the thiol-disulfide status of the cell and its
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environment (Lu et al., 1993). In cultured rat hepatocytes and perfused 
livers, GSH efflux was stimulated by the presence of dithiols and inhibited 
by disulfides. Similarly, GSH uptake was inhibited by the presence of 
dithiols. Although it is not certain whether thiols exert their stimulatory 
effect on the outside of the cell, within the cell membrane, or inside the cell, 
it seems clear that thiol reduction converts a bidirectional GSH transporter 
to a preferentially unidirectional exporter of GSH by inhibiting uptake and 
stimulating efflux. These data are also consistent with the observation that 
the GSH transporter operates as a net efflux pump under normal 
physiological conditions since the majority of plasma and intracellular GSH 
is in the reduced state (Anderson et al., 1980).
Approximately 15-20% of hepatic GSH efflux is directed into the 
biliary system (Kretzschmar and Klinger, 1990). Though Inoue et al. (1983, 
1984) characterized a high affinity, Na+-independent, saturable, carrier- 
mediated system using canalicular membrane vesicles, no saturation of 
GSH efflux into bile has been observed in vivo or in rat perfused liver 
(Kaplowitz et al,  1983; Lauterbergef al,  1984; Ookhtens and Maddatu, 1991). 
Studies utilizing mutant Eisai hyperbilirubinemic rats have demonstrated a 
distinct low affinity electrogenic carrier (Fernandez-Checa et al., 1992) for 
canalicular GSH transport; however, recent evidence suggests the presence 
of high- and low-affinity transport systems for GSH across the canalicular 
membrane (Ballatori et al., 1994). The high affinity system is c/s-inhibited 
by GSH conjugates, other y-glutamyl compounds, and BSP and is thought to 
be a multispecific organic anion transporter.
Though intact GSH is unidirectionally secreted from hepatocytes into 
bile, moderate amounts of GGT and dipeptidases are present along the
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canalicular membrane, bile duct epithelium and, to a lesser extent, in bile 
secretions (Hirata et al., 1984). This permits the degradation of biliary GSH 
and subsequent reabsorbtion of amino acid precursors. The amino acids 
may then be utilized for GSH resynthesis or in the synthesis of other 
peptides or proteins.
GSSG and GSH S-conjugates are also translocated across hepatic 
sinusoidal and canalicular membranes. At least two organic anion 
transport systems have been demonstrated for GSH conjugate transport 
across the sinusoidal membrane based on kinetics, substrate specificity, and 
chloride dependence (Stremmel and Diede, 1990; Min et al., 1991). A 
chloride-independent GSH conjugate efflux system appears to be shared 
with GSH (Sze et al., 1993). The fact that the efflux of GSH across the 
sinusoidal membrane is inhibited by GSH S-conjugates (Lu et al., 1990) also 
suggests a shared transport system.
Although small but significant quantities of GSH S-conjugates are 
released from the liver into the plasma (Sies et al., 1978; Wahllander and 
Sies, 1979), GSH S-conjugates are preferentially released across the 
canalicular membrane into the bile (Sies et al., 1978; Sies et al., 1980; 
Akerboom etal.,  1982a; Akerboom etal., 1982b). Sinusoidal transport is 
electrogenic (Kobayashi et al., 1990) and may augment hepatic excretion of 
GSH conjugates when their concentrations exceed the capacity of the 
transport processes on the canalicular membrane. Many GSH conjugates 
exhibit physiochemical properties favoring their excretion into the bile. 
Compounds with a molecular weight 325 ± 50 or greater and possessing a 
strong polar group are preferentially excreted in the bile (Hirom et al., 1972; 
Sipes and Gandolfi, 1986).
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A high affinity ATP-dependent transport system across the 
canalicular membrane has been demonstrated for BSP-SG (Kitamura et al., 
1990), S-(2,4-dinitrophenyl) glutathione (DNP-SG; Kobayashi et al., 1990; 
Akerboom et al., 1991), and cysteinyl leukotrienes (Ishikawa et al., 1990). 
This system actually mediates the efflux of xenobiotics conjugated with 
GSH, glucuronate, and possibly sulfate (LeBlanc, 1994) and is important not 
only in the elimination of xenobiotics and GSSG, but also in the regulation 
of biologically active GSH conjugates such as leukotriene C4 . This 
transporter is also present in erythrocytes and cardiac muscle and is 
believed to be mediated by a 90 kDa protein with ATPase activity (Pikula et 
a l ,  1994).
ATP-dependent uptake of DNP-SG was czs-inhibited in a competitive 
manner by other GSH conjugates and GSSG but not by GSH (Kobayashi et 
a l ,  1990; Akerboom et al,  1991) and the inhibitory effect of GSH conjugates 
increased with increasing chain length (Kobayashi et al ,  1990). In addition, 
secretion of GSH was fjans-stimulated by GSH conjugates such that GSH 
efflux may drive the uptake of organic anions into the hepatocyte with 
significant toxicological consequences.
In contrast, two ATP-independent GSH conjugate transport 
mechanisms have recently been identified (Ballatori et al ,  1994) at the 
canalicular membrane. While one ATP-independent transport mechanism  
appears to be fairly specific for GSH conjugates, the other ATP-independent 
carrier is analogous to the high affinity system that transports GSH as well 
as other y-glutamyl compounds. This latter system apparently transports 
GSH conjugates of low molecular weight since ethyl-GSH was a substrate 
for this carrier and not the ATP-dependent mechanism. Conversely,
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DNP-GSH is not only a substrate for the high affinity, ATP-dependent 
transporter, but acts as a substrate for at least two other ATP-independent 
mechanisms as well (Ballatori et al., 1994). It appears that the 
physiochemical properties of the S-moiety may determine whether the 
compound is a substrate for a particular transport mechanism. Data 
throughout the literature suggest that multiple transport mechanisms exist 
for GSH and GSH conjugates in both the sinusoidal and canalicular 
membranes.
GSSG also competes with GSH conjugates for transport across the 
canalicular and sinusoidal membranes. As previously mentioned, Inoue et 
al. (1984) demonstrated a low affinity transporter in the hepatic sinusoidal 
membrane involved in the transport of GSH, GSSG, and some GSH 
conjugates.
Lindwall and Boyer (1987) reportedly demonstrated a specific 
transport system for GSH S-conjugates which was not inhibited by GSSG; 
however, ATP-dependent carrier systems have been demonstrated for the 
transport of both GSSG (Akerboom etal., 1991) and GSH S-conjugates 
(Kobayashi et al., 1990) across the canalicular membrane. It has been 
demonstrated that the ATP-dependent GSH conjugate export pump 
transports GSSG as well as various conjugates of GSH out of the cell 
(Ishikawa, 1992). Additionally, a common biliary secretory mechanism is 
shared by GSSG and bilirubin in rats (Kuromma et al., 1993) but whether 
this is a multispecific organic anion transporter shared by GSH conjugates is 
not yet clear.
A second, distinct transport mechanism has been demonstrated at 
the sinusoidal membrane which is thought to secrete excess intracellular
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GSSG when canalicular transport becomes saturated (Akerboom etal.,  
1982b; Ballatori and Troung, 1989; Jaeschke, 1990). Sinusoidal GSSG efflux is 
driven by a K+ concentration gradient which requires ATP only indirectly to 
maintain the intracellular K+ concentration via a Na+-K+ pump (Ozaki et 
a l ,  1994).
The biliary concentration of GSSG is approximately 20-fold higher 
than the intrahepatic concentration (Akerboom etal.,  1982a) and 
intrahepatic concentrations of GSSG are typically very low under normal 
physiological conditions. During periods of oxidative stress GSSG efflux 
increases dramatically and measurement of plasma GSSG is considered a 
reliable index of cellular oxidative stress (Kretzschmar and Klinger, 1990). 
Increased efflux of GSSG during oxidative stress has been reported in the 
ocular lens (Srivastra and Beutler, 1968), erythrocytes (Srivastra and Beutler, 
1969), perfused heart (Ishikawa and Sies, 1984; Ishikawa et al., 1986) and 
liver (Akerboom etal.,  1982b; Ballatori and Troung, 1989; Jaeschke, 1990; 
Younes and Strubelt; 1990), and isolated hepatocytes (Oude Elferink et al., 
1990).
Release of GSSG is thought to be an "emergency" response to high 
intracellular levels of GSSG and loss of reducing capacity. Sinusoidal GSSG 
release during oxidative stress, however, results in a net loss of cellular 
GSH which may play a significant role in the subsequent development of 
toxicity.
The accumulation of intracellular GSH protects cells from oxidative 
damage (Hagen et al., 1988). The kidney is the primary organ for clearance 
of plasma GSH (McIntyre and Curthoys, 1980; Orrenius et al., 1983) and is 
capable of extracting 80-90% of circulating GSH in a single pass (Haberle et
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al., 1979). This results in extremely low levels of plasma GSH (/iM) and a 
11 /2  of only 2 minutes (Wendel and Cikryt, 1980).
Cells exhibiting high levels of GGT activity cleave the y-glutamyl 
linkage and accumulate GSH intracellularly. Renal proximal tubular 
epithelial cells display the highest levels of GGT activity (Goldberg et al., 
1960); however, an appreciable amount is also evident in pancreatic acinar 
and ductile epithelium as well as epithelial cells of the jejunum, biliary 
canaliculi, epididymus, seminal vesicles, bronchioles, thyroid follicles, and 
the retinal pigment epithelium, choroid plexus and ciliary body (Meister et 
al., 1976).
Although it was previously believed that renal GGT was only present 
on the luminal aspect of the tubular epithelial cell, electron micrograph 
studies and immunochemical staining (Spater et al., 1982) identified the 
transpeptidase on the basolateral membrane as well. Additionally, 
Anderson and coworkers (1980) observed that the GSH levels in the renal 
vein contained approximately 2 0 % of the levels found in the renal arterial 
plasma. This suggests that the kidney removes GSH from the plasma not 
only by glomerular filtration, which would account for only 20-30% of the 
GSH removed, but also by a mechanism at the basolateral membrane. 
Furthermore, AT-125, an inhibitor of GGT, decreased the amount of plasma 
GSH cleared by the kidney to levels approximating that removed through 
glomerular filtration. This supports a role for GGT in the renal clearance 
and uptake of GSH. GSH in the plasma or filtered by the glomerulus is 
degraded to its constituent amino acids by membrane-bound GGT and 
aminopeptidase M or cysteinylglycine dipeptidase (Ketterer and Mulder, 
1990).
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GGT is not only capable of catalyzing transpeptidation reactions, but 
may additionally catalyze autotranspeptidation of y-glutamyl peptides or 
amino acids and hydrolytic reactions resulting in the formation of 
glutamate (Laperche et al., 1990).
Despite the fact that the kidney exhibits high levels of GGT and is a 
"net importer" of GSH, 80-90% of renal GSH is actually derived from de 
novo synthesis within the tubular epithelial cell (Meister and Anderson, 
1983). Renal GSH is rapidly synthesized from its amino acid constituents by 
GCS and GSH synthetase and the rate of turnover of cytosolic GSH within 
the kidney is approximately 20 minutes (Sekura and Meister, 1974).
Large amounts of GSH are actively secreted from renal proximal 
tubular epithelial cells into the tubular lumen (Hsu et al., 1984). Under 
normal physiological conditions the normal level of GSH within the 
filtrate is approximately 0.6 //M in the rat. Following administration of AT- 
125, the urinary GSH concentration increased to 3mM indicating that > 99% 
of the tubular GSH is normally reabsorbed (Curthoys, 1990).
Plasma GSH is not only accumulated in the renal proximal tubular 
epithelial cell via degradation and resynthesis, but may be transported intact 
across the basolateral membrane (Lash and Jones, 1983). Intact GSH is taken 
up by a Na+-dependent, probenecid-sensitive electrogenic transporter 
thought to be a general transport mechanism for y-glutamyl compounds 
including GSSG and GSH conjugates (Lash and Jones, 1984; Rankin et al., 
1985; Hagen et al., 1988). GSH transport exhibits a Na+:GSH stoichiometry 
of 2:1 (Lash and Jones, 1984b) and exhibits a rate of GSH accumulation 
approximately 3-fold greater than the GSH synthetic rate from amino acid 
precursors (Hagen et al., 1988). The system appears to have a sufficient
60
driving force to allow uptake of GSH into cells against a GSH concentration 
gradient.
The significance of renal influx of intact GSH is highly controversial. 
Though Abbott and coworkers (1984) demonstrated barely detectable 
transport of intact GSH in the presence of extensive degradation of the 
tripeptide at the basolateral membrane, studies using isolated proximal 
tubular epithelial cells revealed protection by the uptake of intact GSH 
against the potent antioxidant, t-butylhydroperoxide (Hagen et al., 1988). 
Several other epithelial cells have also demonstrated uptake of intact GSH 
by either Na+-dependent (alveolar type II epithelial cells and enterocytes) or 
N a+-independent (buccal epithelial cells, colonocytes, and enterocytes) 
transport systems (Hagen et ah, 1986; Lash et al., 1986b; Vincenzini et al., 
1992). Conversely, erythrocytes, macrophages, retinal pigment epithelial 
cells, and alveolar type I cells did not exhibit uptake of intact GSH (Foreman 
and Skelton, 1990; Sternberg et al., 1993).
Intact GSH is transported across the basolateral membrane from the 
vasculature into enterocytes by a common transport system shared with 
GSH conjugates (Lash et al., 1986b; Vincenzini et al., 1992). The transport of 
GSH into intestinal epithelial cells is thought to protect these cells from 
oxidative or xenobiotic injury and may act as the first line of defense against 
dietary electrophiles. Transport of GSH conjugates from the vasculature 
into enterocytes may also serve as a potential route of excretion. 
Translocation of intact GSH and GSH conjugates across intestinal brush 
border membranes into the luminal space has been demonstrated in rats 
using small intestine brush-border membrane vesicles (BBMV; Linder et 
al., 1984; Vincenzini et al., 1992) and vascularly perfused jejunum (Hagen
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and Jones, 1987). Although Linder and coworkers (1984) described transport 
across the brush-border membrane as Na+-dependent and carrier-mediated, 
Vincenzini et al. (1992) characterized a Na+-independent carrier system. 
Basolateral transport of GSH is competitively inhibited by probenecid while 
the brush-border system is not, suggesting two distinct transport 
mechanisms (Hagen et al., 1987).
Intestinal transport of GSH across the brush-border membrane 
exhibits cis-inhibition and fraus-stimulation in the presence of GSH 
conjugates such that intracellular GSH conjugates inhibit GSH efflux and 
stimulate GSH uptake while extracellular GSH conjugates inhibit GSH 
uptake (Vincenzini et al., 1992). Alternatively, as GSH conjugates cross the 
epithelial cell from the vasculature, GSH is transported from the lumen 
into the cells and finally to the plasma where it is available to other organs.
Trans-stimulation of intestinal transport of GSH across BBMV was 
also observed with amino acids (Corcelli et al., 1982; Lash and Jones, 1984a). 
Trans-stimulation by amino acids would allow increased efflux of GSH into 
the intestinal lumen following a meal. Once within the lumen, GGT may 
release the y-glutamyl moiety which accepts an amino acid prior to 
transport into the cell. By this mechanism amino acid transport could be 
enhanced in the presence of high concentrations of dietary amino acids. It 
also appears that the formation of GSH conjugates within intestinal 
epithelial cells stimulates the uptake of GSH into cells where it is needed 
due to possible depletion from GSH conjugation. GSH may be utilized 
intracellularly or transported to the luminal surface.
Within the intestinal lumen, extracellular GSH, from the bile or 
intestinal secretions, may conjugate electrophiles resulting from microbial
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metabolism or the diet. In vivo studies by Hagen and coworkers (1990) 
revealed that GSH was present within the intestinal lumen under all 
conditions even without supplementation of GSH in the diet. The 
combined activities of y-glutamyl transpeptidase and the GSH uptake 
system were not sufficient to remove all the luminal GSH. In fact, a 
mechanism for reduction of GSSG to GSH was observed in the intestinal 
lumen and it was theorized that GSH within the lumen may detoxify 
xenobiotics in the food or bile to protect the intestinal epithelium from 
injury.
Numerous xenobiotics, or their corresponding metabolites, are 
detoxified by GSH conjugation. GSH conjugation of vinylidene chloride, 
bromobenzene, aflatoxin By  styrene, 1-nitropyrene, paracetemol, and 
monocrotaline (Jollow et al., 1974; D'Souza and Andersen, 1988; Wilson et 
al., 1992; Kataoka et al., 1991; James et al., 1993; Morgan et al., 1993; Gopalan- 
Kriczky et al., 1994) prevents the toxicity and carcinogenic effects of these 
xenobiotic metabolites.
The interorgan translocation of GSH conjugates is complex. The 
liver, receiving the portal circulation from the gastrointestinal tract, is 
responsible for the formation of the majority of GSH conjugates. GSH 
conjugates may be translocated from the hepatocyte into the bile or 
circulation (Dekant et al., 1988). Once present in the circulation, GSH 
conjugates may be taken up intact by the kidney (Lash and Jones, 1984b) or 
the intestinal epithelial cell (Lash et al., 1986b) or may be degraded at the 
basolateral membrane of the kidney and transported into the renal 
epithelial cell as a y-glutamyl amino acid and the cysteine conjugate 
(Rankin et al., 1983; Abbott, et al., 1984). Intact intracellular GSH conjugates
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may be secreted into the urine from the renal epithelial cell (Griffith and 
Meister, 1979; Griffith, 1981; Scott and Curthoys, 1986).
Plasma GSH conjugates may also be filtered by the glomerulus 
(Dekant et al., 1988). Following degradation of the GSH conjugate by y- 
glutamyltranspeptidase and cysteinyl-glycine dipeptidase or aminopeptidase 
M, the cysteine conjugate within the filtrate may be transported into the 
renal epithelial cell from the urinary filtrate or it may be excreted in the 
urine. In the renal epithelial cell, the cysteine conjugate may be excreted 
back into the urine (Dekant et al., 1988) or N-acetylated to the mercapturic 
acid via cysteine conjugate N-acetyltransferase (Duffel and Jakoby, 1982). 
Alternatively, the cysteine conjugate can be converted to a reactive thiol in 
addition to ammonia and pyruvate by renal cysteine conjugate p-lyase 
(Elfarra and Anders, 1984). The potentially reactive thiol is then capable of 
being converted to the methyl thiol derivative by thiol S-methyl 
transferase; the methyl thiol derivative may be excreted in the urine. The 
cysteine conjugate may also be released into the plasma and transported to 
the liver where it undergoes N-acetylation to the mercapturic acid (Dekant 
et al., 1988). It should be noted that at any point mecapturic acids may be 
deacetylated back to the cysteine conjugate (Suzuki and Tateishi, 1981).
GSH conjugates, mercapturates, and cysteine conjugates in the 
plasma may alternatively be taken up by intestinal epithelial cells 
(Vincenzini et al., 1991). Cysteine conjugates and mercapturates excreted 
into the intestinal lumen may be excreted in the feces or they may be 
further metabolized. Cysteine conjugates can be converted to the 
corresponding mercapturic acid or reactive thiol via N-acetyltransferase 
(Meister, 1988b) and bacterial p-lyase (Stevens and jakoby, 1985),
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respectively. The thiol can be methylated to the methyl thiol derivative 
which is excreted in the feces. At any point in the metabolism of these 
compounds a metabolite may undergo enterohepatic recirculation to the 
liver.
GSH conjugates in the plasma that undergo transcellular 
translocation into the intestinal lumen are subject to the same fate as GSH 
conjugates secreted in the bile from the liver. GSH conjugates in the bile 
and intestinal secretions are either transported intact into the intestinal 
epithelium (Dekant et al., 1988) or are degraded to the cysteine conjugate by 
y-glutamyltranspeptidase and dipeptidases present along the biliary 
epithelium and canalicular membrane of hepatocytes (Inoue et al., 1983; 
Meier et al., 1984; Ballatori et al., 1986). Once formed, the cysteine conjugate 
may undergo enterohepatic recirculation or it may be transported to the 
kidney (Dekant et al., 1988). Alternatively, the cysteine conjugate may be 
further metabolized within the intestinal lumen as previously described.
GSH conjugates may also be directly formed in the intestinal 
epithelial cell which may serve as the first line of defense against dietary 
mutagens and carcinogens (Vincenzini et al., 1991). GSH conjugates 
translocated into the plasma from the intestinal epithelial cell are subject to 
uptake and metabolism by renal epithelial cells (Lash and Jones, 1984b).
Although GSH-dependent reactions that terminate in the formation 
and excretion of mercapturic acids play a major role in the detoxification of 
xenobiotics, it has become increasingly obvious that GSH conjugation also 
constitutes an important mechanism of bioactivation for several classes of 
compounds (Monks and Lau, 1987; Monks et al., 1990; Vamvakas and 
Anders, 1990; Koob and Dekant, 1991; Dekant and Vamvakas, 1993). GSH
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conjugates may be either direct acting toxic agents which are noxious 
without further metabolism or they may require further metabolism to 
express toxicity. Ethylene dibromide is a direct-acting GSH conjugate 
widely used as a lead scavenger for gasoline and as a soil fumigant. This 
compound forms the half-sulfur mustard, S-(2-bromethyl)GSH, also 
referred to as a thiiranium or episulfonium (Ozawa and Guengerich, 1983; 
Koga et al., 1986). The half-sulfur mustard reacts with the N 7  of guanine in 
DNA to form the S-[2-(N7-guanyl)ethyl]-GSH adduct and is responsible for 
the carcinogenic effects of this vicinal dihaloalkane (Inskeep et al., 1986). 
Similarly, the genotoxicity of ethylene dichloride is mediated through GSH 
conjugation and episulfonium ion formation (Rannug et al., 1978; 
Guengerich et al., 1980; Storer and Conolly, 1985; Inskeep et al., 1986).
Although l,2-dibromo-3-chloropropane is metabolized by 
cytochrome P450 to a mutagenic metabolite (2-bromoacrolein) and the 
presence of GSH and GST decrease the mutagenicity of this compound 
(Omichinski et al., 1988), the GSH conjugate, 2-(3-chloro-2-bromo- 
propyl)GSH, is an intermediate that spontaneously cyclizes to an 
episulfonium ion. This later metabolite has been shown to be responsible 
for the acute toxicity observed following administration of l,2-dibromo~3- 
chloropropane (Pearson et al., 1990).
Unlike some of the halogenated hydrocarbons, the majority of 
xenobiotics bioactivated by GSH conjugation require further metabolism to 
express toxicity . Many of these compounds appear to target the kidney with 
resultant nephrotoxicity. Because of their structure and physiological 
function, renal epithelial cells are exposed to more chemicals than most 
other organs and tend to concentrate xenobiotics due to the normal
66
functions of filtration, reabsorbtion, and secretion. The kidneys comprise 
only 0.4% of the body weight of most mammals, but receive 25% of the 
cardiac output (Monks and Lau, 1987). In particular, the renal cortex (where 
the majority of the proximal tubules are located) receives greater than 90% 
of the renal blood flow (Maher, 1976). Additionally, the specialized 
functions of renal proximal tubular epithelial cells may enhance toxicity 
through the concentration of xenobiotics. Renal proximal tubular 
epithelial cells possess the highest level of GGT activity (Goldberg et al., 
1960) and are active in the uptake and concentration of metabolites of GSH 
conjugates.
Nephrotoxicity through episulfonium formation has been 
demonstrated for direct-acting compounds including ethylene dichloride 
(Elfarra et al., 1985), l,2-dibromo-3-chloropropane (Pearson et al., 1990), and 
tris(2,3-dibromopropyl) phosphate (Dekant and Vamvakas, 1993). 
Nephrotoxicity following GSH conjugation, however, is more typically 
mediated through the formation of cysteine conjugates, mercapturic acids, 
or reactive thiols. Due to the expression of extremely high concentrations 
of GGT along the basolateral and luminal membranes, the kidney actively 
concentrates cysteine conjugates within proximal tubular epithelial cells. 
Once within the cell, the cysteine conjugate may be directly nephrotoxic or 
may require further metabolism to the corresponding mercapturic acid or 
reactive thiol by N-acetyltransferase or cysteine conjugate (3-lyase, 
respectively (Nelson, 1992).
The cysteine conjugate of bromohydroquinone, a toxic metabolite of 
bromobenzene (Lau et al., 1984), appears to be responsible for 
bromobenzene-induced nephrotoxicity. Substitution of
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bromohydroquinones with cysteine lowers the redox potential and renders 
bromohydroquinone more susceptible to oxidation and increases the 
formation of toxic quinones (Monks and Lau, 1990; Lau et al., 1988a, b). 
Additionally, the reduction of bromohydroquinone-induced nephrotoxicity 
by simultaneous administration of ascorbic acid suggests that processes 
involving oxidation to a reactive quinone and, possibly, peroxidative 
mechanisms are involved in the nephrotoxic effects (Lau et al., 1988b).
The GSH conjugate [S-(l,2-dichlorovinyl)GSH or DCVG] and the 
cysteine conjugate [S-(l,2-dichlorovinyl)-L-cysteine or DCVG] of 
trichloroethylene as well as the cysteine conjugate (S-pentachlorobuta-1,3- 
dienylcysteine) and mercapturic acid [N-acetyl-(S-l,l,2,3,4- pentachloro- 
butadienyl)-L-cysteine] of hexachlorobutadiene have demonstrated 
nephrotoxic effects in vivo and in vitro (Terracini and Parker, 1965; Jaffe et 
al., 1983; Elfarra and Anders, 1984; Reichert and Schutz, 1986). The 
nephrotoxicity of these compounds, however, has been shown to be 
mediated through activation via renal p-lyase (Elfarra and Anders, 1984; 
Lash and Anders, 1986; Dekant and Vamvakas, 1993).
Similarly, haloalkene-induced nephrotoxicity involves bioactivation 
by renal 0-lyase. The cysteine conjugate of chlorotrifluoroethene, S-(2- 
chloro-l,l,2-trifluoroethyl)-L-cysteine, is metabolized by 0 -lyase to 2-chloro- 
1,1,2-trifluoroethane thiol which forms a thionoacetyl fluoride (Dekant et 
al., 1987). This latter metabolite reacts with cellular macromolecules with 
resultant nephrotoxicity.
Inhibition of mitochondrial function appears to be the mechanism of 
toxicity for many of these cysteine conjugates (Lash and Anders, 1986; Lash 
and Anders, 1987; Banki and Anders, 1989). Mitochondria are readily
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targeted by reactive thiols since these organelles contain significant 
quantities of renal p-lyase (Lashef al., 1986a). p-lyase-mediated toxicity 
inhibits cellular oxygen consumption and decreases ATP concentrations.
Renal cysteine conjugate p-lyase is a pyridoxal phosphate (PLP)- 
dependent enzyme present in both cytosolic and mitochondrial cellular 
fractions (Dohn and Anders, 1982; Stevens, 1985a). Renal cytosolic p-lyase 
is identical to glutamine transaminase K (EC 2.6.1.64; Stevens et al., 1986). 
Glutamine transaminase K , found in the cytosol and mitochondria, 
catalyzes transamination reactions between a-keto acids and amino acids 
(Ricci et al., 1986).
Mitochondrial P-lyase has been localized to the outer mitochondrial 
membrane (Lash et al., 1986a) and mitochondrial matrix (Stevens et al., 
1988a). Mitochondrial p-lyase found within the matrix is inhibited by 
antibodies raised to the renal cytosolic enzyme while the enzyme located in 
the outer membrane was not (Stevens et al., 1988a). Thus, there appear to 
be at least two mitochondrial p-lyases in the rat kidney.
The catalytic mechanism of renal p-lyase involves, after Schiff base 
or aldimine formation with PLP, proton abstraction from the a-carbon, a p- 
elimination reaction, and subsequent hydrolysis to eventually yield 
ammonia, pyruvate, and a potentially reactive thiol thought to be 
responsible for the toxicity (Davis and Metzler, 1972). Pyruvate and the 
reactive thiol may also be formed via a C-S cleavage reaction which is not 
catalyzed by renal p-lyase (Tomisawa et al., 1986). Alternatively, p-lyase 
has been demonstrated to catalyze a half-transamination reaction rather 
than a p-elimination reaction and produce an a-keto acid analog of the 
cysteine conjugate. Additionally, L-amino acid oxidase (EC 1.4.3.2),
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identified in the cytosol and mitochondria, may catalyze the oxidative 
deamination of the cysteine conjugate (Stevens et al., 1986).
P-lyase activity is also found in the liver. Hepatic p-lyase is 
different from renal p-lyase activity (Tateishi and Shimizu, 1980; Stevens 
and Jackoby, 1983; Stevens, 1985b), however, and is actually identical to 
kynureninase (Stevens, 1985b).
Renal cysteine conjugate p-lyase activity has been demonstrated to be 
responsible for the formation of mutagenic metabolites from cysteine 
conjugates of various halogenated alkenes (Green and Odum, 1985; Dekant 
et al., 1988; Commandeur et al., 1991). The mutagenicity of these 
compounds was diminished in the presence of aminooxyacetic acid 
(AOAA). AOAA (Figure 1.4) is a competitive inhibitor of pyridoxal 
phosphate-dependent enzymes (Wallach, 1960; Beeler and Churchich, 1976) 
including renal p-lyase (Figure 1.5; Elfarra et al., 1986).
Other inhibitors, such as p-di-/z-propylsulfamoyl benzoic acid 
(probenecid) and (aS, 5S)-a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic 
acid (acivicin or AT-125) have been extensively utilized to elucidate the 
ultimate toxic metabolite for various classes of compounds. Probenecid 
(Figure 1.6) has been used therapeutically to prolong the half-life of 
penicillin (Beyer, 1950; Beyer et al., 1951) and as an uricosuric agent in the 
treatment of gout (Gutman and Yu, 1957).
Probenecid is secreted into the tubular lumen as the glucuronide 
conjugate by the organic anion transport system (OATS; Israeli et al., 1972; 
Dayton et al., 1973; Cunningham et al., 1981). Probenecid inhibits 
glucuronidation of various compounds (Vree et al., 1993; Vree et al., 1994)
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Figure 1.4 Structure of aminooxyacetic acid (AOAA).
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Figure 1.5 Biochemical pathway illustrating the metabolism of 
glutathione conjugates and the inhibitory effect of aminooxyacetic acid 
(AOAA) on renal cysteine conjugate p-lyase.
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Figure 1 . 6 Structure of probenecid (p-di-n -propylsulfamoyl benzoic acid)
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and competitively inhibits renal elimination of weak organic acids such as 
p-aminohippurate and salicylic acid (Figure 1.7; Gutman et al., 1955).
Evidence suggests that there are at least three distinct basolateral 
OATS in rat proximal tubular epithelial cells (Ullrich and Rumrich, 1988; 
Burckhardt and Ullrich, 1989). Once inside the cell, organic anions may be 
transported into the tubular lumen in exchange for another anion. In the 
process of tubular secretion, renal proximal tubular cells can concentrate 
organic anions to levels several hundred times greater than that of the 
interstitial fluid (Goldstein, 1993). Renal secretion via the OATS is confined 
to the proximal convoluted tubule and appears most intense in the 5 2 - 
segment for most organic anions (Shimomura et ah, 1981).
Conversely, AT-125 is a glutamine analog (Figure 1.8) that 
irreversibly inactivates y-glutamyl transpeptidase (GGT; Gardell and 
Tate,1980; Reed et al., 1980) as well as various glutamine amidotransferases 
(Tso et al., 1980) and glutaminases (Jayaram et al., 1975). AT-125 inhibits 
GGT by covalently attaching to the y-glutamyl region of the active site 
(Figure 1.9).
AOAA, probenecid, and AT-125 have been utilized individually as 
well as in tandem to elucidate toxic metabolites responsible for renal 
toxicity for various compounds.
Nitriles
Nitriles are organic compounds with a terminal cyano (CN) moiety 
widely distributed in the environment both as natural and industrially 
produced chemicals (Egekeze and Oehme, 1980). Synthetic aliphatic and 
aromatic nitriles are used extensively in the manufacture of plastics, 
solvents, synthetic fibers, resins, pharmaceuticals, vitamins, and
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Figure 1.7 Diagram depicting the inhibitory effect of probenecid (p-di-n- 
propylsulfamoyl benzoic acid) on the organic anion transport system  
(OATS) at the sinusoidal membrane of the hepatocyte and the basolateral 
membrane of the renal proximal tubular epithelial cell.
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Figure 1.8 Structure of the glutamine analog, AT-125 [acivicin or (aS, 5S)- 
a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid], in comparison with  
the structure of glutamine.
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Figure 1.9 Diagram illustrating the inhibitory effect of AT-125 [acivicin
or (aS, 5S)-a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid] on y- 
glutamyltranspeptidase at the basolateral membrane of the renal proximal 
tubular epithelial cell.
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agricultural insecticides (Whitehill and Smith, 1981). Organonitriles are 
produced from the catabolism of plant cyanogenic glucosides or are derived 
from glucosinolates in plants. There are approximately 2000 species of 
plants that have been shown to be cyanogenic, releasing hydrogen cyanide 
when macerated (Conn, 1980; Vennesland et al,  1982).
Exposure of humans and experimental animals to organic nitriles 
has been documented to cause neurotoxicity ( Farooqui and Mumtaz, 1991) 
in addition to various lesions within the thyroid, liver, adrenal glands, and 
gastrointestinal tract (Silver et al., 1982; Sipes and Gandolfi, 1986; Villarreal 
et al., 1988). Organic nitriles have also been shown to cause teratogenic 
effects in rats (Whitehill et al,  1981a, b).
The acute toxicity of nitriles has been correlated with the in vivo 
release of cyanide (Willhite and Smith, 1981; Farooqui and Mumtaz, 1991) 
with the extent of liberation dependent on the nitrile, animal species, route 
of exposure, and chemical structure of the parent compound (Ahmed and 
Farooqui, 1982; Silver et al., 1982; Tanii and Flashimoto, 1984a, b). Urinary 
excretion of high levels of thiocyanate (SCM~) were observed following 
administration of saturated aliphatic nitriles consistent with detoxification 
of the cyanide ion by rhodanese activity (Sipes and Grandolfi, 1986; Wallig 
et al., 1988a). Additionally, many of these compounds cause classical signs 
of cyanide toxicosis which were ameliorated by standard therapy for cyanide 
intoxication (Pozzani et al., 1968).
Unsaturated aliphatic nitriles such as acrylonitrile, methacrylonitrile, 
crotonitrile, and cinnamonitrile are partially metabolized to the cyanide 
ion, but have also been shown to undergo GSH conjugation in vitro and in 
v i v o  (van Bladeren, et al., 1981a; Cote et al., 1984; Day et al., 1988).
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Administration of unsaturated aliphatic nitriles to experimental animals 
resulted in depletion of tissue GSH levels (van Bladeren, et al., 1981a; Cote 
etal.,  1984; Day et al., 1988) and the formation of mercapturic acids which 
were excreted in the urine (Langvardt et al., 1980; Muller et al., 1987;Tardif 
et al,  1987).
Nitriles, including l-cyano-3,4-epithiobutane (CEB), l-cyano-2- 
hydroxy-3,4-epithiobutane (CHEB), and l-cyano-2-hydroxy-3-butene (CHB), 
derived from cruciferous plants cause only mild increases in urinary 
thiocyanate (SCN~) excretion and are extensively conjugated with GSH in 
vivo (Wallig et al., 1988 a, b; VanSteenhouse et al., 1989). Conjugation with 
GSH bioactivates these organonitriles with resultant toxicity to specific 
target organs.
(S)-l-cyano-2-hydroxy-3-butene (CHB) was selectively pancreatotoxic 
at low dosages (Wallig et al., 1988b; Maher et al., 1991) but acutely 
pancreatotoxic and hepatotoxic at higher concentrations (Nishie and 
Daxenbichler, 1980). Administration of CHB caused exocrine pancreatic 
atrophy with acinar cell apoptosis and hepatocellular necrosis with biliary 
hyperplasia. CHB markedly elevated tissue GSH levels in the liver and 
pancreas while renal GSH was unaffected (Wallig and Gould, 1986; Wallig 
et al., 1992).
Conversely, 2S-l-cyano-2-hydroxy-3,4-epithiobutane (CHEB) was 
acutely nephrotoxic causing dose- and time-dependent renal proximal 
tubular epithelial cell necrosis (Gould et al., 1985). When administered 
chronically, however, CHEB demonstrated hepatotoxicity and 
pancreatotoxicity as well as nephrotoxicity (Gould et al., 1980). Hepatic 
lesions were characterized by bile duct hyperplasia, fibrosis, megalocytosis,
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and hepatocellular necrosis while pancreatic alterations consisted of 
karyomegaly of acinar cells. Lesions within the kidneys were characterized 
by cytomegaly consisting of cytoplasmic enlargement as well as striking 
karyomegaly. CHEB caused marked elevations in renal, hepatic, and 
pancreatic GSH (Wallig and Gould, 1986).
l-Cyano-3,4-epithiobutane (CEB; Figure 1.10) has demonstrated 
teratogenic effects in pregnant Holtzman rats (Nishie and Daxenbichler, 
1980) and nephrotoxic effects in male Fischer 344 rats (VanSteenhouse et al., 
1989). CEB was shown to be selectively nephrotoxic with no lesions evident 
in the liver or pancreas. Administration of a single high dose (125 m g/kg  
body weight) of CEB resulted in epithelial cell necrosis and karyomegaly 
within the pars recta of the renal proximal tubules; administration of a 
single low dose (50 m g/kg body weight) of CEB did not result in epithelial 
cell death but caused karyomegaly within the renal proximal tubule.
In rats administered the high dose of CEB, an initial phase of 
depletion in hepatic GSH was observed, followed by increased GSH by 12 
hours post-CEB administration. Conversely, increased hepatic GSH was 
observed by 12 hours post-CEB administration with no phase of depletion 
in rats treated with low doses of CEB. With both doses, renal GSH was 
elevated at all time periods with no phase of depletion recognized. Urinary 
excretion of nonprotein thiols was increased with both doses. There were 
no significant alterations in pancreatic GSH.
Further investigations by VanSteenhouse et al. (1991) revealed that 
pretreatment with buthionine sulfoximine (BSO; Figures 1.11 and 1.12), an 
inhibitor of y-glutamylcysteine synthetase and a GSH-depleting agent, 
greatly diminished tubular necrosis and karyomegaly induced by CEB.
/ s \
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Figure 1.10 Structure of l-cyano-3,4-epithiobutane (CEB).
Figure 1.11 Structure of buthionine sulfoximine (BSO) in its 
phosphorylated form.
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Figure 1.12 Diagram of the y-glutamyl cylce depicting the inhibitory effect 
of buthionine sufoximine (BSO) on y-glutamylcysteine synthetase.
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Depletion of hepatic GSH, increased urinary excretion of nonprotein thiols, 
and decreased nephrotoxicity following pretreatment with BSO suggest that 
GSH conjugation is an important pathway of bioactivation in CEB 
metabolism with the conjugate, or a metabolite of the conjugate, being 
involved in the nephrotoxicity. Since CHEB is also selectively nephrotoxic 
while CHB is not, it is possible that the epithiol moiety of CEB and CHEB 
may be involved in the nephrotoxicity associated with these compounds.
Objectives
Objectives for subsequent research have focused on elucidation of the 
nephrotoxic metabolite(s) of CEB. To evaluate the role of the GSH 
conjugate, or metabolite of the GSH conjugate, in CEB-induced 
nephrotoxicity and karyomegaly, various inhibitors of GSH transport and 
metabolism were administered to male Fischer 344 rats. The protective 
effect of these inhibitors against the toxicity was evaluated via 
histopathology and karyometry.
Fischer 344 rats were administered a single dose of CEB following 
pretreatment with one of three selective inhibitors of GSH transport and 
metabolism including acivicin (AT-125 or a-amino-3-chloro-4,5-dihydro-5- 
isoxazoleacetic acid), probenecid (p-di-n-propylsulfamoyl benzoic acid), and 
aminooxyacetic acid (AOAA). Additionally, treatment of rats with one of 
the selective inhibitors alone was essential to elucidate the effect, if any, on 
the experimental parameters in the absence of CEB.
AT-125 is a glutamine analog and irreversible inhibitor of y-glutamyl 
transpeptidase (GGT; Allen et al., 1980; Griffith and Meister, 1980). GGT is 
the only known enzyme able to cleave the y-glutamyl moiety of GSH and 
GSH-conjugates (Goldberg et al,  1960). Inhibition of GGT will prevent
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subsequent cleavage of the cysteinyl-glycine conjugate and uptake of the 
cysteine conjugate into the renal tubular epithelial cell. Protection against 
CEB-induced nephrotoxicity afforded by AT-125 would incriminate the 
cysteine conjugate, or a metabolite derived from the cysteine conjugate, in 
the nephrotoxic effect.
Conversely, probenecid competitively inhibits the organic anion 
transport system (OATS; Gutman et al., 1955). Probenecid prevents 
secretion of the N-acetylated cysteine conjugate or mercapturic acid from 
hepatocytes and inhibits subsequent renal uptake at the basolateral 
membrane. Mercapturate biosynthesis is accomplished by the transfer of an 
acetyl group from acetyl coenzyme A to the cysteine S-conjugate by cysteine 
conjugate N-acetyltransferase (Duffel and Jakoby, 1982). If the mercapturic 
acid is responsible for CEB-induced nephrotoxicity in Fischer 344 rats, 
probenecid may diminish the histopathological lesions.
Finally, AOAA inhibits pyridoxal phosphate-dependent enzymes 
including renal cysteine conjugate (3-lyase (Jones et al., 1986). (3-lyase has 
been shown to catalyze the conversion of cysteine conjugates to potentially 
reactive thiols in addition to ammonia and pyruvate (Tateishi and 
Shimizu, 1980). If the reactive thiol is responsible for CEB-induced 
nephrotoxicity, administration of AOAA prior to CEB treatment will 
ameliorate the nephrotoxic effects.
Renal and hepatic GSH levels were also determined following 
pretreatment with these inhibitors. GSH levels were evaluated to assess the 
possibility of the involvement of a CEB-derived metabolite in the GSH- 
enhancing effect. Enhanced renal GSH may prove anticarcinogenic by 
conjugating and detoxifying other electrophiles which may be potential
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mutagens and/or carcinogens. Additionally, elevated renal GSH levels 
may scavenge free radicals associated with oxidative stress and free radical- 
induced mutagenesis and tumorigenesis. The free radical-scavenging 
ability of GSH may also prove beneficial for renal transplant recipients 
during periods of extreme oxidative stress following ischemic injury and 
during the reperfusion phase of renal transplantation (Paller et al ,  1984; 
Ouriel etal.,  1985).
y-Glutamylcysteine synthetase (GCS) activity was measured to assess 
the effect of CEB on the rate-limiting enzyme in GSH synthesis. An 
induction of GCS activity in the presence of CEB suggests that elevated GSH 
levels may be due to increased de novo synthesis of GSH as opposed to 
increased transport of GSH from the liver to the kidney.
Measurement of urinary mercapturates both following 
administration of CEB alone and following pretreatment with the various 
inhibitors was also of interest. Mercapturic acids are metabolic end- 
products of GSH conjugation. Increased excretion of mercapturates into the 
urine would further demonstrate the importance of GSH conjugation in 
CEB metabolism.
Finally, investigations evaluating the effect of CEB on phase I 
xenobiotic metabolizing enzyme systems were pertinent to the elucidation 
of CEB metabolism in its entirety. Although CEB is metabolized through 
GSH conjugation, this does not preclude involvement of phase I 
metabolizing enzymes such as cytochrome P450 and epoxide hydrolase. 
Measurement of total cytochrome P450 levels as well as the activity of more 
specific cytochrome P450 enzymes such as ethoxyresorufin O-deethylase, 
pentoxyresorufin O-depentylase, and 7-ethoxycoumarin O-deethylase, were
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evaluated in the liver and kidney. Renal and hepatic epoxide hydrolase 
activities were also measured following administration of a single dose (125 
mg / kg body weight) of CEB.
The activity of glutathione S-transferases (GSTs) toward l-chloro-2,4- 
dinitrobenzene (CDNB) was also evaluated following administration of 
CEB. CDNB reacts with a broad spectrum of GSTs and is considered a 
general substrate for evaluation of GST activity. Since CEB is conjugated 
with GSH in vivo, it is of interest to assess the effect of CEB on enzymes 
involved in the catalytic reaction.
CHAPTER 2
PROTECTIVE EFFECT OF AMINOOXYACETIC ACID ON CEB-INDUCED 
NEPHROTOXICITY IN FISCHER 344 RATS
Introduction
Cruciferous plants are cultivated extensively for use as livestock feed, in 
the manufacturing of plastics, and for human consumption as condiments, 
vegetables, and oilseed. Glucosinolates, derived from cruciferous vegetables, 
undergo autolytic hydrolysis to yield various cyanoepithioalkanes including 1 - 
cyano-3,4-epithiobutane (CEB; Luthy and Benn, 1980).
CEB, the structure of which was initially proposed by Kirk and 
MacDonald (1974), has demonstrated teratogenic effects in pregnant Holtzman 
rats (Nishie and Daxenbichler, 1980) and nephrotoxic effects in male Fischer 
344 rats (VanSteenhouse, et al., 1989). Administration of CEB to male Fischer 
344 rats resulted in epithelial cell necrosis and karyomegaly within the pars 
recta of the proximal convoluted tubules. CEB treatment also caused an early 
phase of depletion of hepatic glutathione (GSH) followed by a rebound 
elevation. Renal GSH levels, however, were elevated at all time periods 
evaluated with no identifiable phase of depletion. Additionally, CEB-induced 
nephrotoxic and karyomegalic changes were diminished following 
pretreatment with buthionine sulfoximine (BSO), an inhibitor of y- 
glutamylcysteine synthetase (GCS) and GSH-depleting agent (VanSteenhouse, 
etal ,  1991).
GSH, a ubiquitous tripeptide (y-glutamylcysteinyl glycine), conjugates 
and detoxifies a variety of electrophilic, hydrophobic compounds (Mitchell et 
al., 1973; Sinsheimer et al,  1987; Mannervik et al,  1989). GSH conjugation may, 
however, lead to the bioactivation of xenobiotics with resultant cytotoxic or 
genotoxic effects (Elfarra and Anders, 1984; Inskeep etal,  1986; Koga, etal.,
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1986; Guengerich et al., 1987; Anders, 1990; Koob and Dekant, 1991). The rapid 
depletion of hepatic GSH and reduction of CEB-induced nephrotoxicity 
following BSO pretreatment strongly suggest that GSH conjugation and 
bioactivation is a significant pathway in CEB metabolism and toxicity.
The present study was devised to further elucidate the role of the GSH 
conjugate, or a metabolite thereof, in CEB-induced nephrotoxicity and altered 
renal GSH. Elevations of renal GSH may partially explain the chemoprotective 
effects associated with cruciferous vegetables.
Elevations in renal GSH may prevent carcinogenesis in a twofold 
manner. GSH may conjugate and detoxify electrophilic mutagens and 
carcinogens and may scavenge free radicals associated with oxidative stress 
and free radical-induced mu tagenesis and tumorigenesis (Feig et al., 1994; 
Satoh and Lindahl, 1994). The free radical-scavanging ability of GSH may also 
prove beneficial for renal transplant recipients during periods of extreme 
oxidative stress following ischemic injury and during the reperfusion phase of 
renal transplantation (Paller et al., 1984; Ouriel et al., 1985).
Fischer 344 rats were administered a single dose of CEB following 
pretreatment with one of three selective inhibitors of GSH transport and 
metabolism including acivicin (AT-125 or a-amino-3-chloro-4,5-dihydro-5- 
isoxazoleacetic acid), probenecid (p-di-»-propylsulfamoyl benzoic acid), and 
aminooxyacetic acid (AOAA). AT-125 is a glutamine analog and irreversible 
inhibitor of y-glutamyl transpeptidase (GGT; Allen etal., 1980; Griffith and 
Meister, 1980). GGT is the only known enzyme able to cleave the y-glutamyl 
moiety of GSH and GSH-conjugates (Goldberg et al., 1960). Inhibition of GGT 
will prevent subsequent cleavage of the cysteinyl-glycine conjugate and uptake 
of the cysteine conjugate into the renal tubular epithelial cell. Protection
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against CEB-induced nephrotoxicity afforded by AT-125 would incriminate the 
cysteine conjugate, or a metabolite thereof, in the nephrotoxic effect.
Conversely, probenecid competitively inhibits the organic anion 
transport system (OATS; Gutman etal., 1955) preventing secretion of the N- 
acetylated cysteine conjugate or mercapturic acid from hepatocytes and 
subsequent renal uptake of the mercapturate at the basolateral membrane. 
Mercapturate biosynthesis is accomplished by the transfer of an acetyl group 
from acetyl coenzyme A to the cysteine S-conjugate catalyzed by cysteine- 
thioester N-acetyltransferase (Duffel and Jakoby, 1982). If the mercapturate is 
responsible for CEB-induced nephrotoxicity in Fischer 344 rats, probenecid 
may diminish the histopathological lesions.
Finally, AOAA inhibits pyridoxal phosphate-dependent enzymes 
including renal cysteine conjugate p-lyase (Jones et al., 1986). p-lyase has been 
shown to catalyze the conversion of cysteine conjugates to potentially reactive 
thiols in addition to ammonia and pyruvate (Tateishi and Shimizu, 1980). If 
the reactive thiol was responsible for CEB-induced nephrotoxicity, 
administration of AOAA prior to CEB treatment will ameliorate the 
nephrotoxic effects.
Renal and hepatic GSH levels were also determined following 
pretreatment with these inhibitors. GSH levels were evaluated to assess the 
possibility of the involvement of a CEB-derived metabolite in the GSH- 
enhancing effect.
GCS activity in the liver and kidney was similarly measured to assess 
the effect of CEB on the rate-limiting enzyme in GSH synthesis. If renal GCS 
activity is induced in the presence of CEB, elevated GSH levels may be due to
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increased de novo synthesis of GSH as opposed to increased transport of GSH 
from the liver to the kidney.
Finally, rats were administered one of the three selective inhibitors alone 
to evaluate the effect of these compounds on the experimental parameters in 
the absence of CEB.
Materials and Methods 
Animal Maintenance and Treatment
One hundred and thirty eight male, 5-7 week old Fischer 344 rats were 
obtained from Harlan Sprague Dawley, Inc. (Indianapolis, IN, USA). Rats 
were housed in an AAALAC (American Association for Accreditation of 
Laboratory Animal Care)-accredited facility. Rats were initially housed in 
groups of 3-5 under controlled conditions of 12-hour light/ dark cycle at 21 °C 
and 50-70 % relative humidity. For one week prior to treatment rats were fed a 
modified, semi-purified diet, AIN-76A, with cornstarch substituted for sucrose 
to prevent hepatic lipidosis (Hamm etal,  1982). Throughout experimental 
trials rats were housed individually in metabolic cages to facilitate estimation 
of feed and water intake. Water was allowed ad lib. Pair-feeding was 
instituted to abrogate the effects of dietary intake on hepatic GSH levels.
At 8-9 weeks of age rats were divided into one of eight treatment groups 
in a random fashion. The eight groups consisted of a negative, saline control 
group; a positive, CEB-treated control group; an AT-125 pretreated group, a 
probenecid pretreated group, and an AOAA pretreated group; and three 
treatment groups administered one of the three inhibitors alone. Each group of 
rats was further divided into 2  groups (minimum of 6  rats / group) for 
evaluation at 24 or 48 hours post-CEB administration.
91
An intraperitoneal (IP) injection of 10 mg AT-125/ kg body weight was 
administered in sterile saline, pH 6.5, two hours prior to CEB treatment while 
200 mg probenecid/kg body weight was administered IP in 0.1 M sterile 
potassium phosphate buffer, pH 7.4,30 minutes prior to and 5.5 hours 
following CEB administration. One hour prior to CEB administration, the 
AOAA pretreated group received an IP injection of 32.8 mg AO AA/kg body 
weight in 0.1 M sterile phosphate buffer, pH 7.0.
All rats were then orally gavaged with 125 mg CEB/kg body weight or 
the same relative volume of deionized, distilled water with respect to body 
weight. All gavaging was performed between 8  and 9 AM.
Twenty-four or 48 hours following CEB administration, rats were 
anaesthetized under isoflurane inhalation and euthanized via cardiac 
exsanguination. Liver and kidney samples were prepared for histological and 
histomorphometric examination as well as GSH and y- glutamylcysteine 
synthetase (GCS) determination.
In accordance with the Animal Welfare Act, the experimental protocol 
was submitted to and approved by the Louisiana State University Institutional 
Animal Care and Use Committee.
Materials
CEB was graciously synthesized by Dr. Mark McLaughlin and Tamara 
Schaller from the Department of Chemistry at Louisiana State University. A 
modified method of Luthy and Benn (1980) was utilized to synthesize the CEB. 
The bromo group of 4-bromo-l-butene (Janssen Chimica, New Brunswick, NJ, 
USA) was replaced with a cyano moiety from sodium cyanide (Aldrich, 
Milwaukee, WI, USA) to yield l-cyano-3,4-butene. l-Cyano-3,4-butene was 
then oxidized at the unsaturated double bond with magnesium
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monoperoxyphthalate hexahydrate (Aldrich, Milwaukee, WI, USA) yielding 1 - 
cyano-3,4-epoxybutane which was subsequently converted to a thiouronium 
salt in the presence of thiourea (Aldrich, Milwaukee, WI, USA). Final 
conversion to l-cyano-3,4-epithiobutane was achieved in an alkaline 
environment, pH 9.0. The identity of the product was confirmed by nuclear 
magnetic resonance and the purity of l-cyano-3,4-epithiobutane was 
demonstrated to be 98% or greater by gas chromatography (see Appendix).
L-glutamate, L-a-aminobutyrate, adenosine triphosphate, disodium  
salt, bovine serum albumin, reduced glutathione, glutathione reductase 
[NADPH: oxidized-glutathione oxidoreductase (GSSG reductase); EC 1.6.4.2], 
reduced (3-nicotinamide adenine dinucleotide phosphate, 5,5'-dithiobis-(2- 
nitrobenzoic acid) (DTNB), aminooxyacetic acid, AT-125 (acivicin), probenecid, 
and a diagnostic kit for determination of inorganic phosphorus (Procedure no. 
670) were obtained from Sigma Chemical Co. ( St. Louis, MO, USA). Procedure 
23225X-BCA Protein Assay Reagent method for the determination of total 
protein was obtained from Pierce (Rockford, IL, USA). Ethylene diamineacetic 
acid, disodium salt and magnesium chloride were obtained from Ameresco 
(Solon, OH, USA) and Mallinckrodt, Inc. (Paris, KY, USA), respectively. Saline 
was from Baxter Healthcare Corp. (Deerfield, IL, USA). The dietary 
components were obtained from ICN Nutritional Biochemical (Costa Mesa,
CA, USA).
Samples were prepared using a TissumizerR rotor-sator generator 
(Tekmar, Cinncinnati, OH, USA) and a Beckman Model TJ- 6  centrifuge 
(Beckman Instruments, Inc., Fullerton, CA, USA). A Hitachi U-2000 double- 
beam UV/Vis spectrophotometer (Hitachi Instruments, Inc., San Jose, CA,
USA) was utilized to analyze GSH levels and GCS activity.
93
Tissue Preparation
Samples of liver and kidney for GSH and GCS determination were 
collected from the median liver lobe and cortex of the left kidney. The right 
kidney and the remainder of the median liver lobe were utilized for 
preparation of tissue sections for histological and histomorphometric 
evaluation.
Liver and kidney samples taken for histological and histomorphometric 
examination were immediately fixed in neutral buffered 10% formalin. Fixed 
tissues were trimmed, processed, embedded in paraffin, and cut in 3-4 //m 
sections. Sections were stained with haematoxylin and eosin.
A 150-200 mg sample of liver or kidney was collected for GSH analysis 
and added to 4 mis 0.02M EDTA in a stoppered tube on ice. The specimens 
were homogenized for 20-30 seconds using a TissumizerR rotor-sator generator 
(Tekmar, Cinncinnati, OH, USA). Four mis 10% trichloroacetic acid were 
added to the homogenate. The homogenate was allowed to stand for 15 
minutes prior to centrifugation at 4°C for 15 minutes at 3000g. The 
supernatant was saved and frozen at -20°C until analysis.
To determine GCS activity, a 150-200 mg sample of liver or kidney was 
placed in 2 mis of 0.1 M Tris-HCl buffer (pH 8.2). Tissues were homogenized 
for 20-30 seconds. Samples were centrifuged at 1800 rpm for 20 minutes at 4°C 
and the fresh supernatant assayed for GCS activity.
Biochemical Assays
Total GSH levels were determined on the supernatants utilizing the 
colorimetric recycling method of Tietze (1969). A 200 //I supernatant sample 
was added to 700 //I of 0.3 mM NADPH and 100 /d of 6.0 rnM DTNB. Samples 
were incubated for 5 minutes at 30°C and 20 //Is of GSSG reductase
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(25 Units/m l buffer) were added to initiate the reaction. The change in 
absorbance was recorded at 412 nm. GSH activity was expressed in mmol 
GSH /100 g tissue.
GCS activities were evaluated on fresh supernatant using a modified 
method of Sekura and Meister (1977). Kidney and liver samples were diluted 
1:20 and 1:5, respectively. A 200 //I supernatant sample was added to 200 //I of 
10 mM glutamate, 100 //I of 10 mM L-a-aminobutyrate, 200 //I of 20 mM MgCl^ 
100 //I of 2 mM N a2 EDTA, 100 //I of 5 mM Na2ATP, and 20 //g BSA. The 
samples were incubated at 37°C for 30 minutes and the reaction stopped with 
1.0 ml of 20% TCA. Samples were allowed to stand at room temperature for 5- 
10 minutes and centrifuged at 1800 rpm for 10 minutes at 4°C. The liberation 
of inorganic phosphorous was determined by the use of Sigma Diagnostic 
Procedure No. 670. The absorbance of the samples was read at 660 nm. An 
appropriate sample blank was assayed to compensate for ATPase activity.
GCS activity was expressed in //moles GCS/hr/mg protein.
Total protein levels were determined by the Pierce Procedure 23225X- 
BCA Protein Assay Reagent method. The absorbance of the samples was 
recorded at 562 nm. Total protein levels were expressed in mg protein/ml. 
GSH, GCS, and protein determinations were performed on a Hitachi U-2000 
double-beam UV/Vis spectrophotometer.
Histological and Histomorphometric Examination
Hematoxylin and eosin stained tissue sections were evaluated for 
hepatic and renal lesions on a Leitz Labolux 12 transmitting-light microscope 
(Leica, Inc., Rockleigh, NJ, USA) at magnifications x 100 and 400. Areas 
containing the tips of the medullary rays within the renal cortex were 
delineated with ink using a Wild M3 typ 376788 stereomicroscope (Leica, Inc.,
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Rockleigh, NJ, USA). The cross-sectional area of one-hundred and twenty 
proximal tubular epithelial cell nuclei within these regions, excluding affected 
cells with pyknotic nuclei, were measured with a Zeiss axioplan microscope 
(Carl Zeiss, Inc., Thornwood, USA), lOOOx magnification, equipped with a 
semi-automated IM-Series System, Version 3.0 data program (Analytical 
Imaging Concepts, Irvine, CA, USA).
Statistical Analysis
GSH levels and GCS activity were evaluated by analysis of variance 
with respect to treatment group. The means of each treatment group were 
compared to one another by Fisher's least significant difference test for 
multiple comparisons at a 95% confidence level.
Mean nuclear size and frequency distributions of nuclear area were 
determined for each animal and averaged for each respective treatment group 
at 24 and 48 hours. The mean values for the treatment groups were then 
evaluated by analysis of variance using Fisher's least significant difference test 
for multiple comparisons at a 95% confidence level. Comparisons between 24 
and 48 hour CEB treated groups were analyzed by an unpaired t-test with 
respect to time. P-values <0.02 were considered significant.
Results
Renal and Hepatic GSH
Hepatic and renal GSH levels were significantly elevated at 24 and 48 
hours in rats treated with CEB alone or CEB in addition to any of the inhibitors 
with the exception of hepatic GSH at 24 hours in rats pretreated with 
probenecid (Figures 2.1 and 2.2). Additionally, rats pretreated with AT-125 
revealed significantly greater levels of GSH in the kidney at 24 hours as 
compared to AOAA-pretreated rats and rats administered with CEB alone. At
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Figure 2.1 Effect of inhibitor pretreatment or treatment with CEB alone on 
renal GSH levels at 24 and 48 hours post-CEB administration. Value bars 
represent mean GSH levels. Error bars represent the standard errror of the
mean; n = minimum of 6 rats per group. ♦ represents P = 0.0001 as compared 
to controls; t  represents P = 0.0001 as compared to CEB treated group; * 
represents P = 0.0001 as compared to AOAA-pretreated rats.
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Figure 2.2 Effect of inhibitor pretreatment or treatment with CEB alone on 
hepatic GSH levels at 24 and 48 hours post-CEB administration. Value bars 
represent mean GSH levels. Error bars represent the standard errror of the
mean; n = minimum of 6 rats per group. ♦ represents P <0.001 as compared to 
controls; + represents P < 0.001 as compared to CEB treated group; * represents 
P <0.001 as compared to AOAA-pretreated rats.
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48 hours, AT-125 pretreated rats exhibited elevated renal GSH levels as 
compared to CEB controls while rats pretreated with probenecid had increased 
renal GSH levels as compared to CEB controls and AOAA-pretreated rats. 
Hepatic GSH was significantly greater in rats treated with CEB alone or rats 
pretreated with AOAA or AT-125 as compared to probenecid-pretreated rats at 
24 hours. At 48 hours, rats pretreated with any of the inhibitors exhibited 
significantly elevated hepatic GSH levels as compared to CEB treated rats. 
Additionally, AT-125-pretreated rats revealed elevated GSH levels in the liver 
at 48 hours as compared to rats pretreated with AOAA. None of the rats 
pretreated with an inhibitor revealed significantly decreased renal or hepatic 
GSH as compared to CEB treated rats.
Significant elevations in renal GSH were also observed at 24 hours in 
rats treated with AOAA alone (0.244 ± 0.02; p = 0.0001) and at 24 (0.333 ± 0.02; 
p = 0.0001) and 48 hours (0.290 ± 0.03; p = 0.001) in rats treated with AT-125 
alone; however, the magnitude of the elevation of renal GSH in rats receiving 
CEB in addition to AOAA or AT-125 was statistically greater (p = 0.0001) than 
those rats receiving only AOAA or AT-125.
Renal and Hepatic GCS Activity
Rats administered CEB alone, or pretreated with AT-125 or probenecid 
in addition to CEB, exhibited significantly decreased renal GCS activity as 
compared to controls at 24 hours post-CEB administration; however, renal GCS 
activity at 24 hours in rats treated with AOAA in addition to CEB was not 
significantly different from saline controls. No significant differences were 
seen in renal GCS activity at 48 hours or in hepatic GCS activities at 24 or 48 
hours (Figures 2.3 and 2.4). Additionally, there was no significant difference in
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Figure 2.3 Effect of inhibitor pretreatment or treatment with CEB alone on 
renal GCS activities at 24 and 48 hours post-CEB administration. Value bars 
represent mean GCS activites. Error bars represent the standard errror of the
mean; n = minimum of 6 rats per group. ♦  represents P <0.02 as compared to 
controls. No significant differences were observed between CEB treated and 
inhibitor pretreated groups.
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Figure 2.4 Effect of inhibitor pretreatment or treatment with CEB alone on 
hepatic GCS activities at 24 and 48 hours post-CEB administration. Value bars 
represent mean GCS activities. Error bars represent the standard errror of the 
mean; n = minimum of 6 rats per group. No significant differences were 
observed at 24 or 48 hours.
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renal or hepatic GCS activity in rats treated with any of the inhibitors alone at 
24 or 48 hours.
Histological Evaluation
Histologic lesions were confined to the kidney and characterized by 
intensely eosinophilic cells with dense, pyknotic nuclei occurring individually 
or in clusters within the pars recta of the proximal tubular epithelium at the 
tips of the medullary rays. Vesiculated, karyomegalic nuclei were observed in 
many of the neighboring epithelial cells. These cells exhibited normal 
cytoplasmic eosinophilia but possessed a large vesiculated nucleus with a thin 
rim of condensed chromatin and a prominent nucleolus.
Epithelial cell necrosis and karyomegaly were observed sporadically at 
24 hours and consistently at 48 hours in rats treated with CEB alone (Figures 
2.5-2.7). Rats pretreated with AOAA prior to CEB administration revealed no 
histologic changes at 24 hours and were similar to saline treated controls 
(Figure 2.8). By 48 hours, however, significant histological lesions and 
karyomegaly were observed in rats pretreated with AOAA (Figure 2.9). Those 
rats pretreated with AT-125 or probenecid, however, exhibited more severe 
renal lesions as compared to AOAA-pretreated rats at 48 hours.
Rats pretreated with AT-125 or probenecid revealed characteristic 
histopathological lesions at both 24 and 48 hours (Figures 2.10-2.13). Animals 
treated with AT-125, AOAA, or probenecid alone exhibited no significant 
histopathological lesions. No significant histopathological lesions were 
observed in the liver in any treatment group.
Karyometry
Renal karyometric evaluation revealed a marked increase in the nuclear 
size of the cells of the proximal tubules at both 24 and 48 hours in CEB-treated
Figure 2.5 Photomicrograph of normal proximal tubular epithelial cells from a control rat kidney collected at 24 
hours. Tissue sections from kidneys collected at 48 hours from control rats were essentially identical to this 
photomicrograph. Hematoxylin and Eosin stain. Bar = 10 nm.
Figure 2.6 Photomicrograph depicting renal lesions at 24 hours in the pars recta of the proximal tubule from a rat 
treated with CEB alone. Renal lesions are characterized by dense eosinophilic epithelial cells (thin arrow) and 
karyomegalic nuclei (broad arrow). Hematoxylin and Eosin stain. Bar = 10 fim.
Figure 2.7 Photomicrograph depicting renal lesions at 48 hours in the pars recta of the proximal tubule from a rat 
treated with CEB alone. Lesions reveal the same morphologic changes as illustrated in Figure 2.6, but are of greater 
severity. Hematoxylin and Eosin stain. Bar = 10 /zm.
Figure 2.8 Photomicrograph of the pars recta of the proximal tubules at 24 hours from a rat treated with AOAA
prior to CEB administration. Note the absence of significant morphological changes. Hematoxylin and Eosin stain.
Bar = 10 (im.
Figure 2.9 Photomicrograph of the pars recta of the proximal tubules at 48 hours from a rat treated with AOAA 
prior to CEB administration. Dense eosinophilic cells (thin arrow) and karyomegalic nuclei (broad arrow) are evident. 
Hematoxylin and Eosin stain. Bar = 10 jzm.
Figure 2.10 Photomicrograph of the pars recta of the proximal tubules at 24 hours from a rat treated with AT-125 in
addition to CEB. Note the presence of significant renal lesions. Hematoxylin and Eosin stain. Bar = 10 fjm.
Figure 2.11 Photomicrograph of the pars recta of the proximal tubules at 48 hours from a rat treated with AT-125 in 
addition to CEB. Note the presence of significant renal lesions. Hematoxylin and Eosin stain. Bar = 10 f«n.
Figure 2.12 Photomicrograph of the pars recta of the proximal tubules at 24 hours from a rat treated with probenecid 
in addition to CEB. Note the presence of significant renal lesions. Hematoxylin and Eosin stain. Bar = 10 fiin.
Figure 2.13 Photomicrograph of the pars recta of the proximal tubules at 48 hours from a rat treated with probenecid
in addition to CEB. Note the presence of significant renal lesions. Hematoxylin and Eosin stain. Bar = 10 pm.
o
I l l
rats as compared to controls (Figure 2.14). Mean nuclear size as well as the 
number of nuclei > 55 //m2  were significantly increased at 24 and 48 hours in 
rats treated only with CEB as compared to controls. Additionally, the 
frequency distributions of nuclear area for the control rats were significantly 
greater than CEB-treated rats for the 35-55 /<m2 range at 24 hours and 25-55 
;/m2  range at 48 hours. These findings reveal a general shift toward larger 
nuclear area in CEB-treated rats (Figures 2.15 and 2.16).
At 24 hours, rats pretreated with AOAA prior to CEB administration 
revealed no significant difference in mean nuclear size as compared to controls. 
AOAA-pretreated rats also exhibited significantly decreased mean nuclear area 
as compared to rats treated with CEB alone. Similarly, no significant 
differences between control rats and AOAA-pretreated rats were observed in 
the frequency distributions of nuclear area with the exception of those nuclei 
ranging from 45-55 jum2  which were significantly increased in controls as 
compared to AOAA-pretreated rats.
By 48 hours AOAA pretreatment resulted in significantly increased 
mean nuclear area. The mean nuclear area of AOAA-pretreated rats was, 
however, significantly less than that of rats given CEB alone. The number of 
nuclei falling in the 55-85 j/m2  range at 48 hours were significantly greater for 
AOAA-pretreated rats as compared to controls; yet, the number of nuclei >85 
//m2  in AOAA rats were significantly lower than CEB-treated rats. Animals 
pretreated with AT-125 or probenecid demonstrated significantly greater mean 
nuclear areas as compared to negative controls and were equivalent to CEB 
control rats. At 24 and 48 hours the number of nuclei within the 35-55 ;«m2  
range was greater in control rats as compared to rats pretreated with AT-125 or 
probenecid. The number of nuclei within the 55-85 |im 2  and > 85 /»m2  range
□  24 h o u rs  
8  48 h o u rs
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Treatment
Figure 2.14 Effect of inhibitor pretreatment or administration of CEB alone 
mean nuclear size at 24 and 48 hours as measured by histomorphometiy. 
Value bars represent mean nuclear area. Error bars represent the standard 
error of the mean; n = minimum of 6 rats per group; 120 nuclei per rat. ♦  
represents P < 0.001 as compared to controls; t  represents P < 0.001 as 
compared to CEB treated group.
113
♦ -  ■ • C ontrol 
•  — AOAA + CEB  
* — -C E B
Nuclear Area (jim2)
Figure 2.15 Frequency distribution of proximal tubule epithelial cell nuclear 
size with respect to treatment group at 24 hours. AT-125 and probenecid 
pretreated groups were deleted for clarity as these groups were essentially the 
same as animals treated with CEB alone. Data points represent the relative 
number of nuclei within each range of nuclear area. Error bars represent the 
standard error of the mean; n = minimum of 6 rats per treatment group; 120
nuclei per rat. .
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Figure 2.16 Frequency distribution of proximal tubule epithelial cell nuclear 
size with respect to treatment group at 48 hours. AT-125 and probenecid 
pretreated groups were deleted for clarity as these groups were essentially the 
same as animals treated with CEB alone. Data points represent the relative 
number of nuclei within each range of nuclear area. Error bars represent the 
standard error of the mean; n = minimum of 6 rats per treatment group; 120 
nuclei per rat.
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was greater in rats pretreated with AT-125 and probenecid at 24 and 48 hours 
as compared to controls with the exception of the 75-85 /im2  range in rats 
pretreated with AT-125 at 24 hours. Rats pretreated with AT-125 or 
probenecid revealed karyomegalic changes equivalent to CEB controls.
Additionally, rats pretreated with probenecid revealed significantly 
elevated mean nuclear areas as compared to AOAA-pretreated rats at 24 and 
48 hours. AT-125-pretreated rats, however, exhibited significantly increased 
mean nuclear areas as compared to AOAA-pretreated rats only at 24 hours. At 
24 hours the number of nuclei >85 /jm2  was significantly greater in rats 
pretreated with probenecid as compared to AOAA-pretreated rats. At 48 
hours the number of nuclei within the 65-75 /«m2  range and > 85 /im2  were also 
significantly greater in probenecid-pretreated rats while the number of nuclei 
within the 45-55 /<m2  range were significantly decreased as compared to 
AOAA-pretreated rats. Similarly, rats pretreated with AT-125 exhibited 
significantly decreased numbers of nuclei within the 45-55 //m2 range and 
significantly increased numbers of nuclei within the 55-75 //m 2 range and >85 
//m2  as compared to AOAA-pretreated rats.
There was also a time-dependent increase in the mean nuclear area and 
frequency distributions for CEB-treated rats. Mean nuclear area and the 
number of nuclei falling in the 75-85 //m2 and >85 /mi2  ranges were 
significantly greater at 48 hours as compared to 24 hours in rats given only 
CEB.
No significant differences were detected for mean nuclear area or 
frequency distibutions for rats treated with any of the inhibitors given alone as 
compared to controls with the exception of rats pretreated with probenecid
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which revealed an increased number of nuclei within the 35-45 fitn 2 range as 
compared to controls.
Discussion
The present study indicates that the reactive thiol may be at least 
partially responsible for CEB-induced nephrotoxicity. A single dose of 125 mg 
CEB/ kg body weight results in mild nephrotoxicity at 24 hours and more 
severe lesions at 48 hours post-CEB administration. The lesions were 
characterized by epithelial cell necrosis and karyomegaly as previously 
described by VanSteenhouse et al. (1989). The fact that hepatic lesions were not 
observed suggests that the parent compound (CEB) is not directly toxic but 
requires metabolic activation to exert its deleterious effect.
Renal proximal tubular epithelial cells are frequent targets for toxic 
xenobiotics. The kidneys receive 25% of cardiac output (Monks and Lau, 1987) 
and > 90% of the renal blood flow is directed to the renal cortex where the 
majority of the proximal tubules are located (Maher, 1976). Additionally, 
proximal tubular epithelial cells possess specialized functions of transport and 
metabolism which may enhance toxicity through the concentration and 
bioactivation of xenobiotics. Proximal tubular epithelial cells possess the 
highest concentrations of y-glutamyl transpeptidase (Goldberg et al., 1960), the 
only known enzyme able to cleave the y-glutamyl linkage, and are active in the 
uptake and concentration of metabolites of GSH conjugates.
Though CEB targets the renal proximal tubular epithelium, 
pretreatment with AOAA prior to CEB administration exerts a protective effect 
against nephrotoxicity at 24 hours. AOAA competitively inhibits pyridoxal 
phosphate-dependent enzymes including renal cysteine conjugate (3-lyase 
(Elfarra et al., 1986). Renal cysteine conjugate (3-lyase catalyzes P-elimination
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reactions to yield a potentially reactive thiol in addition to pyruvate and 
ammonia. Reactive thiols may be excreted as free thiols, detoxified by 
methylation or glucuronidation, or converted to electrophilic thiol derivatives 
that bind to essential protein macromolecules (Dekant, 1993). Bioactivation by 
cysteine conjugate (3-lyase has been documented for various nephrotoxic and 
nephrocarcinogenic compounds including several haloalkenes (Dekant et al., 
1990) and bromobenzene (Monks etal,  1985).
Numerous cells possess relatively high y-glutamyl transpeptidase 
activity including pancreatic acinar and ductile epithelial cells, epithelial cells 
of the renal proximal tubule, jejunum, bile duct, epididymus, seminal vesicles, 
bronchioles, thyroid follicles, as well as the chroid plexus, ciliary body, and 
retinal pigment epithelium (Meister etal., 1976). These cells may be active in 
the uptake of metabolites of GSH conjugates; however, other factors may also 
play a role in susceptibility of different tissues to toxicity. The relative 
activities of cysteine conjugate N-acetyltransferase and N-deacetylase as well 
as cysteine conjugate |3-lyase may contribute to tissue selectivity. The fact that 
CEB is selectively nephrotoxic and renal cysteine conjugate |3-lyase is unique 
to the kidney further supports the finding that the reactive thiol is the 
nephrotoxic metabolite.
The protective effect of AOAA is diminished by 48 hours. Renal lesions 
and karyomegaly are present by 48 hours in rats pretreated with AOAA and 
are of equivalent severity to rats treated with CEB alone. The decreased 
protective effect of AOAA seen at 48 hours is presumably due to the normal 
metabolism and degradation of AOAA or due to the inability of AOAA to 
competitively inhibit (3-lyase in the presence of increased molecular 
equivalents of the cysteine conjugate. Delayed increases in the cysteine
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conjugate may result from slow or protracted metabolism of CEB and/or  
transport of mercapturates or conjugates of GSH or cysteine from the liver to 
the kidney. Mercapturates may also be deacetylated in the kidney to form the 
respective cysteine conjugate. Such a delay in the formation of the nephrotoxic 
metabolite is supported by the fact that those rats treated with CEB alone 
exhibited more severe renal lesions at 48 hours as compared to 24 hours.
Inhibition of y-glutamyl transpeptidase by AT-125 should also prevent 
nephrotoxicity if the reactive thiol is responsible for the CEB-induced toxicity. 
Renal lesions observed in animals pretreated with AT-125 may be due to a lack 
of complete inhibition of y-glutamyl transpeptidase. Though AT-125 inhibits 
renal y-glutamyl transpeptidase by >95% (Shapiro and Curthoys, 1981), 
sufficient activity may have remained to allow uptake of an adequate amount 
of the cysteine conjugate to cause toxicity.
Additionally, transport of intact GSH conjugates across the basolateral 
and luminal aspects of renal tubular epithelial cells has been documented 
(Ballatori e ta l,  1994). If the GSH conjugate were directly toxic, however, 
AOAA could not have ameliorated the nephrotoxicity in rats pretreated with 
this inhibitor.
Failure of probenecid to protect against CEB-induced nephrotoxicity 
suggests that transport of the mercapturate from the liver to the kidney is not 
responsible for renal lesions. This does not, however, exclude the 
mercapturate as a potential nephrotoxin since mercapturic acids may be 
formed within the proximal tubular epithelial cell via N-acetyltransferase. Yet, 
if the mercapturic acid is directly nephrotoxic, AOAA should not have 
diminished the histopathological lesions since |3-lyase and N-acetyltransferase 
mutually compete for the cysteine conjugate as a substrate. Inhibition of
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P-Iyase in the presence of AOAA would provide adequate substrate for 
mercapturate formation.
The reactive thiol also appears to be involved in diminished GCS 
activity as suggested by the fact that AOAA-pretreated rats did not 
demonstrate decreased renal GCS activity at 24 hours. The reactive thiol may 
reduce amino acid residues within the active site or disulfide bridges essential 
for GCS activity. Conversely, a metabolite of the reactive thiol, such as a 
methylthio or S-glucuronide derivative, could inhibit GCS activity. The 
possibility that AOAA pretreatment actually induced GCS activity is 
contradicted by the fact that AOAA given alone did not induce enzyme 
activity.
Decreased levels of renal GCS activity at 24 hours do not appear to be 
the result of feedback inhibition by elevated GSH since renal GSH levels were 
elevated at 48 hours as well as 24 hours. Renal GCS activity recovered by 48 
hours post-CEB administration despite significant elevations in renal GSH 
levels.
At both 24 and 48 hours a marked shift towards larger nuclear area was 
observed in rats treated with CEB alone. Renal kaiyomegaly has been 
documented following administration of auranofin (Markiewicz, 1988), 
hexachlorobutadiene (Kociba e ta l,  1977), N-(DL-2-amino-2-carboxyethyl)-L- 
lysine (Reyniers etal., 1974), lead acetate (Choie and Richter, 1972), N-(4'- 
fluoro-4-biphenylyl)acetimide (Dees etal., 1980a, b), 2S-l-cyano-2-hydroxy-3,4- 
epithiobutane (Gould etal., 1980), aflatoxin Bi (Butler, 1964), trichloroethylene 
(Maltoni etal., 1988), cisplatin (Goudie etal., 1994), l-(2-chloroethyl-4- 
methylcyclohexyl)-l-nitrosourea (MeCCNU) and chlorozotocin (Kramer etal.,
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1986) and nephrotoxic mycotoxins such as ochratoxin A (Huff, 1991; Mantle et 
al,  1991; Boorman etal., 1992; Mantle, 1994).
Karyomegaly may represent a preneoplastic change and is recognized 
as one of the earliest discernable morphological features in model systems of 
renal carcinogenesis (Dees et al., 1980a, b). There is evidence that nuclear size 
increases during progression from hyperplasia to preneoplastic and neoplastic 
lesions (Young etal., 1984). Karyomegaly preceeds tumorigenesis following 
administration of N-(4'-fluoro-4-biphenylyl)acetimide (Dees et al, 1980a, b), 
aflatoxin Bi (Butler, 1964), ochratoxin A (Boorman et a l,  1992), auranofin 
(Markiewicz, 1988), trichloroethylene (Maltoni et al, 1988), and 
hexachlorobutadiene (Kociba etal., 1977) the latter two of which are selective 
nephrotoxins bioactivated by GSH conjugation and metabolism (Terracine and 
Parker, 1965; Jaffe et al, 1983; Elfarra and Anders, 1984; Reichert and Schutz, 
1986). Renal carcinogenesis subsequent to CEB-induced karyomegaly has not 
been demonstrated and further investigations regarding chronic exposure to 
CEB and DNA adduct formation are needed.
Several nephrotoxic agents cause renal karyomegaly unassociated with 
any neoplastic change (Choie and Richter, 1972; Reyniers et al., 1974). 
Karyomegaly may represent compensatory hyperplasia in response to renal 
tubular epithelial cell necrosis. However, karyomegaly has been observed with 
low doses of CEB in the absence of cell death (VanSteenhouse et al, 1989).
It is also unclear whether increased nuclear size is a direct effect of CEB 
or the GSH conjugate of CEB or is mediated through elevated levels of renal 
GSH. Increased cellular levels of GSH in cultured human bronchial epithelial 
cells and K562 leukemia cells preceeded the major growth phase (Frischer et al, 
1993; Atzori et al, 1994) while depletion of GSH decreased the proliferative
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ability of these cells (Atzori et al., 1994). Additionally, elevations of GSH in 
endothelial cells and fibroblasts prevented inhibition of cellular proliferation 
by transforming growth factor-|3i (Das et a l,  1992; White et al., 1992) and 
hyperbaric oxygen (Honda and Matsuo, 1989), respectively.
The mechanism of increased cellular proliferation in response to 
elevated GSH levels is still unclear. GSH is involved as an electron donor at 
the active site of ribonucleotide reductase via glutaredoxin (Stiyer, 1988). 
Elevated levels of GSH may therefore increase DNA synthesis with resultant 
karyomegaly. GSH also acts as a coenzyme for glyoxalase which catalyzes the 
conversion of methylglyoxal to lactate (Ohmori et al, 1989). Accumulation of 
methylglyoxal retards cell growth (Szent-Gyorgyi, 1965). Increased GSH may 
increase the rate of methylglyoxal degradation and release the cell from its 
inhibitory effects.
GSH may indirectly influence cell proliferation through the modulation 
of peptide growth factors. GSH has been shown to be involved in the release 
of fibroblast growth factor (FGF) from NIH 3T3 cells (Jackson et al, 1995). FGF 
has been demonstrated to cause karyomegaly of glomerular podocytes when 
administered to rats (Mazue etal., 1993).
Though diminished intracellular GSH stimulated cystine transport in 
endothelial cells (Deneke et al, 1992), increased GSH may increase transport of 
cystine, an essential amino acid for cell growth in culture. The efflux of GSH 
from renal proximal tubular epithelial cells is coupled to transport and uptake 
of y-glutamyl amino acids including y-gluta my Icy stine (Griffith etal., 1979a; 
Anderson and Meister, 1983). y-Glutamylcystine may then be reduced by 
transhydrogenation with GSH to form cysteine and y-glutamylcysteine.
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Cysteine may then be utilized for GSH synthesis or in the synthesis of proteins 
or other peptides essential for cell growth.
Alternatively, the GSH conjugate, or a metabolite of the GSH conjugate, 
may also have an effect on cellular proliferation. S-(l,2-dicarboxyethyl) 
glutathione enhances DNA synthesis in the presence of epidermal growth 
factor (Miyazaki e ta l ,  1990). Additionally, cystine transport into human 
erythrocytes was increased in the presence of extracellular l-chloro-2,4- 
dinitrobenzene (CDNB). Cystine was incorporated into fractions of the GSH 
conjugate of CDNB (Otsuka, 1989). Similarly, the GSH conjugate of CEB may 
induce the transport of cystine and stimulate cell growth.
Elevations in renal and hepatic GSH do not appear to be the result of 
induction of GCS activity. Alternative mechanisms for elevations in GSH 
include enhanced transcriptional activation or stabilization of GCS mRNA and 
increased cellular uptake of cysteine or cystine. Cysteine is the rate-limiting 
substrate for GSH synthesis (Deneke and Fanburg, 1989).
Cyanohydroxybutene (CHB), a naturally occurring nitrile also derived 
from cruciferous vegetables, elevates hepatic and pancreatic GSH but does not 
cause significant elevations in hepatic or pancreatic GCS activity. Pancreatic 
and hepatic cysteine equivalents and hepatic GCS mRNA concentrations, 
however, were elevated in CHB-treated rats (Davis etal., 1993).
Increased transport of cystine and cysteine may be mediated by GGT. 
GGT cleaves extracellular GSH and increases transport of y-glutamyl amino 
acids. Increased transport of y-glutamylcystine may elevate intracellular GSH 
levels through reduction of y-glutamylcystine to cysteine and y-glutamyl- 
cysteine. In this manner, increased cysteine transport may bypass y-glutamyl - 
cysteine synthetase and increase intracellular GSH levels. AT-125 did not,
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however, prevent the GSH-enhancing effect of CEB despite its ability to inhibit 
GGT. Alternatively, other transport mechanisms for cysteine or cystine may be 
involved.
Increases in GCS mRNA, as seen with CHB, do not necessarily correlate 
with increased GCS activity. Mercury has been shown to increase GCS mRNA 
without increasing GCS activity (Wood et al, 1992). CEB may actually inhibit 
de novo protein synthesis or post-translational modifications of GCS thereby 
preventing an increase in the active form of the enzyme. The mechanism of 
GSH elevation, therefore, may prove to be multifaceted including increases in 
substrate availability and induction at the genetic level, but does not appear 
dependent on actual induction of GCS activity.
Pretreatment with probenecid appeared to prevent the GSH-enhancing 
effect of CEB in the liver at 24 hours. According to Christensen (1984), amino 
acid transport involves the transport of ions. Systems A, ACS, and L typically 
transport amino acids in the zwitterionic, or dipolar, form (Bannai and 
Tateishi, 1986). Cystine, however, is transported as a tripolar, or anionic, ion 
in human fibroblasts (Bannai and Kitamura, 1980,1981) and hepatocytes 
(Makowske and Christensen, 1982). Since probenecid is also an anion at 
physiological pH and inhibits the organic anionic transport system, it is 
possible that probenecid may also inhibit cystine uptake and subsequent GSH 
synthesis. This suggests that a lack of substrate availability in probenecid 
pretreated rats limits the rate of GSH synthesis in the liver at 24 hours. This 
transport system is independent of GGT-mediated uptake of cystine and 
would therefore not be affected by AT-125. This further supports a role of 
increased cystine transport in elevated GSH levels. Additionally, renal GSH 
was not affected by pretreatment with probenecid presumably since this
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transport mechanism for cystine uptake has been identified only in fibroblasts 
and hepatocytes but not in renal proximal tubular epithelial cells.
AOAA and AT-125 administered alone also increase hepatic and renal 
GSH, though to a lesser extent than CEB in combination with these inhibitors. 
AOAA and AT-125 may theoretically have an effect on amino acid transport or 
influence GSH synthesis at the genetic level; however, the mechanism for the 
GSH-enhancing effect of these compounds is undefined at this time.
The results of these investigations indicate that the reactive thiol, or a 
metabolite of the thiol, is at least partially responsible for CEB-induced 
nephrotoxicity. Despite the fact that the reactive thiol appears to be involved 
in diminished GCS activity, this metabolite does not appear to influence renal 
or hepatic GSH levels since pretreatment with AOAA did not prevent the 
GSH-enhancing effect of CEB in the liver or the kidney.
CHAPTER 3
EFFECT OF CEB ON RENAL AND HEPATIC XENOBIOTIC 
METABOLIZING ENZYMES IN FISCHER 344 RATS
Introduction
Humans and other animal species are constantly exposed to a myriad of 
potentially toxic, lipophilic foreign compounds, or xenobiotics, readily 
absorbed through the skin, mucus membranes, gastrointesinal tract, and across 
pulmonary tissues. Though some xenobiotics may be excreted unchanged, 
most compounds are converted to more polar metabolites for excretion in the 
urine, bile, saliva, and expired air (Mulder, 1990). This process of 
biotransformation is mediated by various cytosolic and membrane-bound 
enzyme systems (Sipes and Gandolfi, 1986).
Biotransforming enzymes are grouped into two general categories 
depending on their catalytic specificity (Sipes and Gandolfi, 1986). Phase I 
enzymes typically catalyze oxidation, reduction, and hydrolysis reactions and 
include the cytochrome P450 and epoxide hydrolase enzyme systems. Phase II 
enzymes, on the other hand, involve conjugation or biosynthetic reactions 
mediated by enzyme families such as the glutathione S-transferases.
The phase I and II xenobiotic metabolizing enzyme systems are 
responsible for the activation of parent compounds and/or detoxication of 
reactive metabolites (Aitio, 1978). Both synthetic and naturally occurring 
carcinogens are typically inert and require metabolic activation to exert their 
deleterious effects (Gonzalez and Gelboin, 1994). The cytochrome P450s 
(P450s) are the principal enzymes involved in the metabolic activation 
(Gonzalez and Gelboin, 1994) of xenobiotics while glutathione S-transferases 
(GST; Ketterer and Mulder, 1990) and epoxide hydrolases (EH; Guenther,
1990) are more frequently involved in the detoxication of reactive P450-derived
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metabolites or parent compounds. EHs (EC 3.3.2.3) represent a group of 
catalytically-related but distinct enzymes which catalyze the hydration of arene 
oxides and aliphatic epoxides to the corresponding dihydrodiols (Sipes and 
Gandolfi, 1986). EHs are believed to have evolved as detoxifying enzymes 
which serve to protect cells from the deleterious effects of epoxides or oxiranes 
formed by cytochrome P450s or lipid peroxidation (Guenther, 1990). Similar to 
EHs, GSTs (EC 2.5.1.18) are an extensive family of multifunctional isozymes 
and usually detoxify xenobiotics or reactive metabolites through glutathione 
conjugation and subsequent metabolism to more polar compounds (Ketterer 
and Mulder, 1990).
The balance between detoxication and bioactivation of a compound 
within a particular species or organ depends on the relative amounts and 
activities of the different forms of xenobiotic metabolizing enzymes (Halpert et 
al., 1994). Inducers of metabolizing enzymes such as GST and EH have been 
shown to inhibit a wide range of potential carcinogenic compounds. Rat and 
human GSTs inhibit covalent DNA binding of food-borne carcinogens (Lin et 
al., 1994) while the dietary antioxidants, 2(3)-ferf-buty 1-4-hydroxyanisole and 
l,2-dihydro-6-ethoxy-2,2,4-trimethylquinoline, enhance hepatic GST activities 
in mice and decrease the level of mutagenic metabolites formed from 
benzo(a)pyrene (Benson etal., 1978). Similarly, the genotoxicity of 
chloromethyloxirane in vitro is reduced in the presence of increased mEH 
activity (Rossi et al., 1983) while the addition of purified mEH reduces the 
mutagenicity (Glatt et al., 1983) and DNA binding of K-region epoxides of 
polycyclic aromatic hydrocarbons (Guenther and Oesch, 1981; Oesch and 
Guenther, 1983) in vitro.
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Cruciferous vegetables including cabbage, cauliflower, broccoli, and 
turnips have become widely regarded as potential cancer chemoprotectives. 
Based on extensive experimental testing of crude vegetable extracts and 
epidemiologic data (Olsen et al., 1991; Kune et al., 1992; LeMarchand et al., 1989; 
Swanson et al., 1992; Schiffman et al., 1988; Kunes et al., 1987; Hoff et al, 1988; 
Chyou et al., 1990; Young et al., 1988), both the National Research Councils' 
Committee on Diet, Nutrition, and Cancer (1982) and the American Cancer 
Society (1984) have recommended increased consumption of cruciferous 
vegetables to decrease human cancer incidence. Despite the well-established 
inverse relationship between cruciferous vegetables and the incidence of 
various types of cancer, the specific dietary constituents responsible for this 
protective effect have not been thoroughly defined.
Various constituents of cruciferous vegetables have demonstrated 
anticarcinogenic potential (Ishizaki et al., 1990; Michnovicz and Bradlow, 1990; 
Smith etal., 1990; Smith etal., 1993;Kojima etal., 1994; Zhang and Talalay,
1994). Though the mechanisms of action of these chemoprotective agents are 
poorly understood, most of these compounds appear to exert their 
anticarcinogenic effect by inhibiting and/or inducing xenobiotic metabolizing 
enzyme systems.
Animals fed cruciferous plants or their degradation products have 
demonstrated elevations in GST activity in various tissues (Sparnins el al., 
1982a, b; Aspry and Bjeldanes, 1983; Chang and Bjeldanes, 1985; Salbe and 
Bjeldanes 1985; Ansher et al., 1986; Kensler et al., 1987; Vos et al., 1988; Bogaards 
et ah, 1990; Wortelboer et al., 1992; Zhang et al., 1992). Additionally, breakdown 
products of crucifers such as indole-3-carbinol (I3C; Ferguson, 1994) and 
isothiocyanates (Ishizaki et al., 1990; Smith et al., 1990; Guo et al., 1992; Smith et
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al., 1993) have been shown to inhibit the activity of different forms of P450s 
and, therefore, the activation of various carcinogenic agents. It is believed that 
GST induction and the inhibition of P450s may at least partially explain the 
anticarcinogenic effect of cruciferous vegetables.
Depending on the plant, the enzymatic activity within the plant, and the 
conditions of hydrolysis, cruciferous vegetables may undergo autolytic 
hydrolysis to yield various cyanoepithioalkanes including l-cyano-3,4- 
epithiobutane (CEB; Luthy and Benn, 1980). CEB, the structure of which was 
initially proposed by Kirk and MacDonald (1974), has demonstrated 
teratogenic effects in pregnant Holtzman rats (Nishie and Daxembichler, 1980) 
and nephrotoxic effects in male Fischer 344 (F344) rats (VanSteenhouse et al., 
1989). Administration of CEB to male F344 rats resulted in epithelial cell 
necrosis and karyomegaly within the pars recta of the proximal convoluted 
tubules. CEB treatment also caused an early phase of depletion of hepatic 
glutathione (GSH) followed by a rebound elevation. Renal GSH levels, 
however, were elevated at all time periods evaluated with no identifiable 
phase of depletion.
GSH, a ubiquitous tripeptide (glu-cys-gly), conjugates and detoxifies a 
variety of electrophilic, hydrophobic compounds (Sinsheimer, etal., 1987; 
Mitchell et al., 1973). Elevations in renal GSH may prevent carcinogenesis in a 
twofold manner. GSH may conjugate and detoxify electrophilic mutagens 
and/or carcinogens and scavenge free radicals associated with oxidative stress 
and free radical-induced mutagenesis and tumorigenesis (Feigetal., 1994;
Satoh and Lindahl, 1994). The free radical-scavanging ability of GSH may also 
prove beneficial for renal transplant recipients following ischemic injury and
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during the reperfusion phase of renal transplantation (Paller et al., 1984; Ouriel 
et al, 1985).
The present study was devised to further elucidate the in vivo 
metabolism of CEB in Fischer 344 rats and demonstrate the role, if any, of 
phase I and phase II metabolizing enzymes in the activation or 
anticarcinogenic potential of CEB. Since exposure to crucifers occurs via the 
oral route of administration, thereby exposing the liver to high doses of the 
compound, and the kidney appears to be the target organ for CEB, hepatic and 
renal enzymes were of primary interest for this investigation.
Although 25-30 distinct forms of P450s have been characterized in 
humans and > 40 forms have been described in rats (Nelson et al., 1993), only 
three gene families (CYP1, CYP2, and CYP3) are currently thought to be 
responsible for the majority of xenobiotic metabolism (Wrighton and Stevens, 
1992). As such, various substrates have been developed to measure the specific 
activity of P450 enzymes belonging to these three gene families. In rats, 
ethoxyresorufin O-deethylation was shown (Burke etal., 1985) to be cataylzed 
by P450s induced by polycyclic aromatic hydrocarbons including 3- 
methylcholanthrene (3MC). Antibody inhibition experiments indicated that 
ethoxyresorufin O-deethylase (EROD) was catalyzed mainly by P450 1 A l and, 
to a lesser extent, 1A2 (Doostdar et al., 1993). In control rats EROD activity was 
shown to be highest in the liver (de Waziers et al., 1990) while lower activity 
(25% of liver) was evident in the duodenum. EROD activity in the rat was 
barely detectable in the kidney and undetectable in the jejunum, ileum, and 
colon. Burke and coworkers (1985) also demonstrated pentoxyresorufin O- 
depentylase (PROD)-specific activity for the phenobarbitol-inducible P450 
enzymes, 2B1 and 2B2. PROD activity was greatest in the duodenum (125% of
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liver) and lung (120% of liver) in untreated rats (de Waziers et al, 1990) and 
appeared to be the main isoenzyme in the small intestine. Weak PROD activity 
was also present in the kidney, although P450 2B1/2B2 was not detectable by 
Western blot.
7-Ethoxycoumarin has also been utilized as a measure of P450- 
dependent O-dealkylation in rats. 7-Ethoxycoumarin O-deethylase (ECOD) 
activity is induced by both phenobarbitol and 3MC and, as such, is a measure 
of both P450 1A l /1 A2 and 2B1 / 2B2.
Renal and hepatic EROD, PROD, and ECOD activities were determined 
to assess the effect of CEB on the induction, or inhibition, of these P450 
enzymes. Although CEB is conjugated with GSH in vivo, that does not 
preclude the involvement of phase I enzymes in CEB metabolism.
Microsomal EH activity was additionally measured in the liver and 
kidney to determine involvement of this enzyme system in CEB metabolism in 
vivo. CEB possesses an electrophilic epithiol moiety similar to an epoxide ring 
and may theoretically act as a substrate for mEH. Cytosolic EH was not 
measured since cEH activity is extremely low in the rat as compared to other 
species (Gill and Hammock, 1980; Ota and Hammock, 1980).
y-Glutamylcysteine synthetase (GCS), the rate-limiting enzyme in GSH 
synthesis, was also measured since previous investigations revealed no 
induction of activity at 24 or 48 hours despite enhanced GSH levels. Samples 
for this study were collected at earlier time points (4 and 12 hours) as 
compared to the previous investigation, so that an early induction in GCS 
activity, if present, could be detected. GST activity was also measured to assess 
the possibility of induction of this enzyme in the presence of high levels of 
GSH.
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Materials and Methods 
Animal Maintenance and Treatment
A total of 6 8  male, 6 - 8  week old, Fischer 344 rats were obtained from 
Harlan Sprague Dawley, Inc. (Indianapolis, IN, USA). Rats were housed in an 
AALAC (American Association for the Accreditation for Laboratory Animal 
Care)-accredited facility. Rats were initially housed in groups of 3 rats per cage 
under controlled conditions of 12-hour light/dark cycle at 21 °C and 50-70% 
relative humidity. For one week prior to treatment rats were fed a modified, 
semi-purified diet, AIN-76A, with cornstarch substituted for sucrose to prevent 
hepatic lipidosis (Hamm, etal, 1982). Throughout experimental trials rats were 
housed individually in metabolic cages to facilitate estimation of feed and 
water intake. Water was allowed ad lib. Pair-feeding was instituted to 
abrogate the effects of dietary intake on xenobiotic metabolizing enzyme 
systems.
At 8-9 weeks of age rats were divided into two treatment groups in a 
random fashion. One group was gavaged with 125 mg CEB/ kg body weight 
while the control group was gavaged with deionized, distilled water at the 
same relative volume with respect to body weight. All gavaging was 
performed between 8  and 9 AM. Each treatment group was then subdivided 
into one of five groups (minimum of 6  rats/group) for evaluation at 4,12, 24,
36, and 48 hours.
At 4,12, 24, 36, or 48 hours following CEB administration, rats were 
anaesthetized under isoflurane inhalation and euthanized via cardiac 
exsanguination. Liver and kidney samples were collected and prepared for 
evaluation of P-450 levels as well as determination of glutathione S-transferase, 
y-glutamylcysteine synthetase, ethoxyresorufin O-deethylase, pentoxyresorufin
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O-depentylase, ethoxycoumarin O-deethylase, and epoxide hydrolase 
activities.
In accordance with the Animal Welfare Act, the experimental protocol 
was submitted to and approved by the Louisiana State University Institutional 
Animal Care and Use Committee.
Materials
CEB was graciously synthesized by Dr. Mark McLaughlin and Tamara 
Schaller from the Department of Chemistry at Louisiana State University. A 
modified method of Luthy and Benn (1980) was utilized to synthesize the CEB. 
The bromo group of 4-bromo-l-butene (Janssen Chimica, New Brunswick, NJ, 
USA) was replaced with a cyano moeity from sodium cyanide (Aldrich, 
Milwaukee, WI, USA) to yield l-cyano-3,4-butene. l-Cyano-3,4-butene was 
then oxidized at the unsaturated double bond with magnesium monoperoxy- 
phthalate hexahydrate (Aldrich, Milwaukee, WI, USA) yielding l-cyano-3,4- 
epoxybutane which was subsequently converted to a thiouronium salt in the 
presence of thiourea (Aldrich, Milwaukee, WI, USA). Final conversion to 1- 
cyano-3,4-epithiobutane was achieved in an alkaline environment, pH 9.0. The 
identity of the product was confirmed by nuclear magnetic resonance (NMR) 
and the purity of l-cyano-3,4-epithiobutane was demonstrated to be 98% or 
greater by gas chromatography (see Appendix).
p-Nitrostyrene oxide and p-nitrostyrene diol were kindly synthesized by 
Dr. David Swenson of the Department of Physiology, Pharmacology, and 
Toxicology, School of Veterinary Medicine, Loiusiana State University by the 
method of Westkaemper and Hanzlik (1980).
L-glutamate, L-a-aminobutyrate, adenosine triphosphate, disodium salt 
(Na2ATP), bovine serum albumin (BSA), reduced glutathione (GSH), reduced
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P-nicotinamide adenine dinucleotide phosphate (NADPH), 
tris(hydroxymethyl) aminomethane hydrochloride (Tris-HCl), glycerol, 
glutathione S-transferase (GST; EC 2.5.1.18), l-chloro-2,4-dinitrobenzene 
(CDNB), potassium phosphate dibasic and potassium phosphate monobasic, 
ethoxyresorufin, pentoxyresorufin, resorufin, 7-ethoxycoumarin, 7- 
hydroxycoumarin, dimethyl sulfoxide (DMSO), p-nitrobenzyl alcohol, and a 
diagnostic kit for determination of inorganic phosphorus (Procedure no. 670) 
were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Procedure 
23225X-BCA Protein Assay Reagent method for the determination of total 
protein was obtained from Pierce (Rockford,IL, USA). Ethylene diamineacetic 
acid, disodium salt (EDTA) was obtained from Amresco (Solon, OH, USA) 
while methanol and magnesium chloride (MgCl2 )were obtained from 
Mallinckrodt, Inc. (Paris, KY, USA). Trichloroacetic acid (TCA) was acquired 
from Curtin Matheson Scientific, Inc. (Houston, TX, USA.) Sucrose was 
obtained from Fisher Scientific, Inc. (Fair Lawn, NJ, USA) while potassium  
chloride (KC1), dithionite, and carbon monoxide (CO) were obtained from 
Aldrich Chemical Company, Inc. (Milwaukee, WI, USA). The dietary 
components were obtained from ICN Nutritional Biochemical (Costa Mesa, 
CA, USA).
Samples were prepared using a Tissumizer® rotor-sator generator from 
Tekmar (Cinncinnati, OH, USA) for homogenizing, a Beckman Model TJ- 6  
centrifuge from Beckman Instruments, Inc. (Fullerton, CA, USA), a Sorvall RC- 
58 Refrigerated Superspeed and a Sorvall OTD-65 Ultra Centrifuge - Oil 
Turbine Drive centrifuge obtained from DuPont, Clinical and Instrument 
Systems Division (Wilmington, DE, USA). Enzyme activities and P450 levels 
were analyzed with a Hitachi F-2000 Fluorescence Spectrophotometer and a
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Hitachi U-2000 double-beam UV/Vis spectrophotometer from Hitachi 
Instruments, Inc. (San Jose, CA, USA).
High performance liquid chromatography analysis was performed 
using a Waters 6000 pump, U6 K injector, and a Cs reverse phase, 4 j/m, 8  mm 
cartridge column from Waters Chromatography (Milford, MA, USA) equipped 
with a Perkin-Elmer LC75 Spectrophotometric Detector (Thurnhill, Ontario, 
Canada).
Tissue Preparation
Liver and kidney samples were collected from the median liver lobe and 
cortex of the left kidney for determination of GST and GCS activities. The 
remainder of the liver and kidney was utilized for microsomal preparations.
A 150-200 mg sample of liver or kidney was placed in 2 mis of 0.1 M 
Tris-HCl buffer (pH 8.2). Tissues were homogenized for 20-30 seconds.
Samples were centrifuged at 1800 rpm for 20 minutes at 4°C and the fresh 
supernatant assayed for GCS activity.
For evaluation of GST activity, a 150-200 mg sample of liver or kidney 
was placed in 3 mis of 0.25 M sucrose/ 0.02 M EDTA buffer and homogenized 
for 20-30 seconds. Samples were then centrifuged at 1800 rpm for 15 minutes 
and the resultant supernatant frozen at -20°C.
Renal and hepatic microsomes were prepared on ice. Tissues were 
rinsed in 125 M KCl, blotted, weighed and diced. Diced tissues were rinsed 
three times in 0.25 M sucrose/1.0 M EDTA/10.0 M Tris-HCl buffer. Liver and 
kidney samples were transferred to 30 mis and 20 mis of 0.25 M sucrose/1.0 M 
EDTA/10.0 M Tris-HCl buffer, respectively. Six individual kidneys from the 
same group were batched to enhance detection of enzyme activities. The
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tissues were homogenized for 20-30 seconds and placed on ice until 
centrifugation.
Liver and kidney samples were centrifuged at 1800 rpm at 4°C for 20 
minutes. The supernatant was collected and consecutively centrifuged at 9,200 
rpm and 11,000 rpm at 4°C for 20 minutes. The collected supernatant was then 
ultracentrifuged at 30,000 rpm at 4°C for 60 minutes. The pellet was 
resuspended in cold 125 M KCl in 20% glycerol, aliquoted, and frozen at -70°C. 
Biochemical Assays
GST activity was determined on supernatants utilizing the method of 
Habig et al. (1974). 50 //I of 0.04 M l-chloro-2,4-dinitrobenzene (CDNB) and 0.2 
ml liver or kidney sample were added to 1.65 ml of 0.121 M potassium  
phosphate buffer (pH 6.5). The reaction was initiated with 0.1 ml of 0.02 M 
GSH and the change in absorbance recorded for three minutes at a wavelength 
of 340 nm. GST activity was expressed in EU GST/ mg protein.
GCS activity was evaluated on fresh supernatant using a modified 
method of Sekura and Meister (1977). Kidney and liver samples were diluted 
1:20 and 1:5, respectively. A 200 //I sample of the supernatant was added to 200 
//I of 10 mM glutamate, 100 //I of 10 mM L-a-aminobutyrate, 200 //I of 20 mM 
MgCli, 100 fil of 2 mM Na2 EDTA, 100 //I of 5 mM Na2ATP, and 20 fig BSA.
Samples were incubated at 37°C for 30 minutes and the reaction stopped with 
1.0 ml of 20% TCA, Samples were allowed to stand at room temperature for 5- 
10 minutes prior to centrifugation at 1800 rpm for 10 minutes at 4°C. The 
liberation of inorganic phosphorous was determined by the use of Sigma 
Diagnostic Procedure No. 670. The absorbance of the samples was read at 660 
nm. An appropriate sample blank was assayed to compensate for intrinsic 
ATPase activity. GCS activity was expressed in //moles GCS/ hr/ mg protein.
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All GST and GCS determinations were preformed on a Hitachi U-2000 double­
beam UV/Vis spectrophotometer.
Renal and hepatic microsomes were evaluated for cytochrome P-450 
levels as well as EROD, PROD, and ECOD activities using a modified method 
of Lake (1987). A 2.0 mg sample of microsomal protein was brought to a total 
volume of 2.0 mis with 0.1 M potassium phosphate/ 1.0m M EDTA buffer (pH
7.4). Dithionite (20 mg) was added to the samples which were subsequently 
divided into two microcuvettes (1 ml per cuvette). A baseline was recorded 
from 400 to 500 nm and the sample cuvette was bubbled with carbon monoxide 
for 30 seconds. A wavelength scan from 400 to 500 nm was then recorded 
against the reference cuvette. Cytochrome P-450 levels were expressed in nmol 
P-450/ mg protein.
For evaluation of EROD, PROD, and ECOD activities, 2.0 nmoles 
ethoxyresorufin, 10 nmoles pentoxyresorufin, and 0.5 pmoles 7-hydroxy - 
coumarin were added, respectively, to aliquots of microsomal protein (1 .0  mg 
microsomal protein from the kidney and 0.5 mg microsomal protein from the 
liver were assayed for EROD and ECOD activity while 1.5 mg microsomal 
protein from the liver or kidney was analyzed for PROD activity). Samples 
were brought to 980 fd total volume with 50 mM Tris-HCl buffer (pH 8.4 for 
EROD and PROD and pH 7.8 for ECOD). Samples were incubated for 5 
minutes at 37°C and the reaction initiated with 20 fil of 50 mM NADPH. The 
change in intensity per minute was recorded at an excitation of 530 nm (EX5 3 0 ) 
and an emission of 580 nm (EM5 8 0 ) for EROD and PROD activities and at 
EX5 3 0  and EM4 5 2  for ECOD activity. The activities of these enzymes were 
expressed in pm ole/m in/m g protein.
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All EROD, PROD, and ECOD determinations were performed on a 
Hitachi F-2000 Fluorescence Spectrophotomete. Cytochrome P-450 levels were 
evaluated on a Hitachi U-2000 double-beam UV/Vis spectrophotometer.
Total protein levels were determined by the Pierce Procedure 23225X- 
BCA Protein Assay Reagent method. The absorbance of the samples was 
recorded at 562 nm. Total protein levels were expressed in mg protein/ml.
Microsomal samples were analyzed for epoxide hydrolase activity using 
a modified method of WestKaemper and Hanzlik (1980). A 50 //I aliquot of 
renal or hepatic microsomal protein was added to 550 //I of 0.1 M potassium 
phosphate buffer (pH 8.0) and the mixture preincubated at 37°C for 2 minutes. 
The reaction was initiated with the addition of 30 pi of 10 mM p-nitrostyrene 
oxide and samples were incubated at 37 °C for 5 minutes. The reaction was 
stopped with 1 ml of 3.45 x 10-5 M p-nitrostyrene alcohol (internal standard), 
tubes were placed on ice, and samples centrifuged for 5 minutes. A 100 pi 
aliquot of the clear supernatant was injected for analysis on a Waters 6000 high 
performance liquid chromatograph equipped with a Waters U6 K injector and a 
Perkin Elmer LC75 spectrophotometric detector operating at a 280 nm 
wavelength and a sensitivity of 0.1 AUFs. Samples were analyzed on a Cg 
reverse-phase, 4 pm column with a methanokwater (30:70) mobile phase 
eluting at 2.0 m l/ min. p-Nitrostyrene diol was utilized as a standard. Peak 
height was used as a measure of the quantity of product formed.
Statistical Analysis
Activities of GST, GCS, EROD, PROD, ECOD, and epoxide hydrolase 
and cytochrome P-450 levels were evaluated at each time point by analysis of 
variance with respect to treatment group. The means of each treatment group
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were compared to one another by Fisher's least significant difference test at a 
95% confidence level. P-values <0.05 were considered significant.
CEB-treated groups were compared to one another with respect to time 
to assess the effect of time on xenobiotic metabolizing enzyme activities. 
However, when control groups were compared to one another with respect to 
time, there was a significant amount of interassay variation between different 
time groups. Any significant differences between CEB-treated animals from 
different time points was, therefore, not considered a valid estimate of the 
effects of CEB.
Results
Renal and Hepatic GCS
Animals treated with a single dose of CEB exhibited significantly 
decreased (p<0.01) renal GCS activity at 12 and 24 hours post-CEB 
administration. Renal GCS activity at 4, 36 and 48 hours and hepatic GCS 
activity at all time periods were not significantly different from control rats 
(Figures 3.1 and 3.2).
Renal and Hepatic GST
Renal GST activity towards CDNB was significantly lower (p<0.01) in 
rats treated with CEB as compared to controls at 4 hours post-CEB 
administration. Similarly, hepatic GST activity was decreased (p<0.01) in CEB- 
treated rats at 12 and 36 hours. No significant differences in hepatic or renal 
GST were observed in any of the other time periods evaluated (Figures 3.3 and
3.4).
Renal and Hepatic Cytochrome P-450, EROD, PROD, and ECOD
Animals treated with a single high dose of CEB exhibited no significant 
difference in cytochrome P-450 levels in the liver or kidney at any of the time
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Figure 3.1 Comparison of renal GCS activity at 4,12,24, 36 and 48 hours in 
CEB-treated and control rats. Value bars represent mean GCS activity. Error 
bars represent the standard error of the mean; n = minimum of 6  rats per 
group, t  represents P < 0.01 as compared to controls.
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Figure 3.2 Comparison of hepatic GCS activity at 4 ,12 ,24,36 and 48 hours 
in CEB-treated and control rats. Value bars represent mean GCS activity.
Error bars represent the standard error of the mean; n = minimum of 6  rats per 
group. No significant differences were observed between control and CEB 
treated groups at any time period evaluated.
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Figure 3.3 Comparison of renal GST activity at 4 ,12,24,36 and 48 hours in 
CEB-treated and control rats. Value bars represent mean GST activity. Error 
bars represent the standard error of the mean; n = minimum of 6  rats per 
group, t  represents P < 0.01 as compared to controls.
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Figure 3.4 Comparison of hepatic GSTactivity at 4,12, 24,36 and 48 hours in 
CEB-treated and control rats. Value bars represent mean GST activity. Error 
bars represent the standard error of the mean; n =minimum of 6  rats per group, 
t  represents P < 0.01 as compared to controls.
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periods studied. Similarly, renal and hepatic EROD and PROD activities 
exhibited no significant differences as compared to controls.
Renal and hepatic ECOD activities, however, were significantly 
decreased in rats administered CEB. Renal ECOD activity in CEB-treated 
animals was decreased (p<0.01) at 24 hours while hepatic ECOD activity was 
diminished (p<0.05) at 12 and 24 hours post-CEB administration (Figures 3.5 
and 3.6).
Renal and Hepatic Epoxide Hydrolase
No significant differences were observed at any time point in renal or 
hepatic microsomal epoxide hydrolase activity.
Discussion
Decreased renal GCS activity at 12 and 24 hours is consistent with a 
previous study in which various inhibitors of GSH transport and metabolism 
were utilized to assess the nephrotoxic effects of CEB (see chapter 2).
Decreased levels of renal GCS at 12 and 24 hours in rats treated with CEB do 
not appear to be the result of feedback inhibition by elevated GSH. In the 
previous study, renal GSH levels were elevated at 48 hours as well as 24 hours. 
Renal GCS levels recovered by 48 hours post-CEB administration despite 
significant elevations in renal GSH.
Decreased levels of GCS may be a direct effect of the reactive thiol as 
suggested by previous investigations. Diminished renal GCS activity was 
observed in all treated groups with the exception of those rats pretreated with 
aminooxyacetic acid (AOAA). AOAA competitively inhibits pyridoxal 
phosphate-dependent enzymes including renal cysteine conjugate |3-lyase 
(Elfarra et al., 1986). Renal cysteine conjugate (5-lyase catalyzes |5-elimination
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Figure 3.5 Comparison of renal ECOD activity at 4,12,24 ,36  and 48 hours 
in CEB-treated and control rats. Value bars represent mean ECOD activity. 
Error bars represent the standard error of the mean; n = minimum of 6  rats per 
group, t  represents P < 0.01 as compared to controls.
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Figure 3.6 Comparison of hepatic ECOD activity at 4 ,12 ,24 ,36  and 48 hours 
in CEB-treated and control rats. Value bars represent mean ECOD activity. 
Error bars represent the standard error of the mean; n = minimum of 6  rats per 
group, t  represents P < 0.05 as compared to controls.
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reactions to yield a potentially reactive thiol in addition to pyruvate and 
ammonia.
Conversely, a metabolite of the reactive thiol, such as a methylthio or S- 
glucuronide derivative could inhibit GCS activity. The possibility that AOAA 
pretreatment actually induced GCS activity is contradicted by the fact that 
AOAA given alone did not induce enzyme activity.
Although it is of questionable biological significance, the slight but 
statistically significant decrease in ECOD activity may represent an 
anticarcinogenic effect associated with CEB. Inhibition of P450 enzymes has 
been associated with decreased xenobiotic bioactivation. Since decreased 
ECOD activity represents inhibition of P450 1A and/or 2B isoenzymes, either 
EROD or PROD activity should also be affected. However, the constitutive 
levels of PROD activity in untreated rats in this study as compared to ECOD 
activity were extremely low. Although 7-ethoxycoumarin and 
pentoxyresorufin are both substrates for P450 2B1/2B2, the difference in the 
constitutive activity for the two substrates indicates a much higher activity of 
P450 2B1 / 2B2 towards 7-ethoxycoumarin. Due to the low constitutive activity 
of PROD, it is possible that inhibition of PROD activity could not be detected 
as it was beyond the lower limits of sensitivity of the assay.
Hepatic and renal ECOD activity in the control rats were approximately 
350 pm ole/m in/m g protein and 25 pm ole/m in/m g protein, respectively, 
while hepatic and renal PROD activity were 5 pmole/ min/ mg protein and 1 
pm ole/m in/m g protein, respectively. EROD activity was 30 pm ole/m in/m g  
protein and 2  pm ole/m in/m g protein in the liver and kidney, respectively. 
These levels were consistent with values found in the literature although 
constitutive levels of hepatic ECOD and PROD in the current study were
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slightly lower than other investigators' findings (Kleinow et al., 1990; de 
Waziers et al., 1990). However, these investigators fed commercial diets which 
have been shown to induce hepatic P450s (Deloria and Mannering, 1986) and 
used a different strain of rat (Sprague-Dawley).
Inhibition of ECOD activity in the absence of inhibition of EROD 
activity and no conclusive PROD data suggest that the P450s 2B1 or 2B2 may 
be inhibited by CEB, or a metabolite thereof. Various anticarcinogenic agents 
have demonstrated selective inhibition of the P450 1A and 2B subfamilies. 
(-)-Epigallocatechin-3-gallate inhibited the catalytic activity of several P450 
enzymes, but most potently inhibited P450 1A and 2B enzymes. Diminished 
P450 1A and 2B activity thereby inhibited 4-(methylnitrosamino)-l-(3-pyridyl)- 
1-butanone oxidation and DNA methylation (Shi etal., 1994). Similarly, 
furafyllin has been shown to be a potent mechanism-based inhibitor of P450 
1A2 activity in human liver microsomes (Kunze and Traner, 1993) while 1- 
aminobenzotriazole inhibited hepatic PROD activitity to a greater extent than 
EROD activity in untreated and phenobarbital-treated guinea pigs (Knickle 
and Bend, 1992). EROD and PROD activities have additionally been shown to 
be inhibited by a series of natural coumarins in vitro (Cai et al, 1993).
Alternative mechanisms for the inhibition of ECOD activity must also be 
considered. According to a process referred to as the "steal phenomenon", it is 
possible that ECOD activity is diminished through substrate-dependent 
competition of different P450 enzymes for NADPH-cytochrome P450 
reductase. Depending on the substrate present, one P450 enzyme can affect the 
function of another P450 enzyme when combined in a reconstituted system. 
This has been demonstrated in the presence of benzphetamine and 
pentoxyresorufin, both preferred substrates for P450 2B4 as compared to 1A2,
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in which P450 1A2 was shown to inhibit the reaction by competing with P450 
2B4 for NADPH-cytochrome P450 reductase molecules (Cawley et al., 1995). It 
is therefore possible that, in the presence of CEB, another P450 enzyme could 
have interferred with P450 2B function and inhibited ECOD activity.
Alternatively, CEB, or a metabolite of CEB, could be directly inhibiting 
ECOD activity through interaction at the active site. Such inhibition would not 
necessarily affect PROD activity since the active site for ECOD and PROD are 
obviously slightly different as they utilize distinct substrates. Theoretically,
ECOD, being catalyzed by both P4501A and 2B, is less selective than PROD 
and could more readily be affected by CEB. It is also possible that ECOD is 
more susceptible to nonspecific inhibition with contaminants although several 
different aliquots of 7-hydroxycoumarin were obtained from the manufacturer.
Although renal and hepatic ECOD activity was diminished, there was 
no significant decrease in total P450 levels at any time period evaluated. Total 
P450 levels may not be as readily affected as ECOD activity since total P450 is a 
less sensitive indicator of induction or inhibition of specific P450 enzymes. 
Additionally, P450 levels are indicative of the amount of enzyme present but 
do not necessarily correlate with actual enzyme activity.
The slight but statistically significant decrease in GST activity in the 
kidney and liver was also of questionable biological significance especially in 
light of the fact that previous investigations by VanSteenhouse et al. (1989) 
demonstrated no effect on GST activity in the liver or kidney at similar time 
points.
Inhibition of GST activity has not been well documented in vivo, 
however, extensive lists of effective in vitro GST inhibitors have recently been 
compiled (Mannervik and Danielson, 1988; Flatguard etal., 1993). This diverse
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group of GST inhibitors includes glutathione analogs, drugs from a variety of 
classes, metal compounds, endogenous substances, and naturally occurring 
compounds such as plant phenols. Although remarkable specificities towards 
certain isoenzymes have been observed, the distinction between substrates and 
inhibitors has not been well defined. In fact, any substrate, by virtue of its 
binding capacity, may act as a competitive inhibitor for other substrates. 
Ethacrynic acid (Ahokas et ah, 1985), bromosulphophthalein (Andersson et al., 
1988), and even CDNB (Adams and Sikakana, 1990) are substrates for GST- 
catalyzed GSH conjugation which inhibit enzyme activity at high doses.
High doses of CEB may conceivably diminish GST activity towards 
CDNB by simply inhibiting CDNB binding at the H site (electrophilic substrate 
binding site) in a competitive manner. Alternatively, the GSH conjugate of 
CEB may directly inhibit GST as suggested by the fact that the GSH conjugate 
of ethycrynic acid is a strong inhibitor of GST isoenzymes (Ploemen et al.,
1990). The CEB-GSH conjugate may act at the G site as a GSH analog or at the 
H site as a "second substrate" analog.
Inhibitors of GST may also act in a noncompetitive, irreversible manner. 
This type of inhibition has been demonstrated with ethylene dibromide 
(Ivanetich etal., 1984), a compound known to be activated by GSH conjugation 
(van Bladeren et al., 1980). It is believed that the highly reactive half-sulfur 
mustard initially formed upon GSH conjugation binds to GST and inactivates 
the enzyme. A similar scenerio following CEB conjugation with GSH might be 
expected to cause immediate decreases in GST activity. Upon GSH 
conjugation, the CEB-GSH conjugate may undergo cyclization to an 
iminothiolane-Jike compound which may exert a cytotoxic effect through
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interaction with lysine residues on cellular proteins. In this manner, GST may 
be inactivated through conjugate-mediated thiolation.
Finally, lipid peroxidation may mediate GST inhibition in vivo. In rats, 
both cytosolic and microsomal hepatic GST activities were inhibited during 
episodes of lipid peroxidation (Beckman and Greene, 1988; Harris and Stone, 
1988; Tampo and Yonaha, 1990; Kawashima et al., 1994). Additionally, Rao and 
colleagues (1982) have found that, in rats, liver tumors induced by peroxisome- 
proliferating agents do not demonstrate increased levels of GST as seen with 
genotoxic agents.
Though the diminished activities of renal and hepatic ECOD and GST 
are of debatable biological significance, it is plausible that decreased ECOD 
activity may be associated with the anticarcinogenic effect of cruciferous 
vegetables. The significance of CEB-induced inhibition of GST is obscure. 
Unfortunately, none of these mechanisms of inhibition explain the relatively 
sporadic inhibition of renal and hepatic GST. GSH conjugation catalyzed by 
GST enzymes generally results in detoxication of xenobiotics although 
numerous compounds have been shown to actually be bioactivated by GSH 
conjugation (Dekant and Vamvakas, 1993). As more compounds are shown to 
be bioactivated by GSH conjugation, particularly those which target the 
kidney, decreased GST activity may actually prove antinephrotoxic and 
possibly anticarcinogenic.
The absence of induction of GST activity in this study does not preclude 
the possibility of GSH conjugation with CEB. Several electrophilic xenobiotics 
have been shown to undergo nonenzymatic conjugation with GSH (Ketterer et 
al., 1986; Takahashi et al., 1987; Peterson and Geungerich, 1988). Alternatively, 
it is plausible that a microsomal GST is responsible for catalyzing the
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conjugation reaction since cytosolic GST was measured in this experiment. 
Finally, the GST isozyme responsible for GSH conjugation with CEB may not 
be specific for the substrate (CDNB) utilized in the in vitro assay although 
CDNB is a nonspecific substrate with broad reactivity for many of the GSTs. 
Obviously, future investigations regarding the effect of CEB on xenobiotic 
metabolizing enzymes are necessary to elucidate the biological significance of 
these alterations in enzyme activity.
CHAPTER 4
IDENTIFICATION OF A CEB-DERIVED URINARY 
MERCAPTURIC ACID IN FISCHER 344 RATS
Introduction
l-Cyano-3,4-epithiobutane (CEB; Figure 4.1) is a naturally occurring 
nitrile derived from glucosinolates found in cruciferous vegetables (Fenwick 
and McDonald, 1974; Cole, 1975). Cruciferous plants are cultivated 
extensively for use as livestock feed, in the manufacturing of plastics, and for 
human consumption as condiments, vegetables, and oilseed (Fenwicketal., 
1983; Lenman, 1992).
Previous investigations by VanSteenhouse etal. (1989, 1991) have 
demonstrated bioactivation of CEB by glutathione (GSH; Figure 4.2) 
conjugation. Administration of CEB to male Fischer 344 rats demonstrated 
epithelial cell necrosis and karyomegaly within the pars recta of the proximal 
convoluted tubules. Treatment with CEB also caused an early depletion of 
hepatic GSH followed by a rebound elevation.
Additionally, CEB-induced nephrotoxicity and karyomegaly were 
greatly diminished following pretreatment with buthionine sulfoximine (BSO; 
Figure 4.3), an inhibitor of y-glutamylcysteine synthetase (GCS) activity and 
GSH-depleting agent (VanSteenhouse etal., 1991). The rapid depletion of 
hepatic GSH and reduction of CEB-induced nephrotoxicity following BSO 
pretreatment strongly suggest that glutathione (GSH) conjugation is a 
significant pathway in CEB bioactivation and toxicity.
The kidneys, particularly proximal tubular epithelial cells, are frequent 
targets for toxic xenobiotics. The kidneys are exposed to numerous 
xenobiotics and xenobiotic-derived metabolites since they receive 25% of 
cardiac output (Monks and Lau, 1987). Additionally, the proximal tubular
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Figure 4.1 Structure of l-cyano-3,4-epithiobutane (CEB).
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Figure 4.2 Structure of glutathione (GSH).
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Figure 4.3 Structure of buthionine sulfoximine (BSO). BSO acts as an 
irreversible inhibitor by binding to the active site of GCS in the 
phosphorylated form.
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epithelium possesses specialized functions of transport and metabolism which 
may enhance toxicity through the concentration and bioactivation of 
xenobiotics. Proximal tubular epithelial cells possess the highest 
concentration of y-glutamyl transpeptidase (Goldberg e ta l ,  1960), the only 
known enzyme able to cleave the y-glutamyl linkage (Meister etal., 1981), and 
are active in the uptake and concentration of metabolites of GSH conjugation.
GSH is a ubiquitious tripeptide present in high concentrations (mM) in 
most living cells and participates in a variety of biological functions (Larsson 
etal., 1983; Meister and Anderson, 1983). GSH conjugation is usually 
associated with the detoxication and excretion of reactive electrophiles; 
however, conjugation occasionally results in bioactivation of xenobiotics with 
resultant toxic consequences (Monks and Lau, 1987; Monks etal., 1990; 
Vamvakas and Anders, 1990; Koob and Dekant, 1991; Dekant and Vamvakas, 
1993).
Compounds conjugated with GSH may be excreted in the urine as their 
corresponding mercapturic acids which are N-acetylated derivatives of the 
cysteine S-conjugates (Tate, 1980). N-acetylation is catalyzed by N- 
acetyltransferase which utilizes acetyl Coenzyme A as the acyl donor. Several 
compounds bioactivated by GSH conjugation are selective nephrotoxins and 
excrete mercapturic acids as the predominant urinary metabolite (van 
Bladeren etal., 1980; Jones and Well, 1981; van Bladeren et al., 1981a; Monks et 
al., 1985,1988; Lau etal., 1988b; Kim and Guengerich, 1989).
Since CEB is bioactivated by GSH conjugation and selectively 
targets the renal proximal tubular epithelium, it is of interest to establish 
whether a CEB-derived mercapturate is excreted as the primary urinary 
metabolite. Elucidation of the structure of the mercapturic acid by gas
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chromotography-mass spectrometry (GC-MS) represents identification of a 
unique compound and provides further evidence for the importance of GSH 
conjugation in CEB metabolism (Nelson, 1992). Detection of other CEB- 
associated urinaiy metabolites is also important to the elucidation of in vivo 
CEB metabolism in its entirety.
Measurement of urinary thioethers by thiol reagents such as 5,5’- 
dithiobis-2 -nitrobenzoic acid represents a less specific and sensitive assay than 
GC-MS but serves as a useful screening technique and as a method of 
demonstrating GSH conjugation of various compounds (Chasseaud, 1988). 
Administration of various inhibitors of GSH transport and metabolism 
followed by determination of urinary thiols and thioethers (mercapturates) 
would elucidate the effect of these inhibitors on CEB metabolism and possible 
mechanisms of toxicity.
In the present study, Fischer 344 rats were administered a single dose of 
CEB (125 m g/kg body weight) alone or following pretreatment with one of 
three selective inhibitors of GSH transport and metabolism: acivicin (AT-125 
or a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid), probenecid (p-di-n- 
propylsulfamoyl benzoic acid), and aminooxyacetic acid (AOAA). AT-125 is a 
glutamine analog and irreversible inhibitor of y- glutamyl transpeptidase 
(GGT; Allen et al., 1980; Griffith and Meister, 1980).
Probenecid competitively inhibits the organic anion transport system  
(OATS; Gutman etal., 1955) preventing secretion of the N-acetylated cysteine 
conjugate or mercapturic acid from hepatocytes and subsequent renal uptake 
at the basolateral membrane. Conversely, AOAA inhibits pyridoxal 
phosphate-dependent enzymes including renal cysteine conjugate
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P-lyase (Jones et al., 1986) and therefore the formation of a potentially reactive 
thiol (Tateishi and Shimizu, 1980).
Materials and Methods
Animal Maintenance and Treatment
One hundred and thirty eight, 5-7 week old Fischer 344 rats were 
obtained from Harlan Sprague Dawley, Inc. (Indianapolis, IN, USA). Rats 
were housed in an AAALAC (American Association for Accreditation of 
Laboratory Animal Care)-accredited facility. Rats were initially housed in 
groups of 3-5 under controlled conditions of 12-hour light/dark cycle at 21 °C 
and 50-70 % relative humidity. For one week prior to treatment rats were fed 
a modified, semi-purified diet (AIN-76A) with cornstarch substituted for 
sucrose to prevent hepatic lipidosis (Hamm etal., 1982). Throughout 
experimental trials rats were housed individually in metabolic cages to 
facilitate urine collection and estimation of feed and water intake. Water was 
allowed ad lib. Pair-feeding was instituted to abrogate the effects of dietary 
intake on the metabolism of CEB.
At 8-9 weeks of age rats were divided into one of eight treatment 
groups in a random fashion. The eight groups consisted of a negative, saline 
control group; a positive, CEB-treated control group; an AT-125 pretreated 
group, a probenecid pretreated group, and an AOAA pretreated group; and 
three treatment groups administered one of the three inhibitors alone. Each 
group of rats was further divided into 2  groups (minimum of 6  rats / group) 
for evaluation at 24 or 48 hours post-CEB administration.
An intraperitoneal (IP) injection of 10 mg AT-125/kg body weight was 
administered two hours prior to CEB treatment in sterile saline, pH 6.5 while 
200 mg probenecid/kg body weight was administered IP in 0.1 M sterile
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potassium phosphate buffer (pH 7.4) 30 minutes prior to and 5.5 hours 
following CEB administration. One hour prior to CEB administration, the 
AOAA pretreated group received an IP injection of 32.8 mg AO AA/kg body 
weight in 0.1 M sterile phosphate buffer, pH 7.0.
Treated rats were gavaged with 125 mg CEB/ kg body weight while the 
negative control group received an equivalent volume of deionized, distilled 
water. All gavaging was performed between 8  and 9 AM.
In accordance with the Animal Welfare Act, the experimental protocol 
was submitted to and approved by the Louisiana State University Institutional 
Animal Care and Use Committee.
Materials
CEB was graciously synthesized by Dr. Mark McLaughlin and Tamara 
Schaller from the Department of Chemistry at Louisiana State University. A 
modified method of Luthy and Benn (1980) was utilized to synthesize the 
CEB. The bromo group of 4-bromo-l-butene (Janssen Chimica, New  
Brunswick, NJ, USA) was replaced with a cyano moiety from sodium cyanide 
(Aldrich, Milwaukee, WI, USA) to yield l-cyano-3,4-butene. l-Cyano-3,4- 
butene was then oxidized at the unsaturated double bond with magnesium 
monoperoxyphthalate hexahydrate (Aldrich, Milwaukee, WI, USA) yielding
l-cyano-3,4-epoxybutane which was subsequently converted to a thiouronium 
salt in the presence of thiourea (Aldrich, Milwaukee, WI, USA). Final 
conversion to l-cyano-3,4-epithiobutane was achieved in an alkaline 
environment (pH 9.0). The identity of the product was confirmed by nuclear 
magnetic resonance (NMR) and the purity of l-cyano-3,4-epithiobutane was 
demonstrated to be 98% or greater by gas chromatography (see Appendix).
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5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), potassium hydroxide, N- 
nitroso-N-methylurea, L-cysteine, aminooxyacetic acid, AT-125 (acivicin), 
probenecid, tris(hydroxymethyl) aminomethane hydrochloride (Tris-HCl), 
and a diagnostic kit for determination of creatinine (Procedure no. 555) were 
obtained from Sigma Chemical Co. (St. Louis, MO, USA). Trichloroacetic acid 
(TCA) was acquired from Curtin Matheson Scientific, Inc. (Houston, TX, USA) 
while hydrogen chloride (HC1) was obtained from Aldrich Chemical 
Company, Inc. (Milwaukee, WI, USA). Nitrogen gas for the evaporation of 
samples was obtained from Lincoln Big Three, Inc. (Baton Rouge, LA, USA). 
Methanol, sodium hydroxide (NaOH), ethyl acetate, and ethyl ether were 
acquired from Mallinckrodt, Inc. (Paris, KY, USA). Ethylene diamineacetic 
acid, disodium salt (EDTA) was obtained from Amresco (Solon, OH, USA). 
Saline was from Baxter Healthcare Corp. (Deerfield, IL, USA). The dietary 
components were obtained from ICN Nutritional Biochemical (Costa Mesa, 
CA, USA).
Urine samples were prepared using a Beckman Model TJ- 6  centrifuge 
from Beckman Instruments, Inc. (Fullerton, CA, USA) and two ml ChemElut 
columns from Analytichem International (Harbor City, CA, USA). Urinary 
metabolites were analyzed by electron impact ionization and chemial 
ionization (methane) using a Hewlett-Packard 5890A Gas Chromatograph 
equipped with a 5970 Series Mass Selective Detector (Palo Alto, CA, USA) and 
a TSQ GC/M S/M S/DS from Finnigan MAT (San Jose, CA, USA), 
respectively. A Hitachi U-2000 double-beam UV/Vis spectrophotometer from 
Hitachi Instruments, Inc. (San Jose, CA, USA) was utilized to analyze urinary 
thiols and mercapturate levels.
160
Biochemical Assays
Total nonprotein (NP) urinary thiols and urinary thioethers (including 
mercapturates) were analyzed according to a modification of the combined 
methods of Seutter-Berlage et al. (1977) and Ellman (1959). Aliquots were 
analyzed from samples obtained at 12, 24, and 48 hours. One ml of rat urine 
was deproteinated with an equivalent volume of 10% TCA. The mixture was 
allowed to sit at room temperature for 15 minutes and samples were 
centrifuged at 1800 rpm for 15 minutes at 4°C. A 0.8 ml aliquot of the clear 
supernatant was added to 0.2 ml of 5N NaOH or 2.0 mis of 0.4 M Tris-HCl 
buffer (pH 8.9) for the determination of thioethers or total thiols, respectively. 
50 nl of 0.01 M DTNB was added to samples for NP thiol evaluation. The 
mixture was inverted and the absorbance promptly recorded at 412 nm.
Samples determined for thioether levels were bubbled with nitrogen 
gas, sealed, and placed in a boiling water bath for 50 minutes. Once removed 
from the water bath, tubes were placed on ice and 0.1 ml of 10 N HC1 was 
added to stop the reaction. Two mis of 0.4 M Tris-HCl buffer (pH 8.9) and 50 
//I of 0.01 M DTNB were sequentially added to each sample tube. The 
absorbance was recorded at 412 nm within 10 minutes of adding the DTNB.
Absorbances for NP thiol and thioether levels were measured on a 
Hitachi U-2000 double-beam UV/Vis spectrophotometer. Cysteine in 0.02M 
EDTA was utilized as a standard.
The thiol concentration from the nonhydrolyzed sample was subtracted 
from the thiol concentration measured in the hydrolyzed sample to calculate 
the level of thioethers present. Urinary NP thiols and thioethers were 
expressed in //M per /(M creatinine. Urine creatinine was measured using a
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quantitative colorimetric alkaline picric acid method developed by Sigma 
Diagnostics (Procedure no. 555).
Gas Chromatography-Mass Spectrometry
Sample Preparation: To identify urinary metabolites in samples obtained at 4, 
12,24,36, and 48 hours, a 0.5 ml sample of rat urine was prepared according 
to a modified method of Brocker et al. (1984). The samples were thawed and 
adjusted to pH 2.0 with 1 N HC1 and 5 N NaOH. Adjusted samples were 
adsorbed onto a 2.0 ml ChemElut (diatomaceous earth) column. Metabolites 
were extracted from the column with 6 . 0  mis ethyl acetate which was 
subsequently evaporated under nitrogen gas.
The remaining residue was derivatized with diazomethane. 
Diazomethane was prepared by adding 20 mis ethyl ether to 20 mis 45% 
potassium hydroxide. N-nitroso-N-methylurea (0.5 gm) was added and the 
layers stirred until the ether (top) layer formed a bright yellow color. A 1-2 ml 
aliquot of the ether layer was added to each sample residue until the solution 
no longer cleared with standing. Samples were allowed to stand at room 
temperature for 10-15 minutes. The ether was then evaporated under nitrogen 
gas.
Gas Chromatography-Mass Spectrometry: GC-MS analysis (electron impact 
ionization) was performed on a Hewlett-Packard 5890A Gas Chromatograph 
equipped with a 5970 Series Mass Selective Detector and a 30-m DB5 capillary 
column (i.D. 0.25 mm) dynamically coated with 5% phenylmethyl silicone 
(0.25 //m film thickness) stationary phase. A 3 /d aliquot of sample residue 
dissolved in 150 /d of ethyl acetate was injected via a Hewlett-Packard 7673A 
automatic sampler into a split/splitless injection port set in the splitless mode. 
Helium was utilized as the carrier gas at a flow rate of 1 m l/ min and a head
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pressure of 15 psi. The temperature of the column was programmed from 
50°C, holding for one minute, rising to 300°C at a rate of 30°C/min.
Temperatures of the injection port and detector were 250°C and 300 °C, 
respectively. The source temperature was 150°C; pressure 5 x 10-5 torr; 
electron energy 70 eV.
GC-MS analysis (chemical and electron impact ionization) was also 
performed on a Finnigan TSQ GC/M S/M S/DS 4500. The same column and 
detector conditions were applied as previously described. Methane was 
utilized as the soft ionization gas at a pressure of 1 torr.
Statistical Analysis
Urine total thiols and thioethers were evaluated by analysis of variance 
with respect to treatment group. The means of each treatment group were 
compared to one another by Fisher's least significant difference test for 
multiple comparsions at a 95% confidence level. P-values <0.02 were 
considered significant.
Results
Urinary Total Nonprotein Thiols
Rats administered CEB in addition to any of the inhibitors exhibited 
significant elevations in the excretion of urinaiy NP thiols as compared to 
controls at 12 hours post-CEB administration (Figure 4.4). At 24 hours urinary 
NP thiol levels remained sgnificantly elevated in rats pretreated with AT-125 
but were not significantly increased in rats pretreated with AOAA or 
probenecid or given CEB alone. By 48 hours urinary NP thiols were 10 times 
greater in animals administered AT-125 in addition to CEB as compared to 
controls; however, the difference between the two groups was not statistically 
significant. Rats treated with CEB alone did not exhibit significantly elevated
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Figure 4.4 Urinary nonprotein thiol excretion at 12,24, and 48 hours post- 
CEB administration in rats pretreated with one of three inhibitors in addition 
to CEB or CEB alone as compared to controls. Values represent means ±SEM; 
n=minimum of 6  per group; + represents P = 0.0001 as compared to controls; ♦ 
represents P = 0.0001 as compared to CEB treated group.
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urinary NP thiol levels although the mean was 10 times greater for the CEB 
treated group as compared to controls. Rats treated with AT-125 in addition 
to CEB also exhibited increased thiol levels at 12 and 24 hours as compared to 
rats treated with CEB alone.
Rats given AT-125 alone demonstrated significantly elevated levels of 
urinary NP thiols at 12 and 24 hours as compared to saline controls (Figure 
4.5). No significant differences were observed in rats treated only with AOAA 
or probenecid alone or at 48 hours in animals given only AT-125.
Urinary Thioethers
Rats administered a single dose of CEB alone or CEB in addition to any 
of the inhibitors exhibited significant elevations in the excretion of urinary 
thioethers as compared to controls at 12 and 24 hours (Figure 4.6). This 
elevation, however, extended out to 48 hours only in AT-125 pretreated 
animals. Additionally, rats pretreated with AT-125 exhibited significantly 
elevated urinary thioethers as compared to CEB treated rats at 12 and 48 
hours.
Animals given AT-125 alone demonstrated significantly elevated levels 
of urinary thioethers at 12 and 24 hours (Figure 4.7). By 48 hours this group of 
animals did not exhibit significantly different levels of thioethers as compared 
to controls. No significant differences were observed between controls and 
animals treated with AOAA or probenecid alone.
Gas Chromatography-Mass Spectrometry
GC-MS analysis of urine samples revealed a single predominant 
metabolite with a retention time of 10.61 ± 0.16 minutes which was unique to 
the CEB-treated rats and absent in the urine of control animals (Figures 4.8- 
4.13). The metabolite was also present in the urine of rats pretreated with
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Figure 4.5 Urinary nonprotein thiols excreted at 12,24, and 48 hours post- 
treatment in rats administered one of the three inhibitors alone. Values 
represent means ± SEM; n=minmum of 6  per group; t  represents P = 0.0001 as 
compared to controls.
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Figure 4.6 Excretion of urinary thioethers at 12,24, and 48 hours post-CEB 
administration in rats pretreated with one of three inhibitors in addition to 
CEB or CEB alone. Values represent means ± SEM; n=minimum of 6  per
group; t  represents P < 0.05 as compared to controls; ♦ represents P < 0.05 as 
compared to CEB treated group.
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Figure 4.7 Excretion of urinary thioethers at 12, 24, and 48 hours post-CEB 
administration in rats treated with one of the three inhibitors alone. Values 
represent means ± SEM; n= minimum of 6  per group, t  represents P < 0.005 as 
compared to controls.
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Figure 4.8 Total ion chromatogram from a CEB control rat demonstrating a 
unique peak at 10.64 minutes (*). Electron impact positive ionization using 
Hewlett Packard instrumentation.
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Figure 4.9 Total ion chromatogram from a saline control rat demonstrating 
the absence of the unique peak at 10.64 minutes (*). Peaks eluting around 
10.64 minutes in the control urine had dramatically different mass spectra as 
compared to the mercapturate. Electron impact positive ionization using 
Hewlett Packard instrumentation.
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Figure 4.10 Electron impact ionization (Hewlett Packard) mass spectrum of 
the unique peak at 10.64 minutes. This spectrum was consistently observed in 
CEB treated and AOAA and AT-125 pretreated urine samples but was absent 
from the negative control urines as well as the probenecid pretreated samples.
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Figure 4.11 Selected ion tracing (extracted ion currents) of the electron 
impact ionization (Hewlett Packard) chromatograph in a CEB control rat. 
These ions are characteristic of the mercapturate which has a retention time of 
10.64 minutes (*).
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Figure 4.12 A similar ion tracing of the electron impact ionization (Hewlett 
Packard) chromatogram in a saline control rat demonstrates the absence of the 
metabolite at 10.64 minutes (*).
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Figure 4.13 Electron ionization mass spectrum from a CEB control sample 
analyzed via Finnigan instrumentation. A similar ionization pattern is 
observed for a unique peak at the same relative retention time as observed 
with the Hewlett Packard GC-MS.
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AT-125 and AOAA but not probenecid pretreated animals. The positive 
electron impact ionization pattern of this metabolite was consistent with the 
N-acetylated cysteine conjugate (mercapturic acid) of CEB or N-acetyl-S-(4- 
cyano-2-thio-l-butyl)-cysteine (Figure 4.14).
Chemical ionization (Cl) with methane revealed a unique peak at the 
same relative retention time as compared to the El chromatograms (4.15-4.16). 
Additionally, a search of the Cl chromatogram for the 305 ion revealed a 
single large peak at scan # 367 (Figure 4.17). The 305 ion represents the 
calculated molecular weight of the mercapturate plus a positive charge (MW + 
H+; 304+1). The mass spectrum of scan # 367 revealed M + 1 (305.2), M + 29 
(333.2), and M + 41 (345.2) peaks consistent with a molecular weight of 304.2 
and the masses for the methane conjugates of this mass, respectively (Figures 
4.18-4.19).
In CEB-treated rats, the majority of the mercapturate was excreted by 
12 hours post-CEB administration as demonstrated by relative quantification 
(peak area) of the mercapturate at different time points (Figure 4.20).
Minimal levels of the mercapturate were excreted by 24 hours post-CEB 
administration and essentially none was observed at 36 and 48 hours. Small 
quantities were inconsistently observed in the urine at 36 and 48 hours. Four 
of 6  rats and 2 of 6  rats revealed detectable levels of the mercapturate at 36 and 
48 hours, respectively.
Pretreatment with both AT-125 and AOAA appeared to decrease the 
relative amount of mercapturate excreted in the urine at 12 hours. A valid 
interpretation of the effects of different treatments on mercapturic acid levels 
could not be attained at 24, 36, or 48 hours since the relative quantities did not 
exhibit large enough variations between experimental groups.
Figure 4.14 Proposed structure for the methylated CEB-associated urinary 
metabolite. The fragment weights of various structural components consistent 
with the electron impact ionization pattern are denoted by numbers in 
parentheses. This structure is consistent with the methylated mercapturic acid 
derived from CEB [N-acetyl-S-(4-cyano-2-thio-l-butyl)-cysteine].
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Figure 4.15 Total ion chromatogram (methane chemical ionization) from a 
CEB treated rat obtained using Finnigan instrumentation The unique peak at 
scan # 368 occurs at the same relative retention time as the mercapturic acid 
on the electron ionzation chromatogram.
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Figure 4.16 Total ion chromatogram (methane chemical ionization) from a 
saline control rat obtained using Finnigan instrumentation. The peak 
observed at scan # 368 in treated rats (figure 4.12) is absent from control 
samples.
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Figure 4.17 A scan of the chemical ionization chromatogram for the 305 ion 
(consistent with the molecular weight of the mercapturate + 1 ) reveals a 
single, predominant metabolite at scan # 367. This peak occurs at the same 
relative retention time as the peak for the mercapturate in the electron 
ionization chromatogram.
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Figure 4.18 Mass spectrum of scan # 367 from the chemical ionization 
chromatogram.
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Figure 4.19 A closer view of the mass spectrum of scan # 367 from the 
chemical ionization chromatogram reveals the M + 1 (305), M + 29 (333), and 
M + 41 (345) ions consistent with a molecular weight of 304.
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Figure 4.20 Relative quantification of the mercapturic acid in urine
samples at 4,12,24,36,  and 48 hours post-CEB administration. The 
mercapturic acid was not observed in the saline control rats and animals 
administered probenecid. The quantity of the metabolite is estimated by the 
peak area from the electron ionization chromatogram.
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An extensive search of the electron impact ionization chromatogram for 
the 127/128 ion (associated with the CEB moiety of the mercapturic acid) 
revealed the existence of other urinary mercapturates or similar compounds 
related to CEB metabolism (Figure 4.21). After thorough and extensive 
investigation of these peaks using pooled samples of urine to increase the 
response and sensitivity of the analysis, however, no consistent, unique 
metabolites could be demonstrated. These peaks were not consistently 
evident in CEB control animals, were not unique to the CEB-treated groups, or 
were present beyond the lower level of sensitivity of the analytical technique. 
The electron impact ionization and methane chemical ionization 
chromatograms were additionally traced for unconjugated CEB and 
"anticipated" metabolites derived from CEB. No detectable levels of any of 
these compounds were observed.
Discussion
Determination of urinary nonprotein (NP) thiols represents 
measurement of GSH, cysteine, and cysteinylglycine, as well as GSH and 
cysteine S-conjugates of CEB and the corresponding mercapturic acid. 
Normally, GSH conjugates and their metabolites would not be considered 
thiols; however, CEB, due to its epithiol moiety, forms a thiol upon GSH 
conjugation. An elevation in urinary NP thiols at 12 hours in groups treated 
with CEB in addition to an inhibitor and an absence of such an increase in rats 
treated with CEB alone suggests that the inhibitors have a pronounced effect 
on excretion of urinary thiols.
A profound increase in thiol excretion was observed in AT-125 
pretreated rats or rats given AT-125 alone at 12 and 24 hours. AT-125 causes a 
mild glutathionemia and pronounced glutathionuria in mice due to inhibition
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Figure 4.21 a and b Comparison of selected ion tracings of the total ion
chromatogram (electron impact ionization) from a) CEB-treated rat urine and 
b) control rat urine for ions associated with the CEB moiety (127 and 128) 
indicating possible CEB-derived metabolites.
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of renal y-glutamyl transpeptidase (GGT) at the basolateral and luminal 
membranes (Griffith and Meister, 1979), GSH and GSH conjugates are freely 
filtered at the glomerulus with greater than 80% of circulating GSH being 
cleared on a single pass through the kidney (Rankin etal., 1985). The majority 
of GSH and GSH conjugates in the filtrate are normally absorbed as cysteine 
or cysteine conjugates, respectively, following degradation by y-glutamyl 
transpeptidase (GGT) and cysteinylglycine dipeptidase on the luminal 
epithelium. Administration of AT-125 and inhibition of GGT prevents 
degradation of GSH and GSH conjugates thereby increasing urinary loss of 
these compounds.
AOAA and probenecid pretreatment also increase the excretion of 
urinary NP thiols though to a lesser extent as compared to AT-125. AOAA 
inhibits the conversion of cysteine conjugates to reactive thiols in addition to 
pyruvate and ammonia (Jones et ah, 1986). The cysteine conjugate of CEB may 
therefore be excreted into the urine or serve as a substrate for N- 
acetyltransferase and increase the formation and urinary excretion of the 
corresponding mercapturic acid.
Probenecid inhibits the renal uptake of mercapturates at the basolateral 
membrane and, though controversial, evidence suggests it also inhibits 
transport of mercapturic acids from the renal epithelial cell into the filtrate 
(Moller and Sheikh, 1983). If this latter point proves valid, inhibition of 
secretion of mercapturates formed within the tubular epithelial cell may 
increase deacetylation of the compound to the corresponding cysteine 
conjugate. Thus, elevations in urinary thiols in probenecid pretreated rats 
may be the result of increased excretion of the cysteine conjugate. Inhibition 
of renal uptake of the mercapturate at the basolateral border may increase the
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filtration of this compound through the glomerulus; however, probenecid also 
inhibits secretion of mercapturates from the hepatic sinusoidal membrane 
thereby decreasing transport from the liver to the kidney.
The fact that AOAA and probenecid when administered alone did not 
increase excretion of urinary NP thiols supports the idea that the cysteine 
conjugate of CEB and / or the corresponding mercapturate are responsible for 
elevations observed in animals pretreated with these inhibitors. Formation of 
large quantities of the cysteine conjugate and mercapturic acid following 
administration of CEB and inhibition of GSH metabolism or transport by 
AOAA and probenecid results in increased excretion of urinary thiols.
It also seems plausible that rats treated with CEB alone should also 
exhibit elevated thiol levels simply due to the formation of cysteine 
conjugates, GSH conjugates, and mercapturic acids. Though there was no 
statistically significant difference between the CEB treated group and the 
control group, there was a distinct trend towards elevated levels of urinary 
thiols in CEB treated rats at 12 and 24 hours. The detection limit of this assay 
may be limited by the naturally occurring background of thiols. A larger 
sample size may actually be needed to detect statistically significant 
differences between these groups.
Although the thioether assay is useful for assessing exposure to 
electrophiles in biological monitoring studies and for demonstrating GSH 
conjugation of experimental compounds, it should not be considered a true 
quantification of urinary mercapturates as it was originally proposed (Seutter- 
Berlage etaL, 1977). Urinary thioethers (R-S-R') include GSH conjugates, 
cysteine conjugates and mercapturates as well as products of further 
metabolism (S-methylation, glucuronidation, etc). Spectrophotometric
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evaluation of urine samples for thioethers is therefore a nonspecific assay and 
the chemical structures of the thioethers determined are generally unknown.
Relative levels of thioethers generally paralleled those of NP thiols.
Rats administered CEB alone exhibited elevated thioether levels at 12 and 24 
hours presumably due to excretion of mercapturates as well as GSH and 
cysteine conjugates. Administration of any of the inhibitors in combination 
with CEB also elevated urinary thioethers at 12 and 24 hours due to excretion 
of cysteine conjugates and mercapturates as previously described. Once 
again, AT-125 caused a profound elevation in urinary metabolites at all time 
points indicating inhibition of GGT and filtration of the GSH conjugate at the 
glomerulus. Typically, compounds with a molecular weight < 68,000 may be 
freely filtered at the glomerulus (Osborne and Stevens, 1981). The GSH 
conjugate of CEB has a calculated molecular weight of 420.5 and therefore 
would be expected to be readily filtered from the plasma at the glomerulus.
Elevations in urinary NP thiols and thioethers at 12 and 24 hours were 
most pronounced in animals pretreated with the inhibitors indicating effective 
inhibition at these time points. The inhibitory effects of AOAA and 
probenecid appear to have diminished by 48 hours while the effect of AT-125 
extended out to 48 hours.
Increased levels of thioethers in rats treated with CEB alone also 
provides further evidence of the role of GSH conjugation in the metabolism of 
CEB. The presence of urinary thioethers suggests excessive excretion of GSH 
conjugates, cysteine conjugates, and the corresponding mercapturic acids.
GC-MS analysis of urine samples can provide a selective and sensitive 
method for identifying urinary metabolites. A single, predominant 
mercapturate was identified in the urine in the present study although
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evidence for other CEB-derived metabolites was also demonstrated. Absolute 
identification will require synthesis of the urinary mercapturate and 
reexamination under the conditions descibed here.
Mercapturic acids are metabolic end-products of GSH conjugation. 
Many mercapturates derived from GSH conjugation are predominantly 
excreted in the urine as a consequence of the high activity of GGT on proximal 
tubular epithelial cell membranes. High levels of GGT expression allow these 
cells to cleave the y-glutamyl moiety of GSH conjugates and transport the 
cysteine conjugate into the cell providing substrates for mercapturic acid 
formation.
Excretion of urinary mercapturates has been demonstrated in rats, 
rabbits, and primates (including humans) following exposure to a wide range 
of electrophilic compounds (te Koppele et al., 1986; Zoetemelk etal., 1986; 
Winter etal., 1987; Chasseaud, 1988; Polhuijs etal., 1989; Monks and Lau, 1990; 
Polhuijs et al., 1991; Nelson, 1992; van Welie et al., 1992; Jensen et al., 1993). 
Though conjugation with GSH generally detoxifies electrophiles, several 
xenobiotics are actually bioactivated by GSH conjugation. 1,2-Dibromoethane 
(DBE) is an extensively utilized industrial chemical and nematocide 
bioactivated by GSH conjugation either directly or following oxidation. In 
rats, the major urinary metabolite of DBE is N-acetyl-S-(2-hydroxyethyl)-L- 
cysteine (van Bladeren et al., 1980; van Bladeren et al., 1981b). GSH conjugates 
of DBE also form DNA adducts in the liver and kidney which have been 
identified as (2-[N-7-guanyl]ethyl)-glutathione (van Welie etal., 1992). 
Interestingly, this adduct is also excreted in the urine as N-acetyl-S-2-[N-7- 
guanyl]ethy!)-L-cysteine (Kim and Guengerich, 1989). Ethylene oxide, a
186
potential human carcinogen, similarly forms N-acetyl-S-(2-hydroxyethyl)-L- 
cysteine following GSH conjugation (Jones and Well, 1981).
Conjugation of benzoquinones with GSH results in the formation of 
selective nephrotoxicants which target proximal tubular epithelial cells 
(Monks et al, 1985,1988; Lau et al., 1988b). 2-bromo-3-(N-acetylcystein-S-yl)- 
hydroquinone was excreted as a major urinary metabolite and the tissue 
selectivity is a consequence of high GGT activity on renal proximal tubular 
epithelial cells (Monks and Lau, 1990).
The selective nephrotoxicity of CEB also appears to be the result of 
high renal epithelial cell GGT activity. Though it is not clear whether the 
mercapturate is involved in the toxicity, identification of this metabolite in the 
urine provides evidence for the importance of GSH conjugation in CEB 
metabolism and represents preliminary identification of a unique compound.
Based on mass spectral data obtained from this study, the 
mercapturic acid derived from CEB may be chemically sythesized and 
analyzed for a more definitive identification of the metabolite. GC-MS 
analysis of the synthetic compound should reveal an identical mass spectrum 
to the mercapturate identified in CEB-treated rat urine.
CHAPTER 5 
GENERAL CONCLUSIONS
l-Cyano-3,4-epithiobutane (CEB) is a naturally occurring nitrile derived 
from cruciferous plants that is bioactivated by glutathione (GSH) conjugation 
in Fischer 344 rats. A single oral exposure to CEB results in epithelial cell 
necrosis and karyomegaly in the pars recta of the renal proximal tubules in 
Fischer 344 rats (VanSteenhouse, et al, 1989). Administration of CEB to rats 
also caused a sustained elevation in renal GSH which may be associated with 
the anticarcinogenic effect characteristic of cruciferous vegetables.
The results of these investigations indicate that the reactive thiol, or a 
metabolite of the thiol, is at least partially responsible for CEB-induced 
nephrotoxicity. Aminooxyacetic acid (AOAA) inhibits renal cysteine conjugate 
p-lyase and exerts a protective effect, though short-lived, against CEB-induced 
epithelial cell necrosis and karyomegaly within the renal proximal tubules.
The reactive thiol also appears to be involved in diminished v-glutamyl- 
cysteine synthetase (GCS) activity. Rats treated with CEB alone or pretreated 
with AT-125 or probenecid exhibited significantly decreased renal GCS activity 
at 24 hours as compared to controls. AOAA-pretreated rats, however, did not 
demonstrate diminished renal GCS activity at 24 hours. Since AOAA inhibits 
the formation of the reactive thiol, these findings suggest that the thiol may be 
involved in decreased GCS activity.
The reactive thiol may inhibit GCS activity through reduction of 
disulfide bridges or amino acid residues within the active site which are 
essential for GCS activity. Conversely, a metabolite of the reactive thiol, such 
as a methylthio or S-glucuronide derivative, could inhibit GCS activity. The
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possibility that AOAA pretreatment actually induced GCS activity is 
contradicted by the fact that AOAA given alone did not induce enzyme 
activity.
Decreased levels of renal GCS at 12 and 24 hours do not appear to be the 
result of feedback inhibition by elevated GSH since renal GSH levels were 
elevated at 48 hours as well as 24 hours. Renal GCS levels recovered by 48 
hours post-CEB administration despite significant elevations in renal GSH.
The mechanism of karyomegaly remains elusive at this time. 
Karyomegaly may represent a preneoplastic change or a compensatory 
regenerative response to renal tubular epithelial cell necrosis. It should be 
noted, however, that karyomegaly was observed with low doses of CEB in the 
absence of cell death (VanSteenhouse et al., 1989). Increased nuclear size may 
be the result of elevated GSH levels or may be a direct effect of CEB or the GSH 
conjugate of CEB.
Renal and hepatic GSH levels were significantly elevated at 24 and 48 
hours in rats administered CEB alone or following administration of CEB in 
addition to any of the inhibitors with the exception of hepatic GSH at 24 hours 
following pretreatment with probenecid. Possible mechanisms for elevations 
in renal and hepatic GSH include increased cellular uptake of cysteine or 
cystine since cysteine is the limiting substrate for GSH synthesis (Deneke and 
Fanburg, 1989) and enhanced transcriptional activation or stabilization of GCS 
mRNA.
Cyanohydroxybutene (CHB), a naturally occurring nitrile also derived 
from cruciferous vegetables, elevates hepatic and pancreatic GSH but does not 
cause significant elevations in hepatic or pancreatic GCS activity. Pancreatic
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and hepatic cysteine equivalents and the hepatic GCS mRNA concentration, 
however, were elevated in CHB-treated rats (Davis et al., 1993).
It appears that elevated GSH levels in the liver and the kidney may be 
under the control of multiple regulatory mechanisms. The lack of enhanced 
hepatic GSH in rats pretreated with probenecid actually supports the theory 
that increased cystine (or cysteine) uptake is involved in elevated intracellular 
levels of GSH. Since cystine is transported as a tripolar, of anionic, ion in 
human fibroblasts (Bannai and Kitamura, 1980, 1981) and hepatocytes 
(Makowske and Christensen, 1982), probenecid may inhibit the organic anionic 
transport system and the uptake of cystine into hepatocytes. This transport 
mechanism has not been described in renal proximal tubular epithelial cells 
and probenecid did not prevent the CEB-induced increase in renal GSH.
Results from these studies also suggest that CEB exerts an inhibitory 
effect on some xenobiotic metabolizing enzymes including ethoxycoumarin O- 
deethylase (ECOD) and glutathione S-transferase (GST). The slight but 
statistically significant decrease in ECOD and GST activity may be of 
questionable biological significance especially considering the fact that 
previous investigations by VanSteenhouse etal. (1989) demonstrated no effect 
on GST activity in the liver or kidney following administration of CEB at a 
similar dose and time.
Inhibition of cytochrome P450 enzymes, such as ECOD, may be 
associated with the anticarcinogenic effect characteristic of cruciferous 
vegetables. Decreased ECOD activity represents inhibition of P450 1A and/ or 
2B enzymes suggesting that either EROD or PROD activity should also be 
affected. The constitutive levels of PROD activity in untreated rats as 
compared to ECOD activity, however, were extremely low. It is therefore
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possible that inhibition of PROD activity could not be detected as it was 
beyond the lower limits of sensitivity of the assay.
Alternatively, inhibition of ECOD activity may be due to a process 
referred to as the "steal phenomenon". Depending on the substrate present, 
one cytochrome P450 enzyme can interfere with the function of another 
cytochrome P450 enzyme by competing for NADPPI-cytochrome P450 
reductase molecules (Cawley et al., 1995). It is therefore possible that another 
P450 enzyme could have interfered with P450 2B function and inhibited ECOD 
activity in the presence of CEB.
Finally, it is also possible that CEB, or a metabolite of CEB, could 
directly inhibit ECOD activity through interaction at the active site. Such 
inhibition would not necessarily affect PROD activity since the active site for 
ECOD and PROD are obviously different since they utilize distinctly different 
substrates.
The slight but statistically significant decrease in renal and hepatic GST 
activity was observed at 4 hours and at 12 and 36 hours, respectively. Any 
substrate, by virtue of its binding capacity, can inhibit GST activity towards 
another substrate. Ethacrynic acid (Ahokas et al, 1985), bromosulphophthalein 
(Andersson et al., 1988), and CDNB (Adams and Sikakana, 1990) are substrates 
for GST-catalyzed GSH conjugation which inhibit enzyme activity at high 
doses. High doses of CEB may diminish GST activity towards CDNB by 
inhibiting CDNB binding at the H site (electrophilic substrate binding site) in a 
competitive manner. It is plausible that lower doses of CEB could actually 
enhance GST activity; however, previous investigations regarding CEB 
metabolism in F344 rats by VanSteenhouse etal. (1989) revealed no alteration in 
GST activity at lower doses (50 m g/kg body w eight) of CEB.
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Alternative mechanisms for inhibition of GST activity include direct 
inhibition of GST activity by CEB or the CEB-GSH conjugate, nonsubstrate 
ligand binding resulting in a conformational change in the enzyme, and 
inhibition of GST in the presence of lipid peroxidation. None of these 
mechanisms of inhibition, however, readily explain the relatively sporadic 
nature of the inhibition of GST in the liver and the kidney.
It should be noted that a lack of induction and decreased activity of GST 
towards CDNB does not preclude the possibilty of GSH conjugation. GSH 
conjugation may occur nonezymatically. Spontaneous reactions with GSH 
have been demonstrated for various quinones, dihaloethanes, and acrylonitrile 
(Ketterer etal., 1986;Takahashi etal., 1987; Peterson and Guengerich, 1988; 
Buffinton et al., 1989). Alternatively, the GST isoenzyme responsible for 
catalyzing GSH conjugation with CEB may be a microsomal GST. Induction of 
a microsomal GST isoenzyme would not have been detected in these studies 
since GST activity was measured only in the cytosolic fraction of the liver and 
kidney. Finally, it is plausible that the GST isoenzyme involved in GSH 
conjugation with CEB may not exhibit activity towards the substrate, CDNB, 
utilized in the in vitro assay.
Analysis of urine samples for thiol and thioether levels demonstrated 
elevated urinary nonprotein thiols and thioethers in rats treated with CEB; yet, 
a more profound increase in metabolite excretion was observed in rats 
pretreated with the inhibitors. Urinary thiols include GSH, cysteine, and 
cysteinylglycine, as well as GSH conjugates, cysteine S-conjugates, and the 
corresponding mercapturic acids. Urinary thioethers (R-S-R') include GSH 
conjugates, cysteine conjugates and mercapturates as well as products of 
further metabolism (S-methylation, glucuronidation, etc).
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AT-125 increases urinary excretion of GSH and GSH conjugates by 
virtue of its inhibitory effect on y-glutamyl transpeptidase (GGT) at the 
basolateral and luminal membranes (Griffith and Meister, 1979). Inhibition of 
GGT prevents degradation of GSH and GSH conjugates since the y-glutamyl 
linkage can not be cleaved.
Aminooxyacetic acid (AOAA) inhibits the conversion of cysteine 
conjugates to reactive thiols thereby allowing excretion of the cysteine 
conjugate into the urine. The cysteine conjugate may alternatively be 
converted to the corresponding mercapturic acid which is subsequently 
excreted in the urine.
Probenecid inhibits the renal uptake of mercapturates at the basolateral 
membrane and, though controversial, evidence suggests it also inhibits 
transport of mercapturic acids from the renal epithelial cell into the filtrate 
(Moller and Sheikh, 1983). Inhibition of secretion of mercapturates formed 
within the tubular epithelial cell may increase deacetylation of the compound 
to the corresponding cysteine conjugate. The cysteine conjugate may then be 
secreted into the urine.
The fact that AOAA and probenecid when administered alone did not 
increase excretion of urinary NP thiols and thioethers supports the concept that 
the cysteine conjugate of CEB and/or the corresponding mercapturate are 
responsible for elevations observed in animals pretreated with these inhibitors.
Increased levels of thioethers in rats treated with CEB alone provides 
further evidence of the role of GSH conjugation in the metabolism of CEB. The 
presence of urinary thioethers suggests excessive excretion of GSH conjugates, 
cysteine conjugates, and the corresponding mercapturic acids.
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Analysis of urine samples by gas chromatography-mass 
spectrometry demonstrated the presence of a single predominant metabolite 
although evidence for trace levels of other metabolites was also demonstrated. 
The metabolite was identified as N-acetyl-S-(4-cyano-2-thio-l-butyl)-cysteine 
according to electron impact and chemical ionization mass spectral data. 
Identification of the mercapturate in the urine provides further evidence for the 
importance of GSH conjugation in CEB metabolism and represents 
identification of a unique compound.
Future research endeavors which may be considered include studies 
evaluating chronic administration of CEB to Fischer 344 rats to assess potential 
carcinogenic effects of the compound. These investigations could include 
evaluation of karyomegalic changes induced by CEB. The possibility of 
increased DNA synthesis may be assessed from Feulgen-stained renal tissues. 
Alternatively, immunohistochemical staining for proliferating cell nuclear 
antigen (PCNA) or bromodeoxyuridine (BrDU) would reveal the relative 
number of cells in the S phase of DNA synthesis. The amount of staining in the 
renal proximal tubules may actually be quantitated through 
histomorphometric techniques.
The mechanism of elevated GSH levels in the liver and kidney could be 
further investigated by measuring cellular uptake of cystine and cysteine. 
Cysteine is the rate-limiting substrate for GSH synthesis. It would also be of 
interest to measure GCS mRNA levels in the liver and kidney to assess 
transcriptional activity following administration of CEB. CEB may induce the 
production of the GCS protein and/or mRNA without inducing actual enzyme 
activity.
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The mechanism of GSH conjugation with CEB could be further 
elucidated through in vitro investigations. Nonenzymatic conjugation may 
occur between GSH and CEB.
The activity of GST isoenzymes could also be further evaluated by 
measuring microsomal GST (cytsolic GST was measured in these 
investigations). Specificity for the cytosolic or microsomal GST isozyme 
involved in catalyzing the conjugation reaction could be increased by utilizing 
CEB as the substrate in an in vitro high performance liqiud chromatography 
assay for measuring GST activity. Additionally, it should be noted that a 
compound which acts as a substrate for GST does not necessarily act as an 
inducing agent.
The activities of cytochrome P450 1A and 2B enzymes also deserve 
further attention. Measurement of mRNA levels of P450 1A and 2B enzymes 
would determine the effect of CEB on transcriptional activation or stabilization 
of the mRNA. Alterations in P450 mRNA levels may occur with or without 
corresponding responses in enzyme activity.
The activity of GST and P450 enzymes at different concentrations of 
CEB should be investigated since high doses of CEB may saturate these 
enzymes and inhibit their activity. Many enzymes follow an inverted 
hyperbolic curve of activity with respect to substrate concentrations so that low  
concentrations may induce activity while high concentrations inhibit their 
activity.
Since these investigations suggest that the reactive thiol is responsible 
for the nephrotoxicity, isolation of protein-thiol adducts using radiolabelled 
CEB and affinity chromatography could identify and isolate the toxic 
metabolite. Soft nucleophiles, such as the CEB-derived thiol, readily form
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protein adducts while hard nucleophiles react with hard electrophiles like 
those found in DNA.
Finally, it is important to establish the nephrotoxic and the GSH- 
enhancing effects of CEB in renal cell culture in rats. Once the effects of CEB 
metabolism are established for in vitro studies in the rat, human cell lines may 
be investigated to assess the validity of extrapolation from rats to humans.
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APPENDIX
Confirmation of the Structure of l-Cyano-3,4-epithiobutane and 
Demonstration of the Purity of the Synthesized Product by Nuclear 
Magnetic Resonance (NMR) and Gas Chromatography (GC)
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FIGURE A.1 NMR (200 MHz) of the distilled product. NMR spectrum
is consistent with the structure of l-cyano-3,4-epithiobutane.
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FIGURE A.2 Enlarged NMR (200 MHz) spectrum of the distilled 1- 
cyano-3,4-epithiobutane. Spectrum depicts increased detail consistent with the 
structure of l-cyano-3,4-epithiobutane.
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FIGURES A.3 a and b GC traces demonstrating the purity of the 
synthesized l-cyano-3,4-epithiobutane: a) GC trace of the reaction at 
completion and b) GC trace of the distilled l-cyano-3,4-epithiobutane.
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